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ABSTRACT
The mammalian mdrl P-glycoprotein (Pgp) has been implicated in xenobiotic resistance of 
drug-resistant cell lines and tumors, and may function in excretion or exclusion of toxic 
xenobiotics at several sites within the body. Pgp gene family members are expressed in 
excretory epithelia of several aquatic taxa and may contribute to the survival o f pollution- 
tolerant aquatic animals in contaminated environments. For this reason the expression of Pgp 
family members was investigated in the livers and liver tumors of creosote-resistant 
mummichog (Fundulus heteroclitus) inhabiting a creosote-contaminated site (Atlantic 
Wood) in the Elizabeth River, Virginia. Expression of members of the Pgp gene family was 
detected by immunochemical methods using monoclonal antibody (mAb) C219. An 
immunoreactive band in the size range of mammalian P-glycoproteins was observed in 
immunoblots of liver membrane fractions and detergent extracts of mummichog liver from 
both Atlantic Wood and a reference site. Immunohistochemical staining of mummichog liver 
demonstrated this antigen on the canalicular surface of hepatocytes in normal liver similar 
to expression in mammalian and guppy liver. The levels of Pgp were 2-3 fold higher in 
immunoblots of nontumorous livers of Atlantic Wood mummichog compared with levels in 
reference site fish. Similar to results reported in mammalian liver neoplasms, Pgp was 
overexpressed and had aberrant immunohistochemical localization in the majority of 
mummichog liver neoplasms. Because mAb C219 was expected to recognize all Pgp gene 
family members expressed in mummichog, molecular techniques were used to characterize 
the individual Pgp genes expressed in mummichog liver. Reverse transcriptase-polymerase 
chain reaction (RT-PCR) was used to amplify Pgp gene transcripts. A cDNA fragment (3004 
bp) was amplified which was most similar to the recently described mammalian sister gene 
to P-glycoprotein (spgp). Northern blots showed predominant expression of this gene in 
mummichog liver. Another cDNA fragment (1713 bp) was amplified from mummichog liver 
and intestine which was a homo log of the mammalian multidrug-resistance or xenobiotic 
transporter (mdrl). These results indicate that a xenobiotic transporter may be elevated in the 
livers and liver tumors of the pollution-tolerant mummichog consistent with the proposed 
role of these proteins in xenobiotic resistance.
xiii
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
EXPRESSION OF THE XENOBIOTIC TRANSPORTER, P-GLYCOPROTEIN, 
IN THE MUMMICHOG {FUNDULUS HETEROCLITUS)
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
Chapter I: General Introduction
2
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
3Multidrug resistance and P-glycoprotein— It has been frequently observed that 
mammalian cell lines which have been selected for resistance to a single cytotoxic 
compound simultaneously become cross-resistant to many different cytotoxins (Dano, 
1972; Riehm and Biedler, 1972; Ling and Thompson, 1974). A remarkable feature of 
this multidrug-resistance (MDR) phenotype is that the resistance extends to many 
compounds which have unrelated modes and sites of activity and are structurally and 
chemically dissimilar. Although MDR cell lines have many biochemical differences 
which distinguish them from sensitive cells, a common distinctive characteristic of the 
MDR cells is high level expression of a large (170 kDa) heavily glycosylated plasma 
membrane protein (Juliano and Ling, 1976; Kartner et al., 1983). This protein was 
originally termed P-glycoprotein (Pgp). The prefix P in this case was meant to stand for 
permeability since expression of Pgp was thought to reduce the permeability o f MDR cell 
lines to cytotoxins (Ling and Thompson, 1974; Juliano and Ling, 1976). Analysis of Pgp 
cDNA sequences expressed in MDR cell-Iines showed that P-glycoproteins had similar 
deduced amino acid sequences and similar predicted domain structures to a variety of 
ATP-dependent bacterial transport proteins (Gros et al., 1986; Chen et al., 1986; Gerlach 
et al, 1986). This suggested that Pgp conferred the MDR phenotype by actively 
transporting cytotoxins outward across the plasma membrane of drug resistant cells. The 
role of P-glycoprotein as a xenobiotic efflux pump in MDR cell lines has now been well 
established (reviewed in van der Bliek and Borst, 1989; Gottesman and Pastan, 1993). 
Expression of full-length P-glycoprotein cDNAs in sensitive cell lines has been shown to
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
confer the MDR phenotype (Ueda et al., 1987; Devault and Gros, 1990). This is 
convincing evidence that high level expression of P-glycoprotein alone is sufficient to 
confer multidrug-resistance to MDR cell lines.
Resistance to multiple chemotherapeutic drugs is also characteristic of many 
human neoplasms and is a major barrier to effective treatment of many human cancers 
(Gottesman et al., 1993). Pgp expression and overexpression have been detected in many 
different human cancers and in several experimental models of rodent 
hepatocarcinogenesis (Fairchild et al., 1987; Thorgeirsson et al., 1987; Teeter et al, 1990; 
Vohm et al., 1990; Bradley et al., 1992). Consistent with the role of Pgp in conferring 
drug resistance in MDR cell lines, overexpression in human tumors has been associated 
with resistance to chemotherapy and poor prognosis (Fojo et al., 1987; Goldstein et al., 
1989; Weinstein et al., 1991; Arceci, 1993). P-glycoprotein expression may arise in 
human cancers that recur following chemotherapy (Chan et al.,1990; Miller et al., 1991). 
Because many of the antineoplastic drugs used in chemotherapy (most notably the Vinca 
alkaloids) have been used as selecting agents for MDR cell lines and are substrates for P- 
glycoprotein in these cell lines, it has been suggested that chemotherapy may select for 
resistant tumor cells that overexpress P-glycoprotein (Gottesman, 1993). However the 
causes and exact role of Pgp expression in the drug-resistance and prognosis of human 
cancers remains controversial (Kaye, 1992). Pgp overexpression has also been associated 
with tumor aggressiveness and metastasis (Weinstein et al., 1991; Bradley et al., 1992). 
Therefore Pgp overexpression may be associated with relapse and poor prognosis in 
human neoplasms because it serves as a marker of a highly malignant phenotype and may
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
5be independent o f any selection for drug resistance (Bradley and Ling, 1994).
The origin o f Pgp overexpression in experimentally induced rodent liver tumors is 
not completely understood. Some evidence from rodent hepatocarcinogenesis models 
suggests that Pgp expression may be selected for in the process of carcinogenesis 
(Fairchild et al., 1987; Thorgeirsson et al., 1987). This may occur through selective 
expansion of xenobiotic resistant preneoplastic cells in the presence of cytotoxic tumor 
promoters or carcinogens (Farber and Sarma, 1987, Thorgeirsson et al., 1987; 
Thorgeirsson et al., 1991 ). Increased Pgp expression was detected at the mRNA level in 
preneoplastic nodules in one model of rodent hepatocarcinogenesis and was associated 
with xenobiotic resistance of these lesions (Fairchild et al., 1987, Thorgeirsson et al., 
1987). However, Pgp overexpression in liver tumors was also observed without 
promotion by xenobiotics (Teeter et al, 1990; Vohm et al., 1990; Bradley et al., 1992). 
This suggests that Pgp overexpression in liver tumors may related to oncogene activation 
and tumor progression (Bradley et al., 1992; Teeter et al., 1990). Support for this idea 
comes from in vitro studies which found that transfection of rat liver epithelial cells with 
the oncogene v-H-ras induced high level expression of Pgp, and that high level 
expression of mutant p53 stimulated the promoter of the human MDR1 gene (Burt et al., 
1988; Chin et al., 1992). Both Ras mutations and p53 mutations are common in 
mammalian neoplasms including hepatocellular carcinoma (Nigro et al., 1989; Hsu et al., 
1991; Wiseman et al., 1991). Thus Pgp overexpression may be intrinsic to neoplastic 
transformation and may be independent of any selection of resistant early preneoplastic 
lesions by xenobiotics.
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In addition to expression in MDR cell lines and tumors, P-glycoproteins are 
expressed in a variety of normal tissue types. In mammals these include the apical 
surfaces o f many epithelial cells including hepatocytes, bile ductular epithelial cells, the 
epithelial cells o f the proximal convoluted tubule of the kidney, and the cells o f the 
intestinal mucosa (Thiebaut et al., 1987; Croop et al., 1989; Thiebaut et al., 1989; Teeter 
et al., 1990). Pgps are also expressed in the capillary endothelial cells forming the blood- 
organ barriers o f the testes and brain (Cordon-Cardo et al., 1989; Thiebaut et al., 1989). 
These sites o f expression along with the role o f Pgp in conferring drug resistance suggests 
that Pgp may be involved in defending against toxic compounds either through excretion 
via the bile or urine or through prevention of uptake in the intestine and blood-organ 
barriers.
Pgp expression is also found in the adrenal cortex (Theibault et al., 1987; 
Sugawara et al., 1987) and the pregnant uterus (Arceci et al., 1988). Expression in these 
locations along with the ability of Pgp to transport certain steroid hormones suggests that 
Pgp may be involved in steroid secretion or uptake in these organs (Ueda et al., 1992; van 
Kalkenetal., 1993).
These expression results are complicated by the presence two or more P- 
glycoprotein genes in all organisms that have been studied. Multiple homologs have been 
identified in vertebrates (Ling et al., 1992) in Drosophila (Wu et al., 1991; Gerrard et al., 
1993) and the nematode, Caenorhabditis elegans (Lincke et al., 1992). Recently a novel 
type of P-glycoprotein, the sister of P-glycoprotein (spgp), has been identified in the rat, 
the pig and the winter flounder (Childs et al., 1995). Thus the gene family in vertebrates
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contains two distinct categories of Pgp genes; those that code for the traditional highly 
related mdr P-glycoproteins and those that code for the sister of P-glycoprotein or spgp 
homologs (Childs et al., 1995). The number o f mdr loci in vertebrate species ranges from 
two in fish and primates to five in the pig as determined by Southern blots o f genomic 
DNA (Ling et al., 1992; Childs et al., 1995; Childs and Ling, 1996). In contrast to the 
mdr genes only a single spgp locus has been detected in the rat and the pig (Childs et al.,
1995).
The mdr genes of humans and rodents are best characterized. Humans have two 
genes termed MDR1 and MDR2 - also called MDR3 (Chen et al., 1986; van der Bliek et 
al., 1988; Chin et al., 1989). Rodents have three mdr genes termed mdr I a -also called 
mdr 3 , mdr lb  -also called mdrl, and mdr 2 in rats and mice (Gros et al., 1986; Gros et al., 
1988; Hsu et al., 1989; Devault and Gros, 1990; Silverman et al., 1991; Brown et al.,
1993). In the hamster these are known as pgpl, pgp2 and pgp3 respectively (Endicott et 
al., 1991). A summary of the rather confusing nomenclature is given in Table 1. These 
mdr genes may be classified based on whether their expression can confer drug resistance 
to sensitive cell lines when transfected with the full-length cDNAs. Expression of m drl- 
type homologs (MDR1, mdr la, mdr lb, pgpl and pgp2) have been shown to confer drug 
resistance to sensitive cells while the mdr2-type homologs (MDR2, mdr2 and pgp3) do 
not (Ueda et al., 1986; Devault and Gros, 1990; Schinckel et al., 1991).
The mdr genes of mammals are expressed in a tissue specific manner which 
suggests specific physiological functions. The mdrl-type P-glycoproteins are expressed
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8in all of the sites o f P-glycoprotein expression including the liver, intestine, kidney, 
uterus and adrenal medulla whereas mdr2-type isoforms are expressed predominately in 
the bile canaliculus o f the liver (Buschman et al., 1992; Smit et al., 1994). Other sites of 
expression of the mdr2 P-glycoprotein include skeletal muscle, the heart and spleen (Smit 
et al., 1994).
The expression patterns o f the mdrl P-glycoproteins along with the specific role 
of the mdrl forms in xenobiotic transport in multidrug resistant cell lines suggests that 
the mdrl forms are involved in the xenobiotic protective role and in steroid transport. In 
mice these putative mdrl functions appear to be partially divided between the mdrl a and 
mdr lb proteins. Predominant expression of the mdr I a gene has been detected in intestine 
and the capillary endothelial cells forming the barriers of the brain and testes whereas in 
the adrenal cortex and the uterus mdr lb  expression is highest (Croop et al., 1989; Teeter 
et al., 1990; Arceci et al., 1988; Schinkel et al., 1993). However, the sites o f expression 
of the mdr2-type P-glycoprotein and its apparent lack of involvement in multidrug- 
resistance give little information about the normal physiological function of the mdr2 
protein.
Recently strains of mice have been developed which carry homozygous 
disruptions (“knock-out”) of the mdr genes (Smit et al., 1993; Schinkel et al., 1994).
Study of these mice has provided important information on the normal physiological role 
of both the mdr2-type and mdrl-type P-glycoproteins. Observations of mdr 2 (-/-) mice 
suggested that the physiological requirement for mdr2-type P-glycoprotein in the bile 
canaliculus is in phosphatidylcholine secretion. The bile of these mice completely lacked
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
phosphatidylcholine, an important component of normal bile. These mice also developed 
liver disease which may have been caused by exposure to bile salts which are normally 
complexed into micelles with phosphatidylcholine (Smit et al., 1993). Another study 
found that mdr2 gene product expressed in yeast secretory vesicles functioned as a 
phosphatidylcholine translocase, flipping the phospholipid in a directed fashion from one 
leaflet to the other within the lipid bilayer (Ruetz and Gros, 1994). Thus evidence 
suggests that the mdr2-type P-glycoprotein may function as phosphatidylcholine 
“flippase” in the canalicular membrane of hepatocytes. Its activity is thought to increase 
the local concentration of phosphatidylcholine in the outer leaflet of the canalicular 
membrane where it is extracted into micelles by bile salts (Higgins and Gottesman, 1992; 
Smit et al., 1993; Ruetz and Gros, 1994).
Strong support for the xenobiotic-protective role of mdrl-type P-glycoproteins 
was recently provided by study of mice which have a homozygous disruption of the 
mdr la  gene (Schinkel et al., 1994). These mice were phenotypically normal and did not 
show any defect until challenged with xenobiotics. The mdr la  deficient mice were 
highly sensitive to the toxic effects of a xenobiotic (ivermectin) which is normally 
tolerated because of the functioning of the blood-brain barrier. These mice also had 
increased accumulation of ivermectin and of the MDR substrate vinblastine in certain 
organs as well as decreased elimination o f these toxic compounds. Possibly any other 
physiological requirement for functional mdr la  expression was compensated by the 
observed increased expression of the functional mdr lb  gene in these mice.
In mammals both mdrl and mdr2 expression may be regulated in part by exposure
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to xenobiotics. This regulation may be a component of an inducible response to certain 
classes of foreign compounds. Exposure to several carcinogens including the cytochrome 
P4501A (CYP1A) inducer 3-methylchoIanthrene (3-MC) has been found to increase Pgp 
mRNA (mdrlb gene transcripts) and Pgp levels in rat liver (Burt and Thorgeirsson, 1988; 
Gant et al., 1991; Thorgeirsson et al., 1991). Transcripts of the mdr2 gene as well as the 
mdr2 P-glycoprotein have also been observed to increase in the livers of monkeys 
following administration of drugs having a biliary excretion pathway (Gant et al., 1995). 
Thorgiersson and colleagues have hypothesized that Pgp gene expression is induced in 
liver by xenobiotics having biliary excretion pathways and may be a part of a coordinated 
response to xenobiotic exposure which includes induction of xenobiotic metabolizing 
enzymes such as CYP1A (Thorgeirsson et al., 1991; Gant et al., 1995).
There is as yet no information on the physiological role o f the spgp P- 
glycoprotein. However, northern blots o f RNA from rat tissues have demonstrated that 
expression of this gene is confined to liver where it is expressed along with mdr2 and 
mdrl P-glycoproteins in the bile canaliculus (Childs et al., 1996). It can be assumed that 
its role here is in excretion of an unidentified substance into the bile.
Despite the diversity of functions, the deduced amino acid sequences of all P- 
glycoproteins are well conserved and predict a highly conserved domain structure for 
these proteins. P-glycoprotein sequences are similar in sequence and domain structure to 
a large number of proteins involved in ATP-dependent transmembrane transport. These 
proteins are members of the ATP binding cassette (ABC) superfamily of transport 
proteins (reviewed in Higgins et al., 1992 and Childs et al., 1994). Other ABC
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transporters include bacterial periplasmic uptake and transport systems (Higgins et al., 
1986), bacterial exporters such as the hemolysin B exporter of E. coli (Higgins et al., 
1986), the pigment transporter products o f the white and brown genes of Drosophila 
(Dreesen et al., 1988), the yeast STE 6 mating factor transporter (McGrath and 
Varshavsky, 1989), the mammalian multidrug resistance associated transporter, MRP, 
(Cole et al., 1992) and the mammalian cystic fibrosis transmembrane conductance 
regulator, CFTR (Riordan et al., 1989). All members of this superfamily have one or two 
well conserved ATP-binding domains or cassettes of about 200 amino acids (Higgins et 
al., 1986; Hyde et al., 1990) which surround and include the Walker A and B consensus 
sequences for nucleotide binding found in the nucleotide binding folds of many proteins 
(Walker et al., 1982). They all also have one or two hydrophobic membrane spanning 
domains (Hyde et al., 1990). The ATP binding domain is believed to be involved in 
coupling the hydrolysis of ATP to the transport of the substrate across the membrane 
which may involve a conformational change that is transmitted to the membrane 
spanning domains (Hyde et al., 1990).
P-glycoproteins conform to the general ABC transporter domain structure (Figure 
1) and appear to be tandemly duplicated molecules with each half containing a 
hydrophobic domain made up of six putative transmembrane helices followed by an 
intracellular ATP- binding domain (Chen et al., 1986; Gros et al., 1986). The sequence of 
these nucleotide binding domains are well conserved among all P-glycoproteins as well 
as other ABC superfamily members. The two halves of the protein are connected by a
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highly hydrophillic region called the linker region (Chen et al., 1986). The sequence of 
this region is not well conserved overall but does contain distinctive protein kinase 
recognition sequences which may confer important differences in regulation to the 
different classes o f homologs within a species (Endicott et al., 1991; Hsu et al., 1989).
Multixenobiotic resistance and P-glycoprotein expression in aquatic 
organisms—  Because of the postulated xenobiotic protective role of mdrl-type P- 
glycoproteins in mammals, investigators have recently begun to investigate the possible 
role of Pgp in tolerance and resistance of aquatic organisms to pollutants. It has been 
observed that aquatic organisms which persist in polluted environments are exposed to 
many different toxic pollutants. These pollution-tolerant organisms must have 
physiological and biochemical mechanisms which allow them to cope with a range of 
toxic compounds which may have differing chemical and biological properties. Kurelec 
and colleagues have noted that this ability of pollution tolerant aquatic organisms to resist 
the toxic effect o f multiple unrelated toxicants is analogous to the MDR phenotype of 
mammalian cell lines. This has led to the hypothesis that the activity of P-glycoprotein 
homologs in the excretory tissues of aquatic organisms is responsible for this multi­
xenobiotic resistance (reviewed in Kurelec, 1992). In support of this multixenobiotic- 
resistance hypothesis, P-glycoprotein-like activities have been detected in excretory 
tissues of several pollution or toxin tolerant aquatic organisms including marine sponges 
(Kurelec and Pivcevek, 1992; Kurelec et al., 1992), mollusks (Kurelec and Pivcevec,
1989; Kurelec et al., 1991; Minier et al., 1993; Kurelec et al., 1995; Cornwall et al., 1995; 
Kurelec et al, 1996) and a marine worm (Toomey and Epel, 1993). All of these reports
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have relied on a competition assay for P-glycoprotein activity using the effect of the 
calcium channel blocker verapamil, a known P-glycoprotein inhibitor, on uptake of 
potential P-glycoprotein substrates by tissues or membrane vesicles o f aquatic organisms. 
Studies have shown verapamil-sensitive ATP-dependent uptake of carcinogens and the P- 
glycoprotein substrate vincristine in the presence of verapamil in membrane vesicles 
made from pollution tolerant marine sponges (Kurelec et al., 1992; Kurelec and Pivcevic, 
1992 ) and from the gills of bivalve mollusks (Kurelec and Pivcivec, 1989; Kurelec et al., 
1991). These results are analogous to those obtained in a similar assay with membrane 
vesicles of MDR cell lines and may identify the activity o f P-glycoprotein homologs in 
these organisms. Using a competitive assay with a fluorescent Pgp substrate Toomey and 
Epel (1993) have also shown P-glycoprotein-like activity in embryos of the innkeeper 
worm (Urechis caupo). Evidence from this study suggests that this activity may protect 
the innkeeper worm from toxins present in marine sediments.
Several studies have found that many important environmental contaminants 
interfere with these P-glycoprotein activities (Kurelec, 1995; Cornwall et al., 1995; 
Galgani et al., 1996). A range of moderately hydrophobic to very hydrophobic 
compounds including the important environmental contaminants pentachlorophenol,
DDT and its breakdown products, and the PCB mixture Arochlor 1254 inhibited the P- 
glycoprotein-like activity in the marine mussel, Mytilus galloprovincialis (Galgani et al.,
1996). However in a similar study using a different species o f mussel (Mytilus 
californicus) only the less hydrophobic compounds interfered with Pgp-like activity 
while the highly hydrophobic compound including Arochlor 1254 and DDT did not
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(Cornwall et al., 1995). Another study has found that a water extract of diesel fuel, and 
organic extracts of polluted river water and sediment pore water interfere with the Pgp- 
like activity in M. galloprovincialis (Kurelec, 1995). While the above results are 
consistent with some environmental contaminants being substrates for Pgp, active 
transmembrane transport of these compounds has not yet been demonstrated and 
mechanisms other than competitive inhibition may be involved.
In addition to Pgp-like activity, investigators have also detected expression of P- 
glycoprotein or related antigens in the tissues of aquatic organisms. Polyclonal 
antibodies raised against Pgp from a colchicine resistant Chinese hamster ovary cell line 
were used to label a 125 kDa glycoprotein band in immunoblots o f detergent extracts of 
two species of marine sponges (Kurelec et al., 1992). Using immunocytochemical 
staining with this antibody and a monoclonal antibody (mAb C219) which recognizes a 
conserved epitope present in all mammalian P-glycoproteins, the authors showed that Pgp 
antigens localized to the plasma membrane of the sponge cells (Kurelec et al., 1992). 
Toomey and Epel (1992) have also used mAb C219 to detect a 140 kDa protein in 
immunoblots of egg membrane fractions of the innkeeper worm and found that this 
antibody labeled a 110 kDa band in immunoblots of adult worm epidermal tissue and 
intestinal tract. Several studies have used antibodies against mammalian Pgp to examine 
Pgp expression in marine mollusks. Using the mAb C219, Minier and collaborators 
(1993) detected two bands at 220 kDa and 240 kDa in immunoblots of detergent extracts 
o f the mussel, Mytilus edulis and the oyster Crassostrea gigas. Galgani and colleagues 
(1996) reported both a 145 kDa band and the 220-240 kDa doublet in immunoblots of gill
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extracts of M. galloprovincialis probed with mAb C219. Kurelec and colleagues have 
reported a 140 kDa band in immunoblots of gills of M. galloprovincialis (Kurelec et al., 
1996) and in the marine snail Monondonta tarbinata (Kurlec et al., 1995) probed with a 
polyclonal antibody directed against a peptide from a conserved region of human MDR1 
P-glycoprotein. Cornwall and colleagues (1995) found that both mAb C219 and a 
polyclonal antibody directed against mammalian Pgp labeled a 170 kDa band in 
immunoblots of M. californicus but did not report the 220-240 kDa band seen in the other 
bivalves. Pgp expression has also been detected in aquatic vertebrates. Hemmer and 
colleagues (Hemmer et al., 1995) used a panel of anti-mammalian Pgp monoclonal 
(including mAb C219) and polyclonal antibodies in an immunohistochemical study of 
Pgp expression in the guppy. Expression of Pgp in the guppy was found to be similar to 
mammals with expression in the apical membrane of the tubular epithelia of the kidney, 
the brush border membrane of the intestinal epithelium and the canalicular surface of 
hepatocytes as well as in the corresponding adrenal-like intrarenal tissue.
There is some evidence that, as in mammals, Pgp expression and activity in 
aquatic animals may be elevated by exposure to toxicants. Increased Pgp-like activity 
and elevated levels of Pgp related antigens were detected in gills and mantle tissues of 
marine mollusks inhabiting polluted sites (Minier et al.,1993; Kurelec et al., 1995;
Kurelec et al., 1996). Increased Pgp-like activity was measured in a marine snail and a 
mussel following laboratory exposure to water polluted with fuel oil (Kurelec et al., 1995; 
Kurelec et al., 1996). In one case increased levels of Pgp antigens were detected in 
immunoblots of tissue extracts following exposure to contaminants (Kurelec et al., 1995).
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These results suggest increased Pgp expression may be an inducible response produced 
by exposure to certain contaminants. This is similar to induction of Pgp expression in 
mammalian liver by xenobiotic exposure. It has been suggested that levels o f  P- 
glycoprotein expression or activity may be correlated with the degree of tolerance or 
adaptation to toxic contaminants in a particular species of aquatic organisms (Minier et 
al., 1996; Kurelec et al., 1995).
Interpretation of data on Pgp expression in aquatic organisms is almost certainly 
complicated by the presence of multiple P-glycoprotein homologs in individual species of 
aquatic organisms. As in mammals, these homologs probably have tissue specific 
expression patterns and distinct substrate specificities. Other than one report in winter 
flounder (Chan et al., 1992), information on the Pgp genes of environmentally relevant 
aquatic organisms is absent. Two partial genomic clones have been sequenced for the 
winter flounder. One of these, JpgpA, has now been identified as being a homolog of the 
recently described mammalian sister o f P-glycoprotein (Childs et al., 1995). The 
relationship of the other winter flounder gene fragment to the mammalian genes has not 
been determined, but its sequence does not fit clearly into either the mdrl or mdr2 gene 
categories (Chan et al., 1992). No information has yet been published on tissue specific 
expression of mdr or spgp genes in fish although the immunohistochemical study in the 
guppy shows tissue and subcellular localization of total Pgp antigens that is similar to that 
of mammals (Hemmer et al., 1995). However, in this study it was not possible to 
distinguish among the different guppy Pgp isoforms.
Clarification of the role of Pgp expression and activity in resistance and tolerance
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of aquatic organisms to pollutants will require molecular and biochemical 
characterization of the individual members of the P-glycoprotein gene families in aquatic 
taxa. Initial molecular studies are needed to acquire sequence data. Even modest 
amounts of sequence data may allow certain functional inferences to be drawn based 
upon similarities to the sequences of mammalian genes o f known function. These data 
will also allow the construction of gene specific probes which may be used to investigate 
regulation of expression of the individual genes. These gene specific probes ultimately 
will be needed to screen cDNA and genomic libraries for full-length cDNA and genomic 
clones. The cDNA clones may be helpful in identifying substrates and function by 
allowing in vitro expression of the individual gene products (transfection) while the 
genomic clones may provide insight into regulation of the specific genes.
Scope of the present work— Several previous studies from our laboratory have 
focused on biochemical changes and adaptations in a small estuarine killifish, the 
mummichog (Fundulus heteroclitus) inhabiting a marsh creek heavily contaminated with 
creosote from a wood treatment facility (Atlantic Wood Industries) in the Elizabeth 
River, Portsmouth, Virginia (Figure 2) (Van Veld et al., 1991; Van Veld and Westbrook, 
1995; Armknecht, 1996). Mummichog from this site have been reported to have a high 
prevalence of hepatic neoplasms and putatively preneoplastic lesions (altered foci) as well 
extrahepatic neoplasms (Vogelbein et al., 1990; Foumie and Vogelbein, 1994). These 
lesions are presumed to result from chronic exposure to polycyclic aromatic 
hydrocarbons (PAHs) present in the creosote. The hepatic tumors of these fish have been 
characterized with respect to expression of the xenobiotic metabolizing enzymes CYP1A
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and glutathione S-transferases (GSTs) (Van Veld et al., 1991; Van Veld et al., 1992). 
These tumors were found to be similar to mammalian hepatic neoplasms and 
preneoplastic lesions in having reduced expression and activity o f CYP1A (Van Veld et 
al., 1992). In another study no increase in GST activity was observed within grossly 
visible lesions. However the entire liver of Atlantic Wood mummichog showed elevation 
of GST expression and activity (Van Veld et al., 1991). This is in contrast to mammalian 
hepatic neoplasms which have been shown to have elevated levels o f GST activity 
(Farberand Sarnia, 1987).
The most remarkable feature of Atlantic Wood mummichog is their resistance to 
the toxicity of creosote. Williams (1994) found that creosote amended sediments as well 
as sediments collected from the Atlantic Wood site were significantly more toxic to 
developing laboratory-spawned embryos of mummichog from an uncontaminated site 
(Catlett Islands, York River, Virginia, Figure 2) than to laboratory spawned offspring of 
mummichog from the Atlantic Wood site. This resistance in embryos was shown to be a 
heritable genetic trait. Atlantic Wood sediment was also observed to be more acutely 
toxic to adult mummichog collected from an uncontaminated site than to adult Atlantic 
Wood mummichog (Wolfgang Vogelbein and Peter Van Veld, unpublished 
observations). Whether this also represents genetic resistance in the adult fish or 
physiological acclimation is uncertain.
The biochemical mechanism of the resistance or tolerance of Atlantic Wood 
mummichog to creosote contaminated sediments is an active area of research in our 
laboratory. Creosote is a complex mixture of toxic xenobiotics which is predominately
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PAHs but also contains phenolic compounds and nitrogen and sulfur containing 
heterocyclic compounds (Mueller et al., 1989). Certain biochemical characteristics o f the 
livers o f Atlantic Wood mummichog may be adaptive in the presence of PAH 
contamination from the creosote. The nontumor-bearing livers of the fish from the 
Atlantic Wood site had elevated levels and activity of the phase II conjugating enzyme 
glutathione S-transferase (GST) and suppression of expression and activity o f phase I 
enzyme CYP1A (Van Veld et al., 1991; Van Veld and Westbrook, 1995; Armknecht, 
1996). Van Veld and Westbrook (1995) have pointed out that these changes are similar 
to the xenobiotic resistance phenotype of drug-resistant cell lines and mammalian 
preneoplastic and neoplastic liver lesions (Farber and Sarma, 1987). As discussed 
previously, another biochemical change associated with xenobiotic resistance is increased 
expression of Pgp. Could increased Pgp expression also be contributing to the creosote 
resistance of these fish? This idea is particularly attractive because of the potential for 
Pgp to provide a mechanism for elimination of multiple toxic lipophilic substrates as 
would be required for managing a complex toxic mixture such as creosote. Furthermore, 
what is the state of Pgp expression in the liver tumors of these fish? Is overexpression of 
Pgp another characteristic along with reduced CYP1A (Van Veld et al., 1992 ) which 
these tumors share with mammalian liver neoplasms? Such biochemical comparisons of 
cancer in fish and mammals are essential for supporting efforts to use fish as 
experimental carcinogenesis models and for understanding the biochemical basis of these 
environmental cancers. In order to begin to address these questions, preliminary work 
was required to develop methods for identification and quantitation of Pgp in
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mummichog tissues and to characterize the nature o f specific Pgp homologs expressed in 
the mummichog. Therefore the work in this dissertation extends our studies of the 
biochemical properties of the livers and liver tumors of the Atlantic Wood mummichog to 
include identification and analysis of Pgp expression and the molecular cloning and 
characterization of mummichog Pgp homologs.
Chapters II and III of this dissertation focus on the development and application 
of immunological techniques using the anti-mammalian Pgp antibody mAb C219 for 
detecting P-glycoprotein expression in mummichog liver and liver tumors. Both 
immunohistochemical and immunoblot techniques were used. The former technique 
provided useful information on the cellular and subcellular localization of Pgp antigens in 
mummichog tissues. The latter technique provided confirmation of the specificity of 
detection of Pgp by the molecular weight of the labeled band and further provided a 
means of determining relative levels of expression of Pgp between reference site fish and 
Atlantic Wood mummichog and between normal and tumorous liver of Atlantic Wood 
mummichog. The immunohistochemical staining results indicated Pgp expression in 
mummichog liver on the canalicular surface of hepatocytes similar to the localization 
reported in other vertebrates. Immunohistochemical staining of the more progressed liver 
tumors (hepatocellular adenomas and hepatocellular carcinomas) demonstrated altered 
localization and overexpression of Pgp compared to the surrounding normal tissue. This 
pattern of expression in the mummichog liver tumors is similar to that reported for 
experimentally induced rodent hepatocellular carcinoma. Immunoblot analysis o f Pgp 
expression in Atlantic Wood mummichog livers indicated elevation in the levels of Pgp
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
21
compared to the levels of Pgp in mummichog liver from an uncontaminated site. The 
causes of this elevation are uncertain but may be due to toxic liver injury, the contribution 
of overexpression in hidden tumors or induction of expression by one or more 
components of creosote. This elevation is also consistent with constitutive elevation as a 
component o f the genetic resistance of these fish.
Because the monoclonal antibody (C219) used in the above immunochemical 
studies recognizes all categories of Pgp (mdrl-type, mdr2-type and spgp), it was 
necessary to identify the categories of Pgp expressed in mummichog liver in order to 
better interpret the toxicological relevance of Pgp expression. The method of reverse 
transcriptase-polymerase chain reaction (RT-PCR) was used to amplify expressed Pgp 
sequences from mummichog liver RNA. Comparison of the acquired sequences to 
mammalian sequences was used to categorize the mummichog Pgp homologs.
Application o f the RT-PCR technique and the analysis of the mummichog Pgp sequences 
acquired in this way are discussed in Chapters IV and V of this dissertation.
Chapter IV of this dissertation reports the sequence of a fragment o f mummichog 
Pgp cDNA which is the closest homolog to the mammalian spgp P-glycoproteins. 
Northern blotting results indicated that this mRNA is moderately expressed in 
mummichog liver but not in intestine or kidney. This liver-specific expression is 
consistent with that observed for the mammalian spgp gene. The mummichog spgp P- 
glycoprotein likely contributes significantly to the signal seen in immunohistochemical 
and immunoblot detection o f Pgp in mummichog liver. The toxicological relevance of 
this protein is unknown as its function has not yet been investigated in any animal.
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However, the highly conserved sequence between teleosts and mammals and liver- 
specific expression of this gene indicate an essential function in liver as a canalicular 
transporter of an unidentified substrate.
Chapter V of this dissertation reports the sequence of a fragment of a 
mummichog mdr P-glycoprotein. Overlapping fragments of this cDNA were obtained by 
RT-PCR of mummichog liver and intestinal RNA. While sequence similarities indicated 
that this product is most similar to the mammalian and Xenopus mdr-type P-glycoprotein, 
overall sequence comparison did not clearly assign this homolog to either the mammalian 
mdrl or mdr2 categories. Concerted evolution among the mammalian Pgp genes has 
apparently greatly diminished sequence differences between the mammalian mdrl and 
mdr2 homologs over large portions of the sequence making assignment of the 
mummichog homolog difficult. However the presence of mdrl-specific protein kinase 
recognition sequences in the linker region of the deduced amino acid sequence of the 
mummichog mdr cDNA fragment establish that this is a mummichog mdrl-type P- 
glycoprotein and is likely to be a xenobiotic transporter. Amplification of this cDNA 
from both liver and intestine is consistent with the mammalian tissue specific expression 
of mdrl-type P-glycoproteins. These results indicate that mummichog liver expresses a 
xenobiotic transporter homolog. Increased expression of this protein could contribute to 
the survival of mummichog at the Atlantic Wood site. However it is not known at this 
time which of the Pgp isoforms are elevated in the liver and liver tumors of the Atlantic 
Wood mummichog.
Further work along several lines of investigation is required to determine if Pgp
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expression in Atlantic Wood mummichog has toxicological relevance and contributes to 
the tolerance or resistance of these fish to their highly contaminated environment. A 
comparison of Pgp-like activity in liver o f Atlantic Wood mummichog and reference site 
fish is necessary to corroborate expression results. The effect o f creosote and its 
components on this activity also must be investigated. Now that two mummichog partial 
cDNA sequences are available, gene specific probes may be produced to assess 
expression of the specific forms and determine which isoform is elevated in the Atlantic 
Wood mummichog. This will require cloning at least a fragment of the expected 
mummichog mdr2 homolog. These gene specific probes may also be used to further 
investigate regulation o f expression of the mummichog Pgp homologs in laboratory 
exposures of mummichog to creosote and its components and to investigate relative 
levels of Pgp forms in resistant and sensitive fish. The cDNA fragments described in this 
dissertation may also be used to screen a mummichog liver cDNA library for full-length 
sequences of mummichog P-glycoprotein mRNAs expressed in liver. The cloning of 
full-length cDNAs may allow expression of these mummichog proteins in cultured cells 
and should permit functional characterization of these gene products.
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Table 1. Nomenclature and classification of mammalian mdr genes. Alternative 
designations are given in parentheses
Pgp class human hamster mouse/rat multidrug
resistance
mdrl-type MDRl PgP I mdr la. (mdr3) yes
mdrl-type - Pgp2 mdr lb (mdr 1) yes
mdr2-type MDR2 (MDR3) Pgpl mdrl no
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Figure 1. Model of P-glycoprotein in the plasma membrane showing the domain 
structure of the protein. IN and OUT refer to cytoplasmic and extracellular side of the 
plasma membrane respectively. The protein is made up of two similar halves connected 
by a poorly conserved hydrophillic segment (Linker). The first extracellular loop of the 
N-terminal half contains the glycosylation sites (branched structure). Each half of the 
protein contains a transmembrane domain (TMD) made up of six membrane spanning 
helices. Each half also has an ATP binding cassette (ABC) which contains a highly 
conserved ATP binding fold (circled) within which are the Walker motifs (A and B) 
found in a variety of nucleotide binding proteins.
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Figure 2. Map of the lower Chesapeake Bay and tributaries showing the locations o f the 
creosote contaminated site (Atlantic Wood, AW) and the two uncontaminated reference 
sites (King Creek, KC and Catlett Islands, Cl) discussed in this work.
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INTRODUCTION
P-glycoprotein expression in mammals—  P-glycoprotein (Pgp) is a membrane 
transport ATPase that plays a role in efflux of cytotoxic agents from multidrug-resistant 
(MDR) mammalian cell lines (Kartner et al., 1983; van der Bliek and Borst, 1989, 
Gottesman and Pastan, 1993). The MDR phenotype arises in cell lines selected for 
resistance to one cytotoxic agent. These cells are cross-resistant to a variety o f other 
toxicants with differing structures and modes of action. A consistent biochemical change 
in these cell lines is increased expression o f P-glycoprotein (reviewed in van der Bliek 
and Borst, 1989; Gottesman and Pastan, 1993). Studies of accumulation and efflux of 
labeled Pgp substrates in MDR cell lines indicate that Pgp expression is associated with 
decreased accumulation and increased ATP dependent efflux of drugs in these cells 
(Hamada et al., 1988; Horio et al 1988). Although drug-resistant cell lines often have 
many biochemical alterations that distinguish them from sensitive cells, transfection of 
sensitive cells with full length cDNA clones of Pgp transcripts has been found to be 
sufficient to confer dmg resistance (Ueda et al., 1987; Devault and Gros, 1990). This is 
convincing evidence that overexpression of Pgp alone is sufficient to confer the MDR 
phenotype.
Since the initial discovery of Pgp in MDR cell lines, normal tissues have been 
found to express Pgp. The apical surface of many excretory epithelia including those of 
the intestine, liver and kidney show Pgp expression (Thiebaut et al., 1987; Thiebaut et al., 
1989; Bradley et al., 1990). This pattern of expression along with the role of Pgp in 
efflux of cytotoxins from cell lines suggests that the normal role of Pgp may be the
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excretion of endogenous or exogenous toxic compounds or their metabolites. Pgp may 
therefore represent a line o f defense against toxic compounds. Up regulation o f Pgp 
expression could be an adaptive response of organisms to toxicants. In the liver o f  the 
rat, Pgp mRNA levels increase following exposure to many xenobiotics including some 
of the classic P450 inducers (Burt and Thorgiersson, 1988). Thus it is possible that Pgp 
expression in mammals may be a part of the inducible xenobiotic response pathway that 
includes the phase I and phase II xenobiotic metabolizing enzymes (Burt and 
Thorgeirsson, 1988; Thorgeirsson et al., 1991). Although there are many hints that the 
normal function of Pgp is elimination of xenobiotics or toxic metabolites, the normal 
substrates for Pgps are unknown, and the relevance of these proteins to toxicology 
remains uncertain.
In addition to expression in normal tissues, Pgp expression and overexpression are 
seen in human and animal neoplasia. Overexpression of Pgp occurs in a number o f 
human neoplasms derived from a variety of tissue types (Miller et al., 1987; Fojo et al., 
1987; Chan et al., 1990; Goldstein et al., 1990; Weinstein et al., 1991; Gottesman, 1993). 
In many human tumors Pgp expression is associated with resistance of the tumors to 
chemotherapy and poor prognosis (Chan et al., 1990; Weinstein et al., 1991; Gottesman 
et al., 1993). Some cases o f overexpression are associated with tumors that recur 
following chemotherapy (Chan et al., 1990; Miller et al., 1991). Chemotherapy may 
select for tumor cells that are resistant because of Pgp overexpression (Gottesman, 1993). 
Pgp overexpression has also been observed in several different laboratory models of 
rodent hepatocarcinogenesis (Fairchild et al., 1987; Thorgeirsson et al., 1987; Teeter et
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al., 1990; Bradley et al., 1992). Evidence from one model suggests that Pgp 
overexpression occurs early in carcinogenesis and is related to promotion of xenobiotic 
resistant preneoplastic liver lesions (Fairchild et al., 1987; Thorgeirsson et al., 1987). 
Other evidence suggests that Pgp overexpression in hepatocellular carcinoma may arise 
without promotion by xenobiotics (Teeter et al., 1990; Bradley et al., 1992).
P-glycoprotein expression in aquatic animals—  Because of the importance of 
Pgp in conferring MDR, there is interest in the role that Pgp expression may play in 
tolerance or resistance o f aquatic organisms to toxicants. Pgp expression and activity 
have been detected in tissues o f a number of aquatic organisms (Kurelec and Pivcivec, 
1991; Kurelec and Pivcivec, 1992; Kurelec et al., 1992; Kurelec 1992; Toomey and 
Eppel, 1993; Minier et al., 1993). Kurelec and co-workers have hypothesized that certain 
strains or species of aquatic organisms that are tolerant of pollutants may be so because of 
the presence and activity o f Pgp homologs (reviewed in Kurelec, 1992). They suggest 
that chemical pollutants or natural toxins may be excluded from these organisms by the 
externally directed pumping activity of Pgp homologs in epithelial tissues. They have 
termed such a mechanism "multixenobiotic resistance" (MXR) since, by analogy to the 
MDR phenotype, such organisms may show cross-resistance to a variety of structurally 
unrelated toxicants.
Although the above studies suggest a role for Pgp in resistance or tolerance to 
toxicants, the significance of Pgp expression in aquatic organisms is not clear. Additional 
studies are needed to establish whether differences in relative levels of Pgp expression or 
activity are associated with sensitivity of aquatic organisms to toxicants. There is also a
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need for the development of methods that would allow measurement of Pgp expression in 
aquatic organisms.
We are currently investigating expression of Pgp in the liver of the mummichog, 
Fundulus heteroclitus, a small estuarine killifish. Our study site in the Elizabeth River, 
Virginia is heavily contaminated with polycyclic aromatic hydrocarbons (PAHs) derived 
from creosote (Vogelbein et al., 1990). High prevalences o f hepatic (Vogelbein et al., 
1990) and extra-hepatic neoplasms (Foumie and Vogelbein, 1994; Vogelbein and 
Foumie, 1994) have been reported in mummichog from this site. This situation gives us 
a unique opportunity to study both the response of Pgp expression to environmental 
exposure to PAHs in fish liver and to examine alterations in Pgp expression occurring in 
neoplastic and putative preneoplastic lesions during environmental hepatocarcinogenesis 
in fish.
The purpose of this Chapter is to describe protocols that we have developed for 
the immunochemical detection of Pgp expression in fish tissues, primarily liver and liver 
tumors. These methods should be applicable to other fish tissues and possibly tissues of 
other aquatic organisms as well. Detailed protocols are given for both 
immunohistochemical staining and immunoblotting procedures. Whenever possible we 
use both techniques because of the complementary information that can be derived from 
each.
MATERIALS REQUIRED
Where manufacturers are not given, materials are readily available from many sources.
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Pgp Immunohistochemistry
1. Staining rack and jars: (Shandon, Tissue Tek II).
2. PAP pen: (Research Products International, Mount Prospect IL, cat. no. 195500).
3. Ethanol: 100%, 95% and 70%.
4. Xylene.
5. Elite Avidin-Biotin Complex (ABC) immunohistochemical staining kit, murine: 
(Signet Laboratories, Dedham MA, cat. no. 2158).
6. Normal Horse Serum: (Sigma, cat. no. H0146).
7. Bovine Serum Albumin (BSA), Fraction V: ( Sigma, cat. no. A9647).
8. 3,3'-Diaminobenzidine Substrate Tablets: (Sigma, cat. no. D4168).
9. Permanent Mounting Medium: (Preservaslide, EM Science, or equivalent).
10. Phosphate Buffered Saline (PBS): (10 mM sodium phosphate, pH 7.4, 150 mM
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NaCl). This is prepared as a 1 OX stock. 14.2 g of anhydrous dibasic sodium 
phosphate and 87.7 g o f NaCl are added to 900 ml of deionized water. The pH is 
adjusted to 7.4 with 6 M NaOH. The volume is then made up to 1 I with 
deionized water. The solution is sterilized by filtration (0.2 pm) and stored at 
room temperature. The 10X stock is diluted with 9 parts deionized water 
immediately before use.
11. Blocking Solution: (10% normal horse serum, 0.02% sodium azide in 1 X PBS). 
This solution can be divided into aliquots and stored at - 20° C.
12. 3% Hydrogen Peroxide: This solution must be prepared fresh daily by dilution of 
1 part 30% hydrogen peroxide into 9 parts deionized water.
13. Antibody Buffer: (1% w/v BSA, 0.02% w/v sodium azide in 1 X PBS). This 
solution is stored at 4° C. It is stable for at least 2 weeks.
14. C219 mAb: (Signet, cat. no. 2158). This reagent is provided lyophilized (100 pg) 
by the manufacturer. It is diluted with 1 ml of antibody buffer and stored frozen 
(-70° C) in 20 pi aliquots. For immunohistochemistry, aliquots are diluted 
immediately before use with 1.3 ml of antibody buffer (1% BSA in PBS).
15. Mouse Myeloma (UPC 10) Protein (IgG 2a,K): (Sigma, cat. no. M 9144). The
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lyophilized protein is diluted to 1.5 pg/ml with antibody buffer and stored in I ml 
aliquots at -20° C.
16. Harris Hematoxylin: 5 g of hematoxylin powder (Fisher Scientific, cat. no. H345)
is dissolved in 50 ml of 95% ethanol. 100 g of potassium alum is dissolved in 
1000 ml of deionized water in a 2 liter Erlenmeyer flask on a heating stirplate.
The hematoxylin solution is added to the alum solution, and the mixture is 
brought to a boil while stirring. 2.5 g of mercuric oxide is carefully added to the 
hot solution. The solution is heated until a deep purple color is obtained and then 
is cooled by plunging the flask into cold water. It then is filtered and stored at 
room temperature. The solution is filtered before each use. The stain is stable for 
several months at room temperature.
Immunoblotting
1. Power Homogenizer. We use an electric drill (Sears Roebuck Co., model 15 
315.10042) mounted in a drill press stand (Sears model 25921) to drive a 2 ml 
Potter-Elvehjem tissue grinder (Wheaton, no. 358003).
2. Vertical Slab Gel Electrophoresis Apparatus, MiniPROTEAN II: (Bio-Rad, cat. 
no. 165-2940).
3. Electrophoretic Transfer Apparatus, Mini Trans-Blot: (Bio-Rad, cat. no. 170-
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3935).
4. Electrophoresis Power Supply: (Bio-Rad, Model 200/2.0, cat. no. 165-4761).
5. Nitrocellulose Membranes: (Bio-Rad, cat. no. 162-0147).
6. 40% Acrylamide Stock (37.5:1, Acrylamide:Bis-Acrylamide): (Fisher Scientific, 
cat. no. BP 1410-1).
7. C219 mAb: (Signet, cat. no. 2158). For immunoblotting, the lyophilized mAb 
(100 (ig) is dissolved in 40 ml immunoblot antibody dilution buffer (see below), 
divided into two aliquots and stored at - 20° C. Each aliquot can be saved after 
use, frozen and used again at least ten times.
8. Goat Anti-Mouse IgG Alkaline Phosphatase Conjugate: (Bio-Rad, cat. no. 170- 
6520). The undiluted conjugate is stored at 4° C. Immediately before use the 
conjugate is diluted 1:3000 with immunoblot antibody dilution buffer.
9. Lysis Buffer Stoct. 6.06 g tris(hydroxymethyl)aminomethane (Tris) (Sigma, cat. 
no. T-8524), 8.77 g NaCl, 1.86 g disodium ethylenediaminetetraacetate (EDTA) 
(Sigma, cat. no. E-4884), 10.0 g sodium deoxycholate (Sigma, cat. no. D-6750),
1.0 g sodium dodecyl sulfate (SDS)(Sigma, cat. no. L-4390) and 10 ml Triton X-
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100 (Sigma, cat. no. X-100) are dissolved in 800 ml deionized water. The 
solution is adjusted to pH 7.4 with 6 M HC1. The volume is made up to 960 ml. 
The buffer is stored at 4° C. Just before use, the volume of lysis buffer required is 
prepared in a tube on ice by adding the protease inhibitors from stock solutions.
10. Protease Inhibitor Stocks:
N-p-tosyl-L-arginine methyl ester HC1 (TAME): (Sigma, cat. no. T 4626). A 
stock solution of 38 mg/ml in deionized water is prepared fresh before use.
Penylmethylsulfonyl flouride (PMSF): (Sigma, cat. no. P 7626). PMSF is 
dissolved at a concentration of 10 mg/ml in 100% 2-propanol. The solution is 
stable for several months at room temperature.
Aprotinin solution (10 units/ml): (Sigma, cat. no. A 6279). This stock is used as 
is from the producer.
Leupeptin: (Sigma, cat. no. L 2023). Leupeptin is dissolved in deionized water at 
5 mg/ml. The solution is divided into 20 pi aliquots and is stored at - 20° C.
11. I X  Lysis Buffer. (50 mM Tris HC1, pH 7.4,150 mM NaCl, 1% v/v Triton X-100, 
1% w/v sodium deoxycholate, 0.1% w/v SDS, 5 mM EDTA, containing freshly
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added 2% v/v aprotinin solution, 380 pg/ml N-tosylamido-L-arginine methyl 
ester, 100 (ig/ml phenylmethylsulfonyl fluoride, 10 pg/ml leupeptin). The 
following are mixed in a tube on ice immediately before use.
Aprotinin solution (10 U/ml) 0.200 ml
TAME (38 mg/ml) 0.100 ml
PMSF (10 mg/ml in 2-propanol) 0.100 ml
Leupeptin (5 mg/ml) 0.020 ml
Lysis Buffer Stock 9.6 ml
12. Electrode Buffer: (25 mM Tris, 192 mM glycine, 0.1% w/v SDS). This is made 
as a 5X stock containing 15 g Tris base, 72 g glycine and 5 g SDS per liter of 
solution. The pH of the 5X buffer is near 8.5. The pH should not be adjusted 
with acid or base as this will increase the electrical conductivity. 5X electrode 
buffer is diluted with 4 parts water before use.
13. I M Tris HCl, p H 6.8: This buffer is stable for several months at 4 °C.
14. 1.5 M  Tris HCl, p H 8.8: This buffer is stable for several months at 4 °C.
15. 10%  w/v SDS: This is stored at room temperature.
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16. 1 MDithiothreitol (DTT): This is divided into aliquots and stored at -20° C.
17. 10%  w/v Ammonium Persulfate (10% APS): 100 mg of APS is added to 1 ml of 
deionized water. This solution is prepared fresh daily.
18. N,N,N',N'-Tetramethylethylenediamine(TEMED): This is used undiluted from the 
bottle.
19. SDS Sample Buffer: (60 mM Tris-Cl, pH 6.8,2% w/v SDS, 10% v/v glycerol, 
0.025% bromphenol blue, 100 mM dithiothreitol). This is prepared as a stock 
without the reducing agent dithiothreitol (DTT). The stock is stable at room
temperature.
Water 24.5 ml
1.0 M Tris, pH 6.8 3.0 ml
10% SDS 10.0 ml
Glycerol 5.0 ml
0.5% Bromphenol blue 2.5 ml
Just before use, 100 pi of 1 M DTT is added to every 0.9 ml of sample buffer 
needed for the experiment.
20. Resolving Gel (5.6 %> total acrylamide): This is made in a 15 ml disposable
screwcap tube. This recipe makes enough for two mini-gels (0.075 cm X 8.0 cm
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X 7.3 cm).
Water 5.9 ml
40% Acrylamide stock 1.4 ml
1.5 M Tris, pH 8.8 2.5 ml
10% SDS 0.1ml
Just before pouring, 100 pi of 10% APS and 8 pi of TEMED are added. The tube 
is mixed by inversion, and the gels are poured immediately.
21. Stacking Gel (3% total acrylamide): This is made in a 15 ml disposable tube.
This recipe makes more than enough for two 1 cm stacking gels for the mini-gels.
Water 2.34 ml
40% Acrylamide stock 0.225 ml
1 M Tris, pH 6.8 0.375 ml
10% SDS 0.030 ml
Just before pouring, 30 pi o f 10% APS and 3 pi TEMED are added. The tube is 
mixed by inversion, and the gels are poured immediately.
22. Tris Buffered Saline (TBS): (20 mM Tris HCl, pH 7.5,0.5 M NaCl). This buffer
is prepared as a 1 OX stock. 24.2 g of Tris and 292.2 g of NaCl are dissolved in 
800 ml of deionized water. The pH is adjusted to 7.5 with 6 M HCl. The volume 
is made up to 11 with deionized water. The buffer is sterilized by filtration (0.2 
pm) and is stored at room temperature. Before use, the 10X buffer is diluted with 
9 volumes of deionized water.
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23. Tris Buffered Saline with Tween 20 (TTBS): (IX  TBS + 0.05% v/v Tween-20 
(Sigma, cat. no. P-9416)). This buffer is usually made up fresh for each run. 
About I I is required.
24. Transfer Buffer: (25mM Tris, 192 mM glycine, 20% v/v methanol). This buffer is 
made up for each run (1 1) and is chilled before use. 14.4 g glycine (Sigma, cat. 
no. G-7032) and 3.0 g Tris are mixed with 200 ml methanol. The volume is made 
up to 1 I with deionized water. As with SDS-PAGE electrode buffer, the pH 
should be around 8.5 and should not be adjusted with acid or base.
25. Blocking Buffer: (5% w/v nonfat dry milk, 0.02% sodium azide in TTBS). This 
buffer is stable for at least two weeks at 4° C.
26. Immunoblot Antibody Dilution Buffer: (1% nonfat dry milk, 0.02% sodium azide 
in TTBS). This buffer is stable for at least two weeks at 4° C.
27. Alkaline Phosphatase Buffer (AP Buffer): (lOOmM Tris HCl, pH 9.5, 100 mM 
NaCl, 50mM MgCU). 12.1 g of Tris and 5.8 g of NaCl are dissolved in 900 ml of 
deionized water. The pH is adjusted to 9.5 with 6 M HCl before adding 10.0 g o f 
MgCl2-6H20 . The volume is then adjusted to 1 1 with deionized water. This 
buffer is filter sterilized (0.2 pm) and stored at room temperature.
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28. 5-Bromo-4-chloro-3-indolyl-phosphate, toluidine salt (BCIP'): (50 mg/ml in N,N- 
dimethylformamide, Boehringer Mannheim, cat. number 1383 221). This 
solution is stored at -20° C.
29. 4-Nitro blue tetrazolium chloride (NBT): (100 mg/ml in 70% v/v N,N- 
dimethylformamide, Boehringer Mannheim, cat. no. 1383 213). This solution is 
stored at -20° C.
30. Alkaline Phosphatase Substrate Solution: 45 pi NBT stock solution and 35 pi
BCIP are added to 10 ml of AP buffer. This solution is unstable and light 
sensitive. It should be prepared immediately before use.
31. TE: (10 mM Tris HCl, pH 8.0, ImM EDTA). This buffer is filter sterilized (0.2
pm) and stored at room temperature.
METHODS
For both immunoblotting and immunohistochemical staining we have used the 
monoclonal antibody (mAb) C219. This mAb was originally raised against membrane 
fractions from MDR Chinese hamster ovary cells (Kartner et al., 1985). C219 recognizes 
a highly conserved linear epitope which is found in all Pgp deduced amino acid 
sequences including the only published fish sequences (Georges et al., 1990; Chan et al., 
1992). This epitope is denaturation resistant which makes the mAb useful both in
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immunoblots and in immunohistochemical staining on formalin-fixed paraffin-embedded 
tissues.
Method I: Pgp Immunohistochemistry
Immunohistochemical staining provides information on Pgp expression at the 
cellular and subcellular levels. Relative levels of expression in different cell types can be 
compared on the same slide within the same section. However, variability from slide to 
slide and from block to block makes this technique difficult to use for quantitative 
comparisons of expression between individuals. More quantitative information can be 
obtained from immunoblots (see below).
Several controls are necessary to avoid artifacts in this technique. It is standard 
practice to include both a positive and a negative control on each slide in the form of a 
tissue that is known to express Pgp and one that does not. It is also important to incubate 
sections with an irrelevant antibody to control for nonspecific binding of IgG. For our 
studies mummichog liver sections serve as both positive and negative tissue controls 
since these contain cell types that express Pgp (hepatocytes) and cells that apparently do 
not such as red blood cells. For an antibody control we use a matched isotype mouse 
myeloma protein (IgG2a, kappa) at the same dilution as C219 (1.5 (ig/ml). The irrelevant 
antibody control can be performed on the adjacent section on the same slide if the 
sections are circled with a PAP pen (Research Products International). This pen deposits 
a hydrophobic film on the slide which will retain the antibody solutions on the section 
and prevent spill-over between sections.
We have developed the immunohistochemical staining protocol for use with
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Bouin's fixed paraffin-imbedded tissues. This has allowed us to examine much of the 
archival material from past histopathological studies when we have routinely fixed 
specimens in Bouin's fluid. Other fixatives, such as neutral buffered formalin, should 
give similar results.
Whenever fresh material is used, sub-samples of normal liver and tumors are 
taken and frozen immediately in liquid nitrogen for analysis by immunoblot (see below). 
The remaining tissue is fixed and rinsed as follows. Tissues are fixed in Bouin's fluid 
(Luna, 1968) for 18-24 hrs. The fixed specimens are rinsed in running tap water 
overnight and are then soaked in several changes of Li2C 03 saturated 50% ethanol to 
remove soluble picrates. Specimens are then stored in 70% ethanol prior to processing.
The Signet ABC reagents in conjunction with mAb C219 are used for detection of 
antigen. Biotinylated horse anti-mouse IgG is used as a secondary antibody. Bound 
secondary antibody is detected with an avidin-biotinylated horseradish peroxidase 
complex (ABC). 3,3' diaminobenzidine (DAB) and hydrogen peroxide are used as 
chromogenic substrates.
The following procedure begins with 5 pm thick paraffin-embedded tissue 
sections adhered to slides with gelatin. A section from each specimen is also stained with 
hematoxylin and eosin (H&E) to allow histopathologic diagnosis o f any lesions present. 
Processing of small fish for histopathological studies has been described by Foumie and 
colleagues (1996).
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Procedure
This procedure is most easily carried out with the aid of a hand staining rack 
(Shandon, TissueTek II) to hold the various baths. A humidity chamber is required for 
the antibody incubations. Plastic food storage boxes with tight fitting lids work well for 
this purpose. The bottom of the box is covered with several layers of wet paper towels or 
other bibulous paper (Whatman 3MM or similar).
Tissue sections on slides are deparaffinized and rehydrated by the following series 
of baths: xylene, 2 changes, 5 minutes each; 100% EtOH, 2 changes, 3 minutes each;
95% EtOH, 2 changes, 3 minutes each, deionized water, 2 changes, 2 minutes each 
followed by a 5 minute bath in deionized water. Then slides are transferred to PBS for 5 
minutes. Endogenous peroxidase activity in the sections is then blocked by a bath in 3% 
hydrogen peroxide for 5 minutes. The slides are returned to the PBS bath for 5 more 
minutes. Slides are removed from the PBS, and the area surrounding the sections is 
wiped dry. The section is circled with a PAP pen. This deposits a ring of hydrophobic 
material around the specimen and serves as a well to retain the antibody solutions on the 
specimens.
The slides are placed in the humidity chamber and a solution of 10% (w/v) normal 
horse serum in PBS is applied to each section using a transfer pipet. In this and all 
subsequent steps, enough solution is applied to completely fill the ring made by the PAP 
pen and form a bead of solution over the section. The sections are blocked with the horse 
serum for 1 hour at room temperature. The slides are then held upright and tapped to 
remove excess blocking solution. The primary antibody solution (C219, 1.5pg/ml in PBS
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
4 7
containing 1% BSA) is applied and the slides are incubated in the humidity chamber 
overnight (18 hrs.) at 4° C.
The following morning the ABC reagent is prepared according to the 
manufacturers instructions. This solution must be prepared fresh daily and requires a 30 
minute incubation at room temperature before use to insure complete complex formation. 
The slides are tapped to remove the primary antibody solution and then are rinsed with 
PBS by gently flooding the surface of the slide several times using a transfer pipet. The 
biotinylated secondary antibody (biotinylated horse anti-mouse, used at the kit 
concentration) is then applied to the sections, and the sections are incubated in the 
humidity chamber at room temperature for 20 minutes. The secondary antibody solution 
is tapped off, and the slides are rinsed with PBS. The sections are then incubated with the 
ABC reagent for 20 minutes at room temperature. During this incubation the DAB/H20 , 
(SYgmaFast, Sigma) solution is prepared. After rinsing the slides with PBS, the DAB 
solution is applied to the sections, and the reaction is allowed to proceed for 3-5 minutes. 
The reaction is quenched by rinsing the slides with deionized water. The slides are then 
given a 5 min. tap water rinse, and are counterstained by dipping them for 3-5 seconds in 
Harris' hematoxylin. The sections are then differentiated in saturated, aqueous NaHC03 
for 2 minutes. The slides are rinsed in tap water and dehydrated through graded alcohols 
to xylene. The sections are coverslipped using synthetic mounting media (Preservaslide, 
EM Science).
Method II: Immunoblot analysis of tissue extracts
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Immunoblotting provides both a means of quantifying Pgp expression and a check 
on specificity o f detection. Immunoblots have been used frequently to assay expression 
of Pgp in mammalian organs and tumors (Richert et al., 1988; Lieberman et al., 1989; 
Fredericks et al., 1991). In these studies crude membrane fractions or microsomes are 
prepared to generate a Pgp enriched sample. The small size of tissues and especially 
tumors from small fishes makes this approach of limited use for our application. We 
routinely use detergent lysates (modified RIPA lysis buffer) of unfractionated organ and 
tumor samples in immunoblots. This greatly simplifies sample preparation and, in our 
system, results in sufficient Pgp signal on the blots.
Immunoblots can provide supporting evidence that the signal seen in 
immunohistochemistry results from Pgp expression and not from an unrelated cross- 
reactive protein. The expected molecular weight for Pgps is in the vicinity of 170 kDa 
(Kartner et al., 19832). In addition, known Pgps are heavily glycosylated and are 
expected to produce a somewhat diffuse band in an immunoblot due to 
microheterogeneity in glycosylation (Richert et al., 1988). A single band in immunoblots 
in this molecular weight range and of this characteristic appearance is consistent with 
specific detection of Pgp.
We use pre-stained, calibrated molecular weight standards for SDS-PAGE (Bio- 
Rad, cat. no. 161-0309) in our immunoblots. These give visible molecular weight 
markers on the membrane following transfer. They also provide a check on transfer 
efficiency, thus eliminating the need to stain the nitrocellulose membrane for total protein 
following transfer.
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Usually a Pgp positive control sample is loaded with each run. We use extracts o f 
the colchicine resistant CHRC5 cell line (a generous gift from Dr. Victor Ling, Ontario 
Cancer Institute) for this purpose. Extracts of any convenient mammalian tissue known 
to have a high level o f expression of Pgp should also be useful for this (e.g. adrenal 
gland).
Densitometric scans of immunoblots can be used to quantify relative levels of 
expression between individuals with different exposure histories or between tumor and 
normal tissue. For this purpose it is necessary to load several different amounts o f a Pgp 
standard. This can be prepared from the tissues of interest (e.g. pooled mummichog liver 
extract) or can be made from any convenient source of Pgp. The different loadings of the 
Pgp standard are used to form a standard curve of densitometric peak area versus total 
protein. It is important that standards and samples fall within the linear range of this 
assay. In our blots using mummichog liver extracts as a standard, this range is usually 
between 1 and 20 pg of total protein per lane.
The following procedure is used in our laboratory for extraction o f Pgp from mummichog 
liver and liver tumors and subsequent analysis and quantitation of expression by 
immunoblotting. We use the traditional Laemmli discontinuous sodium dodecyl sulfate- 
polyacrylamide gel electrophoresis (SDS-PAGE) system (Laemmli, 1970) followed by 
'wet1 electrophoretic transfer to nitrocellulose membranes (Towbin et al., 1979). Pgp is 
detected on the membrane using an indirect technique. The mAb C219 is incubated with 
the membranes. Bound C219 is detected with alkaline phosphatase conjugated goat anti­
mouse IgG followed by reaction with NBT/BCIP.
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Procedure
a. Preparation o f  Tissue Extracts— Fish are anesthestized by placing them in a 
bath o f tricane methanesulfonate (200 mg/1 in seawater). Fish are then killed by cervical 
transection. Samples o f liver or other tissues are excised as quickly as possible and either 
used immediately or snap frozen in liquid nitrogen and stored at -70° C. Homogenization 
of soft tissues such as liver is accomplished in a teflon-glass homogenizer powered by a 
electric drill motor. The sample is allowed to just thaw and is placed in the prechilled (on 
ice) teflon glass homogenizer (Potter-Elvejehm type) containing 5 volumes of cold lysis 
buffer. The tissue is homogenized by 3 up and down strokes at full speed.
The resulting crude homogenate is transferred to a 1.5 ml polypropylene 
microcentrifuge tube and is spun at full speed for 5 minutes in a microcentrifuge 
(Eppendorf, model 5415) in the cold. The homogenate separates into three layers during 
centrifugation; a floating layer o f lipid material, a layer of clear supernatant and a pellet 
of insoluble tissue debris plus nuclear DNA. The lipid layer is carefully removed with a 
cotton tipped applicator. The supernatant is then transferred to a fresh tube on ice. The 
clear lysate can be stored frozen at -70° C at this stage or can be used immediately in 
immunoblots.
Protein concentrations are determined using a modified Lowry assay that is 
compatible with the detergents in the lysis buffer (Bio-Rad, Dc Protein Assay, cat. no. 
500) using BSA as a standard.
b. SDS-PAGE— Samples are resolved on discontinuous SDS-PAGE Laemmli 
gels using the Bio-Rad Miniprotean II apparatus. We use resolving gel concentration of
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5.6% total acrylamide and a 3% stacking gel with the standard buffer. We find it 
unnecessary to degas the gels if  the concentration of ammonium persulfate in the gel 
recipes is increased to 1%. Gels are prepared from a 40% acrylamide stock solution 
(acrylamide:bismethylene acrylamide ratio 36.5:1). The electrophoresis apparatus is 
assembled according to the manufacturer's instructions. The resolving gel is prepared and 
is poured between the plates using a 10 ml pipet to within 1 cm of the bottom of the gel 
comb. The gel is then immediately overlain with 0.5 ml of deionized water using a 
syringe needle. The resolving gel is allowed to polymerize for 30 minutes. The water 
overlay is poured off, and the residual liquid is blotted out with filter paper. The stacking 
gel is prepared and poured with the comb in place. After another 30 minutes the combs 
are removed, and the gel sandwiches are set up in the electrophoresis box according to the 
manufacturer's instructions.
While the gels are polymerizing, the samples are prepared for electrophoresis. 
Samples are thawed and kept on ice at all times. Each sample is diluted with Laemmli 
sample buffer to a final protein concentration of 0.5 to 2 pg/pl. Samples are heat 
denatured in a 65° C water bath for four minutes and then placed on ice until they are 
loaded onto the gel. (Note: Higher denaturation temperatures result in polymerization of 
Pgp.) Usually between 1 and 20 pg o f total protein per lane is loaded in a 10 pi volume of 
sample buffer for mummichog liver samples. Samples are loaded with a Hamilton 
syringe. Using the small well combs of the minigel apparatus, up to 15 pi of sample can 
be loaded in each well. Normally a lane of molecular weight standards and a lane 
containing a Pgp positive control sample are also loaded.
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The gels are run at 200 V (constant voltage) at room temperature until the dye 
front just reaches the bottom of the gel. This takes about 30 minutes.
c. Electrophoretic Transfer to Nitrocellulose Membranes— At the end of the run, 
the gel sandwiches are disassembled. The somewhat fragile gels are best manipulated 
while still stuck to the glass plate. Each sandwich is held horizontally with the large plate 
down, and the small plate is gently pried off using one of the spacers. Usually the gel 
remains stuck to the large plate. The stacking gel is cut off of each gel and is discarded. 
This is easily accomplished using one of the gel spacers to gently pull this stacking gel 
away. The first lane of each gel is marked by cutting off the comer of the gel over the 
first lane. If two gels are run at the same time they may be identified by cutting different 
sized pieces from each one.
Each gel is gently floated off of its plate by dipping the plate with the attached gel 
in a plastic dish containing 100 ml of transfer buffer until the gel slides into the dish. The 
gel is washed in transfer buffer for 20 minutes at room temperature with gentle agitation.
The blotting materials are prepared while the gels are equilibrating. The 
nitrocellulose membranes are cut to a size slightly larger than the gels. These are then 
soaked in transfer buffer. Four sheets (per gel) of chromatography paper (Whatman 
3 MM) cut to the size of the transfer cassette are also soaked in cold transfer buffer. After 
20 minutes the transfer buffer is carefully poured off of the gels and replaced with 100 ml 
of fresh transfer buffer. The gels are now ready to be placed in the transfer cassette.
The cassette is placed cathode side (black side) down in a baking dish containing 
a few cm of cold transfer buffer. One of the porous plastic pads provided by the
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
manufacturer (a rectangular plastic scouring pad also works) is placed in the dish and any 
bubbles are forced out. The saturated pad is placed on top of the cathode side o f the 
transfer cassette. The gel is then moved onto a stack o f two sheets of saturated paper by 
submerging the papers in the dish containing the gel and floating the gel onto the center 
of the paper stack. The papers and the gel are then placed on top of the plastic pad in the 
transfer cassette. All air bubbles are carefully removed from beneath the gel and the 
blotting paper by rolling a test tube over the surface of the gel. The pre-wetted 
nitrocellulose membrane is then placed on the gel, and all air bubbles are removed as 
before. The transfer sandwich is completed by placing two more sheets of buffer- 
saturated paper on top of the nitrocellulose followed by another saturated plastic pad.
The cassette is then placed in the slot in the transblot device. The ice pack is placed next 
to it, and the buffer chamber is filled with cold transfer buffer. About 1 1 of buffer is 
required for each run. The assembled transfer chamber is placed in a chromatographic 
refrigerator (4° C). The gels are transferred for 16-18 hours at 34 V (constant voltage). 
Under these conditions, the apparatus draws about 50 mA of current at the beginning of 
the run. By the next day the ice in the cooling pack has melted, and the current has 
increased to about 80 mA.
d. Detection o f  Immune Complexes— After transfer, the cassettes are 
disassembled and each membrane is cut to the exact size of its gel. The corresponding 
comer is cut off to provide unambiguous orientation and the membrane is labelled on the 
back with a pencil to identify it.
It is possible to stain the membrane for total protein at this point using Ponceau S
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to verify transfer efficiency. Membranes are placed directly into Ponceau S solution 
(0.1% w/v Ponceau S in 5% acetic acid, Sigma, cat. no. P7170) for 10 minutes. This 
reversibly stains all protein bands on the blot. If molecular weight standards are included, 
the position of these is marked at this time with a pencil. If no bands appear, it is not 
worth continuing, since transfer did not occur. A common cause of this is failure to 
orient the transfer cassette correctly in the transfer apparatus (cathode(black)-gel- 
nitrocellulose-anode(red)).
An easier alternative to check transfer efficiency and provide size standards is to 
use pre-stained molecular weight standards as mentioned previously. These are readily 
visible on the membrane. All but the highest molecular weight standard should 
completely transfer from the gel. This lane unambiguously shows the orientation of the 
blot and makes cutting a comer of the blot unnecessary.
After transfer is verified, the membranes are placed in a covered plastic dish 
containing 100 ml o f blocking buffer for 1 hour at room temperature. During all 
incubation and washing steps, constant gentle agitation is provided by an orbital shaker 
platform. The membranes are transferred to another plastic dish containing 20 ml of 
diluted C219 at a concentration of 2.5 jig/ml (1:40 dilution of reconstituted C219) in 
antibody buffer. Membranes are incubated in the primary Ab for 1 hour at room 
temperature. (Note: The primary antibody solution can be saved at - 20° C and reused at 
least 10 times before loss in sensitivity becomes noticeable.) After 1 hr., the membranes 
are transferred to a container with 100 ml of TTBS and washed for 5 minutes. The wash 
step is repeated before transferring the membranes to the secondary Ab conjugate
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solution. The membranes are incubated for 1 hour at room temperature with 25 ml of 
freshly diluted goat anti-mouse alkaline phosphatase conjugate (1:3000 in antibody 
dilution buffer). The membranes are then washed with two changes of TTBS as before, 
followed by another 5 minute wash in TBS without Tween 20. The membranes are then 
given a final wash for 2 minutes in AP buffer. The membranes are then placed in a 
plastic bag containing 10 ml o f BCIP/NBT substrate solution. All air bubbles are 
removed from the membrane surfaces, and the membranes are incubated in the dark until 
the lowest concentration bands become visible. This usually takes about 15 minutes.
The color development reaction is stopped by washing the membrane in deionized water 
and placing it in TE. Membranes are stored at 4° C in TE.
Blots are then photographed (Polaroid Pos./Neg. film type 665) and are subjected 
to densitometry if quantitation is desired. We use a Shimadzu 930 TLC scanner set at 
550 nm for quantitation.
RESULTS and DISCUSSION 
Immunohistochemistry—  Immunohistochemical staining has been used to detect 
Pgp expression in normal mammalian tissues. This technique has shown Pgp expression 
on the canalicular surface of hepatocytes in normal liver (Thiebaut et al., 1987; Thiebaut 
et al., 1989; Bradley et al., 1990). We have found that immunohistochemical staining of 
sections of normal mummichog liver showed specific staining that corresponds to the 
mammalian pattern of expression with allowances for the differing architecture o f fish 
liver (Hampton et al., 1985). The immunoperoxidase stain clearly showed the structure
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of the bile canaliculi within the section (Figure 3A). There was no stain in the cytoplasm 
or other organelles in normal hepatocytes. No other hepatocellular elements were stained 
in these preparations. This pattern o f  subcellular localization is consistent with the 
hypothesis that P-glycoprotein may have an excretory function in fish liver as has been 
suggested for mammals (Arias, 1990; Thorgeirsson et al., 1991).
Increased expression of Pgp has been detected by C219 immunohistochemical 
staining in human neoplasms (Weinstein et al., 1991). Immunohistochemical staining has 
shown Pgp overexpression in experimentally induced rat hepatocellular carcinoma and 
advanced preneoplastic lesions (Bradley et al., 1992). Using mummichog from a 
creosote contaminated site with a high prevalence of hepatic neoplasms, we were able to 
examine Pgp expression in hepatic tumors of fish. Many tumors showed increased C219 
immunoperoxidase staining (overexpression) as well as alterations in the pattern of 
expression (Figure 3B). Often there was a loss of polarity with the entire plasma 
membrane staining. Cytoplasmic staining and some paranuclear (Golgi) staining was 
also evident. The alterations in pattern and degree of immunohistochemical staining 
observed in these fish liver tumors were similar to those reported for rat liver hyperplastic 
nodules and hepatocellular carcinoma (Bradley et al., 1992).
In both tumor and normal liver preparations we observed no staining when mouse 
myeloma protein was used in place o f C219 (Figure 3C).
Immunoblots— Immunoblots have been used to identify and quantify Pgp 
expression in drug resistant mammalian cell lines (Kartner et al., 1985) and in 
mammalian tumors and normal tissues (Hitchins et al., 1988; Liberman et al., 1989;
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Fredericks et al., 1991). Immunoblots have also been used to identify Pgp family 
members in some aquatic organisms (Kurelec et al., 1992; Toomey and Eppel, 1993; 
Minier et al., 1993). We have identified a single main immunoreactive band in 
immunoblots of mummichog liver and tumor extracts (Figure 3D). The mummichog Pgp 
band migrated at a relative molecular weight o f 177 kDa. This is a higher molecular 
weight than that of the immunoreactive band in extracts o f the multidrug-resistant CHRC5 
cell line in our system (165 kDa) but is within the molecular weight range reported for P- 
glycoproteins. The mummichog liver and liver tumor Pgp bands also had the same 
characteristic diffuse appearance as the mammalian Pgp. This is consistent with 
glycosylation of the putative mummichog Pgp. These results help confirm that the 
antigen labeled in immunohistochemical staining is a Pgp family member.
Densitometric analysis of the immunoblot shown in Figure 3D indicated 
approximately a three fold increase in expression of Pgp in a mummichog liver adenoma 
compared to the adjacent normal tissue. These results are consistent with the 
overexpression seen in immunohistochemical staining of this adenoma and allow a 
quantitative estimate of overexpression.
Advantages of Combined Immunochemical Methods—  We have found that 
using immunohistochemical staining and immunoblotting together provides information 
that neither one alone could give. Immunoblots combined with densitometric analysis 
have allowed comparison of relative levels of expression between individuals and 
between discrete proliferative lesions and surrounding non-neoplastic liver.
Immunohistochemical staining has proved less quantitative but has provided
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important information on the relative level of expression at the cellular and subcellular 
levels which is destroyed in whole organ homogenates. In our system the two techniques 
have supported the assumption that the protein labelled is a P-glycoprotein. Immunoblots 
show specific staining of a single band of the correct molecular weight and 
characteristics. Immunohistochemical staining shows that in normal fish liver, as in 
mammalian liver, Pgp is present only on the canalicular surface of hepatocytes; whereas 
in hepatic tumors there is often overexpression as well as loss of polar expression of this 
antigen.
Further Applications—  We are continuing to use these techniques in our studies 
of Pgp expression in the mummichog. We are investigating induction of Pgp in 
mummichog liver in response to environmental and laboratory exposures to PAHs. We 
are also studying relationships between relative Pgp expression and hepatic lesion 
classification in fish from the PAH contaminated site. The highly conserved nature o f the 
C219 epitope and the high specificity demonstrated with mummichog tissues should 
make the immunochemical techniques described here useful in detecting Pgp expression 
in many other aquatic organisms.
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Figure 3. C219 immunochemical detection of Pgp in liver and hepatic proliferative 
lesions of mummichog. A: Immunochemical localization of Pgp in normal mummichog 
liver on the bile canalicular surface (arrowheads) o f hepatocytes. B: Immunochemical 
localization of Pgp in a mummichog liver adenoma showing overexpression, paranuclear 
(Golgi) staining (arrowheads) and degeneration of polar membrane expression including 
staining of the sinusoidal surface (arrows) of hepatocytes. C: Matched isotype mAb 
negative control o f section adjacent to that shown in B. D: Immunoblot of paired 
samples of grossly visible lesions (lanes 2 and 4) and adjacent uninvolved liver (lanes 1 
and 3); the pair in lanes 1 and 2 are subsamples of the liver and lesion shown in A and B. 
Positions of standards are shown with their molecular weight (kDa) at the left.
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INTRODUCTION
Chapter II (Cooper et al., 1996) o f this dissertation presented methods that use 
monoclonal antibody (mAh) C219 (Kartner et al., 1985) in immunoblots and 
immunohistochemical staining to detect and measure relative levels of Pgp expression in 
mummichog liver and in mummichog liver tumors. Results using these methods 
indicated that one or more P-glycoprotein homologs are expressed in the bile canalicular 
surface of hepatocytes in mummichog liver. This expression pattern is consistent with 
expression reported in mammalian (Thiebaut et al., 1987; Thiebaut et al., 1989; Bradley 
et al., 1990) and guppy liver (Hemmer et al., 1995). We also have found that some 
mummichog liver tumors from mummichog inhabiting a heavily creosote-contaminated 
site (Atlantic Wood) overexpress P-glycoprotein and have altered subcellular localization 
of this antigen. This is similar to the altered expression of Pgp reported for mammalian 
hepatic neoplasms (Fairchild et al., 1987; Thorgeirsson et al., 1987; Teeter et al, 1990; 
Vohm et al., 1990; Bradley et al., 1992). The conditions at the Atlantic Wood site 
provide a unique opportunity to study the response of Pgp expression in fish liver to 
environmental contaminant exposure and to examine changes in Pgp expression during 
environmental hepatocarcinogenesis in a teleost. In the present Chapter, we have used 
our immunochemical techniques to survey expression patterns and levels o f Pgp antigens 
in environmentally induced liver tumors and in the livers of mummichog from the 
Atlantic Wood site.
We have compared levels of Pgp expression in the non tumor-bearing livers of 
chemically resistant fish from the Atlantic Wood site to levels to expression in sensitive
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fish from an uncontaminated environment (King Creek) in order to determine whether the 
analogy to the xenobiotic resistance phenotype reported for these livers (Van Veld and 
Westbrook, 1995) extends to increased expression of Pgp. In order to address whether 
changes in Pgp expression in the livers o f resistant fish could result from induction of Pgp 
expression by exposure to PAHs, we have measured Pgp expression in sensitive fish 
following exposure to a single carcinogenic PAH (3-methylcholanthrene). We have also 
extended our studies of the biochemical properties of hepatic proliferative lesions of these 
fish to include Pgp, a putative marker of the drug-resistance phenotype in mammalian 
liver tumors (Farber and Sarma, 1987; Fairchild et al., 1987; Thorgeirsson et al., 1987; 
Thorgeirsson et al., 1991).
Results reported here demonstrate detectable increases of Pgp expression in non­
tumor bearing liver of Atlantic Wood mummichog as well as high level overexpression 
and altered patterns of expression in a majority of hepatic neoplasms examined from 
these fish. This is the first report of increased Pgp expression in a teleost from a polluted 
environment and is the first study of Pgp expression in the tumors of a lower vertebrate. 
These results are similar to what is known about Pgp expression in mammalian liver and 
liver tumors. This increased Pgp expression may have implications for the tolerance or 
adaptation of these fish inhabiting a contaminated environment.
MATERIALS AND METHODS 
Collection of mummichog livers—  Mummichog were collected with minnow 
traps in October of 1994 and July of 1996 from a creosote contaminated site and a
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relatively uncontaminated site. The contaminated site was a marsh creek that collects 
run-off from a defunct wood treatment facility (Atlantic Wood Products) in the Elizabeth 
River in Portsmouth, VA. This site has been reported to have very high sediment 
concentrations of PAHs (2200 mg/Kg dry sediment) (Vogelbein et al., 1990). The 
uncontaminated site was King Creek, a marsh creek tributary to the Severn River in 
Gloucester County, VA. Fish from each site were collected within one day of each other 
and were killed within 48 hr with an overdose of tricaine methane sulfonate (Sigma, St. 
Louis, MO). Livers were removed, snap frozen in liquid nitrogen and stored at -70° C 
until use. Only male fish without grossly visible tumors were used in these analyses.
Preparation of liver extracts—  Processing of mummichog livers essentially 
followed the protocols given in Chapter II of this dissertation (Cooper et al., 1996). 
Mummichog livers were homogenized in 5 to 10 volumes of ice cold lysis buffer (50 mM 
Tris HC1, pH 7.4, 150 mM NaCl, 1% v/v sodium deoxycholate, 0.1% w/v SDS, 5 mM 
EDTA) which contained freshly added protease inhibitors (2% v/v aprotinin solution 
(Sigma), 380 pg/ml N-toluenesulfonylamido-L-arginine methyl ester, 100 pg/ml phenyl 
methyl sulfonyl fluoride, 10 (ig/ml leupeptin). Livers were homogenized in a Polytron 
homogenizer (Brinkman Instruments, Westbury, NY). Homogenates were allowed to 
stand on ice for 10 minutes and then were clarified by centrifugation in an Eppendorf 
model 5415 microcentrifuge (10 min, 12000 rpm, 4° C). Protein concentrations of the 
extracts were determined using the Lowry assay with bovine serum albumin as a 
standard.
Immunoblotting of mummichog liver extracts with the monoclonal
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antibodies C219, JSB1 and C494— The procedure for SDS-PAGE, electrophoretic 
transfer and immunodetection using mAb C219 essentially were as described in Chapter 
II (Cooper et al., 1996). Mummichog liver extracts were diluted to a concentration of 0.5 
mg/ml with SDS-PAGE sample buffer (60mM Tris-HCl, pH 6.8, 2 % w/v SDS, 10% v/v 
glycerol, 100 mM dithiothreitol, 0.025% bromphenol blue). Samples were heated to 65° 
C for 4 min, and were then loaded onto a 5.6% (total) acrylamide SDS-PAGE mini-gel 
(7.3cm X 8.0 cm X 0.075cm) at 2 pg per lane. Several different amounts o f a pooled 
extract of 5 livers from the uncontaminated site were also loaded onto each gel to serve as 
a quantitation standard. Usually 0.5 pg, 2 pg, 4 pg and 8 pg of this reference extract 
were loaded in separate lanes. Samples were electrophoresed under standard conditions 
(200 V, 30 min). The SDS-Page gels were then transferred electrophoretically (34 V, 18 
hr) to nitrocellulose membranes (BioRad, 0.2 pm). The transfer buffer was 25 mM Tris 
base, 192 mM glycine containing 20% v/v methanol. Following transfer, the 
nitrocellulose membranes were blocked in Tris buffered saline (TBS) (20mM Tris-HCl, 
pH 7.5, 0.5M NaCl) containing 5% w/v nonfat dry milk and 0.1%Tween-20. Following 
blocking the membranes were incubated with mAb C219 (Signet, Dedham, MA) (2.5 
pg/ml, in TBS with 1% Tween-20, 1% nonfat dry milk) for 1 hr at room temperature.
The membranes were washed twice for 5 min in TBS-Tween 20 and were then incubated 
for 1 hr at room temperature with goat antimouse IgG-alkaline phosphatase conjugate 
(BioRad, Richmond, CA) (1:2000 in TBS-Tween 20). The membranes were then washed 
twice in TBS-Tween 20. After a final wash in TBS, immune complexes were detected on 
the membrane using 5-bromo-4-chloro-3-indolyl phosphate (BCIP) and p-nitro blue
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tetrazolium chloride (NBT) as chromogenic substrates for alkaline phosphatase. In 
addition to mAb C219 two other mammalian monoclonal antibodies, C494 and JSB1 
(Signet, Dedham, MA), were also used in immunoblots. The procedure used for 
detection using these antibodies was similar to that given here for C219 except that these 
antibodies were used at higher concentrations (10 pg/ml) and were incubated with 
immunoblot membranes for up to 24 hrs with the goal of increasing sensitivity. Up to 30 
pg of total protein was loaded per lane in gels used with these antibodies.
Estimation of relative Pgp content in mummichog liver extracts—  The 
intensity o f staining of immunoblots probed with mAb C219 was measured with a 
Shimadzu CS-930 scanning densitometer set at a wavelength of 550 nm. The 
densitometric peak area for each Pgp band was normalized by comparing it to a standard 
curve of peak area versus total protein for varying amounts of a pooled extract o f King 
Creek mummichog liver loaded on each blot. Values of Pgp expression were then 
expressed relative to this standard extract. Arbitrary units were devised by assigning a 
value of 100 to the signal obtained from 1 pg of the pooled King Creek liver extract. The 
specific content of Pgp in each sample was then expressed in terms of these arbitrary 
units per microgram of protein.
Laboratory exposure of mummichog to 3-methylcholanthrene—  Male 
mummichog collected from King Creek that had been maintained in captivity for several 
months were used in this portion of the study. Fish were given intraperitoneal (i.p.) 
injections of either 3-methylcholanthrene (Sigma, St. Louis, MO) dissolved in com oil 
(10 mg/ml) or com oil alone. Injection volumes were adjusted so that each fish received
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a dose of 100 mg/Kg body weight or 10 ml com oil/Kg body weight. The two groups of 
fish were maintained in separate 10 gallon aquaria provided with flowing water from the 
York River for 24 hrs before and for 36 hrs following treatment. The fish were fed once 
daily during this period. Thirty six hrs after injection the fish were killed by overdose 
with tricaine methane sulfonate and their livers were removed, frozen in liquid nitrogen 
and stored at -70° C. Detergent extracts of the livers were analyzed for Pgp expression as 
described above. In addition these extracts were analyzed for relative levels o f CYP1A 
expression as described in the next section using the monoclonal antibody (mAb 1-12-3) 
produced against the CYP1A protein of the scup (Park et al., 1986). This antibody has 
been used to measure cytochrome P4501A levels in many fish species including the 
mummichog (e.g. Van Veld et al., 1992; Van Veld et al., 1990; Gallagher et al., 1995).
Student’s t-test was used to test for significant differences among means of 
expression levels between the contaminated and uncontaminated sites or between 
3-methylcholanthrene exposed fish and control fish.
Immunodetection of cytochrome P4501A in extracts of 3-MC treated 
mummichog liver— Immunodetection of cytochrome P4501A in 3-MC treated liver 
followed a similar protocol to the one given above for Pgp immunodetection with the 
substitution of mAb 1-12-3 (Park et al., 1988) as the primary antibody. (This antibody 
was a generous gift o f Dr. John Stegeman, Wood’s Hole Oceanographic Institute.) 
Samples were analyzed by electrophoresis on 10% acrylamide gels instead of 5.6% 
acrylamide gels because of the lower molecular weight of the CYP1A protein. For 
CYP1A analysis, 20 pg of total liver protein was loaded per lane of the blot. All other
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electrophoresis, transfer and incubation conditions were identical to those for immunoblot 
detection of Pgp with mAb C219.
Immunohistochemical staining of mummichog liver and liver lesions—  Many 
of the mummichog liver and tumor specimens used in this study were archival specimens 
used in previously reported histopathological studies (Vogelbein et al., 1990). These 
specimens were collected in August 1989 and 1990 from the Atlantic Wood site in the 
Elizabeth River. Additional specimens were collected in 1992 from both Atlantic Wood 
and King Creek. The fixation and processing of the fish tissues were as described 
(Vogelbein et al., 1990). Over 90 histologic sections o f livers from the creosote 
contaminated site containing proliferative lesions were stained for Pgp. 
Immunohistochemical staining of Bourn’s fixed paraffin embedded tissue sections 
followed the protocols presented in Chapter II (Cooper et al., 1996). For 
immunohistochemical staining with mAb C219, 5 pm thick sections were cut from the 
paraffin blocks and were adhered to slides with gelatin. A section from each block was 
also processed for routine staining with hematoxylin and eosin (Luna, 1968). To control 
for nonspecific binding of the primary and secondary antibodies, histologic sections were 
also incubated with mouse myeloma protein (Sigma) o f the same isotype as mAb C219 
(lgG 2a, kappa) and processed as described for mAb C219.
Tissue sections were deparaffinized in xylene and rehydrated through graded 
alcohols to phosphate buffered saline (PBS). Endogenous peroxidase activity was 
blocked by a bath in 3% aqueous H20 2. After rinsing in PBS, sections were incubated in 
10% normal horse serum in PBS to block nonspecific binding. The sections were then
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incubated for 18 hrs at 4° C with mAb C219 (Signet, Dedham, MA) (1.5 pg/ml in PBS 
with 1% bovine serum albumin). Detection of C219 was accomplished using a 
biotinylated secondary antibody (biotinylated horse anti-mouse) and an avidin- 
biotinylated horseradish peroxidase complex (Elite Avidin-Biotin Complex 
Immunohistochemical Staining Kit, Signet Laboratories, Dedham, MA). Immune 
complexes were stained using 3,3' diaminobenzidine and H20 2 (Sigmafast tablets, Sigma, 
St. Louis, MO) as chromogenic substrates for horseradish peroxidase. Sections were 
counter stained lightly with Harris’ hematoxylin and differentiated in aqueous NaHC03. 
Sections were dehydrated through graded alcohols to xylene and mounted in synthetic 
mounting medium (Preservaslide, EM Science).
RESULTS
Immunoblot detection of Pgp in normal liver— Three different monoclonal 
antibodies to mammalian Pgps were used in immunoblots to detect P-glycoprotein 
expression in mummichog liver. Immunoblots of extracts of mummichog liver using the 
mAb C219 showed a highly immunoreactive band at a size near 170 kDa (Figure 4A).
The mAb JSB-1 also reacted with a protein o f this molecular weight in mummichog liver 
extracts although the signal was much weaker (Figure IB). In the present study no 
immunoreactive proteins were detected in mummichog liver extracts using the mdrl 
specific mAb C494 (Georges et al., 1990) under the same conditions (not shown).
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Immunoblot measurement of increased expression of Pgp in livers of mummichog 
from a creosote contaminated site—  The mAb C219 was used to evaluate changes in 
Pgp expression in mummichog exposed to PAHs. Analysis of mummichog liver extracts 
from Atlantic Wood and King Creek mummichog collected at two different times 
indicated a significant increase (Student’s t-test, p<0.05) in Pgp expression in the livers of 
Atlantic Wood mummichog (Figure 5, Table 2). The average increase in expression of 
the Pgp was 3.2 fold and 2.6 fold (Table 2) in the livers of fish from Atlantic Wood in 
1996 and 1994 respectively.
Immunoblot assay of Pgp expression following i.p. administration of 3-MC—  
There was no significant increase in the intensity of staining for Pgp in immunoblots of 
liver extracts o f mummichog given intraperitoneal injections of 3-methylcholanthrene (3- 
MC) compared to a group of fish injected with com oil (36 hrs post injection). The 
relative Pgp contents in the two treatments were 144±30 units/pg protein and 128±32 
units/pg protein for the 3-MC and com oil treatments respectively. However the levels of 
CYP1A were found to be ten-fold higher in the 3-MC treated fish in immunoblot analysis 
(Figure 6). This increase in CYP1A established that effective exposure of the fish to the 
3-MC had taken place.
Immunohistochemical detection of Pgp expression and overexpression in 
mummichog hepatic neoplasms and advanced preneoplastic lesions— We used 
immunohistochemical staining with C219 to examine samples of mummichog liver and 
liver tumors for Pgp expression. Histologic sections of normal livers of fish from either 
the creosote contaminated site or from a relatively clean site showed typical specific
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immunohistochemical staining of the canalicular surface of hepatocytes (Figure 7). No 
staining o f mummichog liver or liver tumor sections was observed when a matched 
isotype mouse myeloma protein was used in place of mAb C219 in the 
immunohistochemical staining protocol (Figure 8).
There was no clear indication of altered expression of Pgp in putative early 
preneoplastic lesions (altered foci) of Elizabeth River mummichog (not shown) although 
many of the livers exhibited regional heterogeneity o f staining for Pgp. Unlike the early 
proliferative lesions however, many of the hepatocellular carcinomas and adenomas 
exhibited obvious alterations in expression of P-glycoprotein (Figure 9). Eight 
adenomas, sixteen hepatocellular carcinomas and two hepatoblastomas were examined. 
These lesions have been described previously (Vogelbein et al, 1990; Van Veld et al., 
1992; Vogelbein et al., 1996). Many of these lesions had elevated levels of 
immunohistochemical staining indicating over-expression of Pgp (Figure 9A-F). Of the 
sixteen hepatocellular carcinomas ten had clear overexpression compared to the 
surrounding parenchyma while the remainder had reduced or approximately equivalent 
expression to the surrounding normal tissue. Many of the carcinomas had aberrant 
localization of the Pgp antigen as well. There were examples of cytoplasmic staining 
(e.g. Figure 9C&D), paranuclear or “Golgi” staining (e.g. Figure 9G ), and varying 
degrees o f loss of polarity ranging from an increase in size of the region stained 
surrounding the bile canaliculus (Figure 9B) to staining of the entire plasma membrane 
(Figure 9E ). Six of the eight adenomas had elevated Pgp staining. There was 
predominant polar staining of the bile canaliculus in all cases (Figure 6 A). Three of
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these lesions also had tracts o f extreme overexpression, and in these regions there was 
loss of polarity. High level expression of Pgp was observed in the two hepatoblastomas. 
One hepatoblastoma had very well developed canalicular staining (Figure 9F ) while the 
second exhibited loss o f polar expression. These patterns o f expression are consistent 
with the degree of differentiation of the two lesions at the ultrastructural level (Vogelbein 
et al., 1996). Overall the retention of polar (canalicular) staining in all three categories of 
progressed proliferative lesions was correlated with the degree of differentiation of the 
lesion (morphological resemblance to normal liver).
DISCUSSION
We found elevated expression of one or more P-glycoprotein homologs in the 
livers and liver tumors of mummichog inhabiting an environment severely contaminated 
with P AHs. This is believed to be the first evidence of increased expression o f Pgp in 
teleosts from a polluted environment. It also is the first evidence of P-glycoprotein 
overexpression in the tumors of a lower vertebrate.
Chapter II of this dissertation reported immunoblot and immunohistochemical 
techniques for detection of Pgp in mummichog liver tumors using mAb C219 (Cooper et 
al., 1996). Results reported here with mAb C219 and JSB-1 confirm specific 
identification of Pgp isoforms in immunoblots of mummichog liver. The molecular 
weight (170 kDa) and characteristic broad appearance of the labeled band in immunoblots 
indicating a high degree of glycosylation strongly suggest that the C219 and JSB-1 
monoclonal antibodies are detecting Pgp homologs expressed in mummichog liver. C219
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reacts with a highly conserved epitope (VQEALD) present in all known Pgp deduced 
amino acid sequences including the only published fish sequences (Georges et al., 1990; 
Chan et al., 1992). JSB-1 reacts with an unknown epitope present in human and rodent 
drug-resistance Pgp isoforms (Scheper et al., 1988). This antibody has been reported to 
react in a specific manner with bile canaliculi o f guppy liver in immunohistochemical 
staining (Hemmer et al., 1995). The failure o f the MDRl/pgpl specific mAb C494 
(Georges et al., 1990) to react with mummichog liver extracts in immunoblots is also 
consistent with the reported absence of immunohistochemical staining o f guppy 
hepatocytes with this antibody (Hemmer et al., 1995).
The specificity of detection in immunoblots using mAb C219 shows that the 
increased staining seen in immunoblots of Atlantic Wood mummichog livers represents 
elevated levels of one or more P-glycoprotein isoforms in the livers of these fish.
Elevated levels of Pgp related antigens have been reported in gill and mantle tissue of 
marine mollusks from contaminated sites (Minier, et al., 1993; Kurelec et al., 1995; 
Kurelec et al., 1996). This is the first report of elevated levels of Pgp in a teleost 
associated with environmental contaminants. There may be several possible causes for 
this elevation in the nontumor bearing livers of the Atlantic Wood site: 1) specific Pgp 
genes may be induced in response to specific components of creosote or their 
metabolites; 2) Pgp levels may be elevated as a more general response to toxic injury 
resulting from hepatotoxic contaminant exposure; 3)There may be some contribution to 
Pgp expression from overexpression in hidden liver tumors; 4) Pgp levels in these fish 
may be constitutively elevated in the livers of mummichog from this site and are a
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component of the observed genetic adaptation of these fish to the acutely toxic effects of 
creosote. Each of these possibilities is discussed in turn below.
Because Pgp genes are induced in mammalian livers following exposure to 
xenobiotics including PAHs, it seems likely that Pgp genes may be induced in 
mummichog liver by exposure to xenobiotics (presumably PAHs) present at the Atlantic 
Wood site (Thorgeirsson et al., 1988; Gant et al., 1990; Gant et al., 1995). Thorgiersson 
and colleagues have hypothesized that Pgp gene expression is induced in liver by 
xenobiotics or their metabolites having biliary excretion pathways (Thorgeirsson et al., 
1988; Gant et al., 1995). In fish as well as in mammals biliary excretion is an important 
route of elimination of PAH metabolites (Varanasi et al., 1989; Schintz et al., 1993). In 
the present study however we were not able measure increase in Pgp in King Creek 
mummichog 36 hr following i.p. injection of 3-MC. These conditions did produce a large 
increase in immunodetectable CYP1A however. While 3-MC has been found to induce 
expression of Pgp in rat liver, exposures in these cases were for longer times 
(Thorgeirsson et al, 1988; Gant et al., 1990). Long term exposures to 3-MC may produce 
induction of Pgp in the mummichog as well. However it is possible that the Pgp genes of 
fishes may not be responsive to PAHs or their metabolites.
Another explanation for these observations is that the elevated levels of Pgp in 
mummichog liver from the creosote contaminated site are a result of liver damage in 
these fish rather than induction of mummichog Pgp genes by PAHs. The livers of 
mummichog from this site show a high prevalence of pathological changes associated 
with toxic injury and cell death in addition to the proliferative lesions (Vogelbein et al.,
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1990; Wolfgang Vogelbein, personal communication). Levels of Pgp mRNA has been 
observed to increase in rodent liver under conditions of liver injury such as partial 
hepatectomy, cholestasis (Thorgeirsson et al., 1987; Marino et al., 1990; Teeter et al., 
1991; Schrenk et al., 1993). The Pgp genes in mummichog liver may respond in a similar 
manner to toxic injury.
Although livers without grossly visible lesions were chosen for this study, it is 
possible that many of these livers contained neoplasms that were not externally visible. 
The contribution of Pgp overexpression in small tumors present in Atlantic Wood 
mummichog liver to the elevated signal seen in immunoblots cannot be ruled out.
Finally, there is also a possibility that elevated levels of hepatic Pgp in Atlantic 
Wood mummichog are component of the observed genetic resistance of the mummichog 
at this site to the acute toxicity of creosote (Horton et al., 1993; Williams et al., 1994).
Van Veld and Westbrook (1995) have hypothesized that the toxicity resistance in these 
fish may be related to constitutive alterations in levels and activities o f liver enzymes 
involved in biotransformation and detoxification. These changes are similar to alterations 
observed multixenobiotic-resistant preneoplastic liver lesions and multidrug-resistant 
mammalian cell lines and include suppression of phase I oxidative enzymes involved in 
activation of carcinogens and elevated levels of phase II detoxifying enzymes (such as 
GSTs) in nontumor-bearing livers of these fish (Van Veld et al., 1991; Van Veld and 
Westbrook, 1995). Another biochemical alteration seen in chemically resistant cells is 
increased expression of Pgp. Thus the livers of mummichog from the creosote 
contaminated site have several of the changes associated with the “resistant hepatocyte”
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phenotype seen in chemical carcinogenesis and multidrug resistant cell lines (Farber, 
1984a; Farber, 1984b; Farber and Rubin, 1991). These alterations may contribute to the 
survival of these fish in a PAH contaminated environment. Whether any of these changes 
in liver biochemistry are inherent or whether they are a result of acclimation (i.e. 
induction) and other reversible changes is unknown at this point.
Immunohistochemical results reported here confirm localization of Pgp to the 
canalicular surface of hepatocytes in teleost liver. Similar staining patterns have been 
reported for histologic sections of guppy liver using this antibody (Hemmer et al., 1995). 
These staining patterns of teleost livers indicate that the expression of Pgp in fish liver is 
homologous with the expression pattern of Pgp in mammalian liver with allowances for 
the differing architecture of fish liver (Hampton et al., 1985). This pattern of expression 
suggests that Pgp is involved in biliary excretion in teleosts.
We observed overexpression of Pgp in the majority of mummichog hepatic 
neoplasms examined in this study. Overexpression of Pgp is characteristic o f mammalian 
liver tumors (Goldsmith et al., 1990; Huang et al., 1992; Teeter et al, 1990; Bradley et al., 
1992). The altered immunohistochemical staining patterns seen in the mummichog 
neoplasms here are strikingly similar to those reported for experimentally induced rodent 
liver neoplasms, human hepatocellular carcinoma and human colon carcinoma (Bradley 
et al., 1992; Weinstein et al., 1991). These altered patterns include cytoplasmic and 
paranuclear staining as well as nonpolar plasma membrane expression.
Thus, Pgp overexpression is another biochemical property of mummichog tumors 
in addition to reduced CYP1A which is similar to biochemical alterations observed in
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mammalian liver tumors and that are associated with xenobiotic resistance ( Farber 
1984a, Farber 1984b; Fairchild et al., 1987; Farber and Rubin, 1991; Van Veld et al.,
1992, Van Veld and Westbrook, 1995).
The origin of Pgp overexpression in liver tumors is not well understood. It has 
been associated with xenobiotic resistance in preneoplastic lesions (Thorgeirsson et al., 
1987). Selective promotion of Pgp-expressing lesions in the presence of cytotoxic 
carcinogens may account for the overexpression observed in hepatocellular carcinoma. 
However, Pgp overexpression in liver tumors has also been observed without promotion 
by xenobiotics (Teeter et al, 1990; Bradley et al., 1992). Therefore Pgp overexpression in 
liver tumors may be a late event related to oncogene activation and tumor progression 
(Teeter et al., 1990; Bradley et al., 1992; Bradley and Ling, 1994). The environmentally 
induced liver tumors in mummichog from the Elizabeth River provide an interesting 
system in which to examine these two alternatives, Pgp expression arising from selection 
of Pgp overexpressing lesions versus Pgp overexpression as a marker of neoplastic 
transformation. Mummichog inhabiting the creosote contaminated site are exposed 
continuously to a mixture of toxic xenobiotics that includes carcinogenic PAHs 
(Vogelbein et al., 1990). Such conditions seem ideal for the promotion of xenobiotic 
resistance in early preneoplastic lesions and their eventual progression to resistant tumors. 
The livers of fish from this site show a variety o f microscopic histopathology including 
several categories of altered foci. Some of these are presumed to be preneoplastic lesions 
(Vogelbein et al., 1990). If selection of Pgp expression is occurring during 
carcinogenesis in these fish, then Pgp overexpression should have been apparent in
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putative early lesions. This was not the case however. Over 90 different mummichog 
livers were stained for Pgp expression using mAb C219. Within these livers, only 
neoplasms (hepatocellular adenomas and hepatocellular carcinomas) showed evidence of 
overexpression of Pgp. While the majority of these neoplasms overexpressed Pgp, some 
had reduced or equivalent levels o f Pgp expression. Thus Pgp overexpression in these 
fish tumors is probably a late event which may be independent o f selection of xenobiotic 
resistance in the lesions. This overexpression may be caused by activation of specific 
oncogenes during tumor progression in mummichog liver.
Consistent with this hypothesis are reports that transfection of rat liver epithelial 
cells with the oncogene v-H-ras induces high level expression of Pgp, and that high level 
expression of mutant p53 stimulates the promoter of the human MDRI gene in vitro (Burt 
et al., 1988; Chin et al., 1992). Both Ras mutations and p53 mutations are common in 
mammalian neoplasms including hepatocellular carcinoma (Nigro et al., 1989; Hsu et al., 
1991; Wiseman et al., 1991). It seems reasonable to assume that these kinds of mutations 
are also common in hepatocellular carcinoma of teleosts and are responsible for Pgp 
overexpression in mummichog liver tumors.
Summary—  The results reported here show evidence for moderate increases in 
expression of one or more Pgp homologs in the livers of mummichog from a creosote 
contaminated site. In addition liver neoplasms of these fish show overexpression of Pgp 
which is similar to that seen in mammalian hepatocellular carcinoma. The mechanisms 
responsible for this up regulation of Pgp in these fish livers are unknown. Further work is 
required to determine if increased expression of Pgp can be induced in laboratory
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exposures of these fish to components of creosote particularly individual PAH 
components. Although no increase in expression of Pgp in mummichog liver was 
observed following i.p. injection of 3-MC, these results must be viewed as inconclusive 
since longer times may be required for up regulation of these genes. In tumors high level 
expression beginning at the neoplasm stage rather than earlier suggests that oncogene 
activation rather than a role of Pgp expression in chemical resistance of preneoplastic 
lesions may be responsible for increased expression seen in these tumors.
In the case o f both normal mummichog liver and mummichog liver tumors the 
question of which Pgp family members are increased remains to be answered. Because 
the antibody used in the present study recognizes an epitope found in all known Pgp 
deduced amino acid sequences, our expression results include all isoforms expressed in 
mummichog liver. Further understanding of the relevance o f increased Pgp expression to 
the survival of mummichog in the creosote contaminated environment will require 
characterization of the Pgp genes expressed in mummichog liver and liver tumors and the 
development of gene specific probes for these genes. Chapters IV and V of this 
dissertation report the identification, partial sequence and molecular analysis of two 
distinct Pgp isoforms expressed in mummichog liver.
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Figure 4. Immunoblot detection of Pgp in mummichog liver extracts from the creosote 
contaminated site (Atlantic Wood) in the Elizabeth River and from a clean reference site 
(King Creek). A: Immunoblot probed with mAb C219 (1.5 pg/ml). Lanes 1-5 Elizabeth 
River mummichog liver extracts. Lanes 6-10 King Creek mummichog extracts. B: 
Immunoblot probed with mAb JSB-l (10 pg/ml). Lane 1 Pgp standard, multidrug- 
resistant CHRC5 cell line extract. Lanes 1-5 King Creek mummichog liver extracts, 
Lanes 6-10 Elizabeth River mummichog liver extracts. Positions of molecular weight 
standards are shown at the left.
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Figure 5. Expression of Pgp in liver extracts of mummichog from the creosote 
contaminated site (Atlantic Wood) and an uncontaminated reference site (King Creek) 
determined from immunoblotting of mummichog liver extracts using mAb C219. Five 
fish from each site were used. Expression is reported in arbitrary units per microgram of 
liver protein. Units are defined so that 1 pg of a pooled liver extract from reference site 
mummichog contains 100 units. A: Mummichog collected July 1996. B: Mummichog 
collected October 1994. At both times, Elizabeth River mummichog from the creosote 
contaminated site showed significant elevation of the C219 antigen (Student’s t-test, 
P<0.05).
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Table 2. Relative content o f Pgp antigens in liver extracts o f mummichog from the 
creosote contaminated site (Atlantic Wood) and an uncontaminated reference site (King
Creek) determined by densitometric analysis of immunoblots using mAb C219.
Site
Date Atlantic Wood King Creek Relative Increase
July 1996 374±167a 115=1=11 3.25
October 1994 199±66a 75±52 2.65
Values are arbitrary Pgp units per microgram of liver protein, average of 5 livers from 
each site ±SD ;a significantly different from reference site (King Creek) (Student’s t-test, 
p<0.5). Relative increase is the ratio of expression in livers of Atlantic Wood fish to 
expression in King Creek fish.
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Figure 6. Immunoblot of liver extracts of mummichog (4 pg/lane) 36 hr following i.p. 
injections of 3-methylcholanthrene in com oil (3-MC) or com oil alone (CO). Upper blot 
was probed with anti P-glycoprotein antibody (mAb C219). The lower blot was probed 
with anti scup CYP1A (mAb 1-12-13).
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Figure 7. Sections of normal mummichog liver from King Creek. Top panel: C219 
immunohistochemical staining. Positive immunoperoxidase stain is reddish brown and 
localizes to the bile canalicular surface of hepatocytes. Bottom panel: H&E stained 
section from the same liver.
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Figure 8. Demonstration of specific immunohistochemical staining with mAb C219.
Top panel: Immunohistochemical staining using C219 of overexpressing hepatocellular 
carcinoma with connective tissue component. Note absence of immunoperoxidase stain 
in connective tissue component (central portion). Bottom panel: Immunohistochemical 
staining of adjacent serial section to the one shown in the top panel using matched iso type 
mouse myeloma protein (IgG2a, kappa) as primary antibody negative control.
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Figure 9. Neoplasms from Elizabeth River mummichog showing various types o f C219 
immunohistochemical staining. Top panel: Immunohistochemical staining with C219. 
Bottom panel: H&E staining. A: Hepatocellular adenoma showing overexpression and 
polar staining for Pgp. Note the well defined border between the over expressing 
neoplasm and adjacent nonneoplastic liver. B: Well differentiated hepatocellular 
carcinoma showing overexpression of Pgp and predominant polar staining. C, D & E: 
Hepatocellular carcinomas showing overexpression and loss o f polar expression for Pgp 
including cytoplasmic staining ( C & D) and expression on the entire plasma membrane 
(E). F: Hepatoblastoma with hepatocellular carcinoma component showing high level 
polar expression for Pgp within the hepatoblastoma (top panel, lower left). The 
hepatocellular carcinoma component shows overexpression and loss of polarity (top 
panel, extreme upper right). G: Hepatocellular carcinoma (lower left) with very large 
cells showing apparent reduction in staining for Pgp as well as paranuclear staining.
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INTRODUCTION
In Chapters II (Cooper et al., 1996) and III of this dissertation we have used 
immunohistochemical and immunoblot techniques to examine Pgp expression during 
environmental hepatocarcinogenesis in mummichog from the creosote-contaminated 
Atlantic Wood site. The results reported there indicate that a protein or proteins related to 
P-glycoprotein is elevated in non-tumor-bearing liver o f AW mummichog. The elevation 
in normal liver may be a result of environmental induction by components of creosote or 
other reversible changes. However it may also be a component of the genetic resistance 
of these fish. Similar elevation of Pgp-like activity or antigens have been reported in 
pollution-tolerant mollusks from contaminated sites, and it has been suggested that 
increased levels of Pgp activity may play a role in the survival of these organisms in 
contaminated habitats (Minier et al., 1993; Kurelec et al., 1995; Kurelec et al., 1996). We 
also found that Pgp was overexpressed and had altered patterns of expression in the 
majority o f the progressed environmentally induced liver tumors of the AW mummichog. 
These results are similar to those reported for experimentally induced rodent liver 
neoplasms (Teeter et al., 1990; Bradley et al., 1992). The association of increased 
expression of specific Pgp isoforms (mdrl-type) with xenobiotic resistance in 
mammalian cell lines suggests that this increased expression of Pgp may contribute to the 
survival of these fish in the highly contaminated environment.
However, the specific forms of Pgp expressed in the livers and liver tumors of 
these fish are unknown. The antibody (mAb C219) used in the studies reported in 
Chapters II and III of this dissertation binds a highly conserved epitope found in the
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deduced amino acid sequences of all known Pgp gene family members (Kartner et al., 
1983; Georges et al., 1990). Thus multiple Pgp homologs may contribute to the signal 
seen in immunoblots and immunohistochemical staining of normal mummichog liver and 
liver tumors. Southern blots of genomic DNA of several fish species indicate that fish 
have at least two Pgp genes (Ling et al., 1992; Chan et al., 1992). As is the case with 
mammalian mdr and spgp genes, the teleost homologs o f these genes are probably 
regulated differently from each other, and their gene products have distinct functions. 
Further understanding o f the significance of expression of Pgp in mummichog from the 
creosote contaminated environment will require characterization of the Pgp gene 
sequences expressed in mummichog liver and liver tumors.
In the present Chapter we have used reverse transcriptase-polymerase chain 
reaction (RT-PCR) to amplify Pgp sequences expressed in mummichog liver. Our goals 
were to amplify, clone and sequence Pgp related sequences expressed mummichog liver, 
to use these sequences as probes to investigate tissue specific expression of the 
mummichog gene in northern blots and to relate these sequences to other vertebrate Pgps 
of known function. These studies are necessary background to investigating the nature of 
Pgp sequences which are elevated in mummichog from contaminated environments.
We report that we have amplified and cloned overlapping cDNA fragments that 
are most closely related to the winter flounder pgpA gene and the rat and pig spgp P- 
glycoproteins. This Chapter presents a comparison o f the sequences from mummichog 
liver to that of other vertebrate spgp and Pgp cDNA sequences. Evidence presented here 
supports the spgp gene category as a distinct and highly conserved branch of the Pgp
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multigene family. In the mummichog, as in mammals spgp is most strongly expressed in 
liver. To our knowledge, this represents the first cDNA sequence of a Pgp homolog from 
a teleost and is the first report on tissue specific expression of a Pgp gene in a fish.
MATERIALS AND METHODS
Fish collection and tissue preparation— Mummichog were collected in a 
minnow trap from King Creek a tributary of the Severn River in the Gloucester County 
Virginia. Fish were sacrificed within 48 hrs of capture by overdose with tricaine methane 
sulfonate (Sigma). Livers, anterior kidney, brain and intestine were excised and either 
processed immediately or snap frozen in liquid nitrogen and stored at -70° C until use.
RNA isolation—  A l aqueous solutions used with RNA were either treated with 
dethylpyrocarbonate (DEPC) (Sigma, St. Louis, Missouri) or were made with DEPC- 
treated water (DEPC H20 ) to inhibit any contaminating exogenous ribonucleases (Farrell, 
1993).
Total RNA was prepared by a modification method of Chomczynski and Sacchi 
(1987) using the commercial preparation Tri-Reagent (Chomczynski, 1993) according to 
the manufacturers instructions (Molecular Research Center, Inc., Cincinnati, Ohio). 
Frozen organs were quickly broken into small pieces with a hammer and added to 10 
volumes of ice cold Tri-Reagent in a Potter-Elvjehm Teflon-glass homogenizer. 
Homogenization was accomplished using an electric drill motor to drive the Teflon 
pestle. Seven or more up and down strokes at full speed were used to ensure complete 
disruption of tissues. Phase separation was achieved with chloroform as described in the
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Tri-Reagent protocol. The overlying aqueous phase was collected and total RNA was 
precipitated from it with isopropanol. The precipitated RNA was colected by 
centrifugation and washed with 75% ethanol. The pellet was then resuspended in 0.5% 
SDS, and the concentration of total RNA was estimated by measuring the absorbance of 
the solution at 260 nm (Farrell, 1993). RNA was then precipitated with sodium acetate 
and ethanol. Precipitated RNA was stored as a suspension at -80° C until use. The 
integrity and yield of total RNA was confirmed by agarose/formaldehyde gel 
electrophoresis using 0.66M formaldehyde concentration in both the gel and the sample 
buffer (Farrell, 1993). Ethidium bromide was included in the sample buffer so that the 
RNA bands could be visualized without staining and destaining the entire gel.
A polyA+ enriched RNA fraction was prepared from mummichog liver total RNA 
using oligo-(dT) cellulose columns (Molecular Research Center) according to standard 
protocols (Sambrook et al., 1989). The frozen suspension o f total RNA was thawed on 
ice and an aliquot containing between 1 and 1.5 mg of RNA was removed, pelleted in a 
microcentrifuge, and washed with 75% ethanol. The pellet was then dissolved in 1 ml of 
binding buffer (0.5 M LiCl, 50 mM disodium citrate, 0.1% SDS) and heated to 70° C for 
5 minutes. After cooling on ice for 5 minutes, the entire solution was applied to the 
equilibrated column. The flow through fraction was collected in a tube on ice and applied 
onto the column again. The column was then washed with four 0.5 ml portions of 
binding buffer. A poly A enriched fraction was eluted as a single fraction with 0.6 ml of 
elution buffer (ImM disodium citrate, 0.1% SDS). This fraction was collected in a pre­
chilled microcentrifuge tube on ice. Yield of the poly A+ enriched RNA was estimated
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by measuring the absorbance of the solution at 260 nm. This poly A+ fraction was then 
precipitated with 0.1 volume of sodium acetate, 5 pi of Microcarrier gel (Molecular 
Research Center) and 2 volumes of ethanol. Precipitated RNA was stored at -80° C until 
use.
First strand cDNA synthesis—  First strand cDNA was synthesized using poly 
A+ liver RNA and recombinant Moloney murine leukemia virus-reverse transcriptase 
(MoMLV) (Superscriptll™ reverse transcriptase, Life Technologies, Bethesda,
Maryland). Reverse transcription was primed with either random hexamers (Life 
Technologies, Bethesda, Maryland) when the resulting cDNA was to be used for 
amplifying internal segments or an oligo-(dT)17 adapter primer (Table 3, custom 
synthesis, Life Technologies) when amplification of the 3' end of the cDNA was sought 
(Frohman, 1988 ). (See the description of 3' RACE given below under Amplification o f  
the 3' end (S2) o f  the mummichog spgp cDNA.) An aliquot of suspended poly A+ RNA (1 
gg) was pelleted, washed with 75% ethanol and dried in a SpeedVac (Savant,
Farmingdale, New York). The pellet was dissolved in 17.5 pi o f DEPC treated water 
(DEPC H20 ) containing either 125 ng of random hexamers or 500 ng of the oligo-(dT)17 
adapter primer (Table 3). This primer-RNA mixture was heated to 70° C for five 
minutes, chilled on ice and used immediately in the first strand synthesis reaction. All 
first strand reactions took place in 50 pi IX reverse transcriptase buffer (50 mM Tris- 
HC1, pH 8.3, 75 mM KC1, 3mM MgCL) containing dithiothreitol (lOmM), Rnasin (1 
unit/pl) (Promega, Madison, Wisconsin) and the four deoxynucleotide triphosphates 
(dNTPs, 500 pM each, Life Technologies). Reverse transcriptase (MoMLV, 300 units)
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was added to start the reaction which was incubated for 10 minutes at room temperature 
and then placed in a 42° C water bath for 1 hour. First strand cDNA pool was 
precipitated with sodium acetate /ethanol and stored overnight at -20° C. On the 
following day, the cDNA pool was pelleted in a microcentrifuge, washed with 75% 
ethanol and dissolved in 100 pi of DEPC H20 . The cDNA pool was then divided into 10 
pi aliquots and stored in 0.2 ml PCR tubes at -20° C until use.
General conditions for amplification of first strand cDNA— The polymerase 
chain reaction (PCR) was used to amplify specific regions o f the mummichog spgp first 
strand cDNA. Oligonucleotide primers were synthesized by Genosys (The Woodlands, 
Texas) and Life Technologies Inc. (Bethesda, Maryland). Taq DNA polymerase was 
from Boehringer-Mannheim (Indianapolis, Indiana). Sequences of the primers as well as 
the regions amplified are given in Table 3. Amplifications were performed on Biometra 
UNO-Thermoblock™ thermocycler (Biometra, Tampa, Florida). All reactions took place 
in 100 pi IX PCR buffer (lOmM Tris-HCl, pH 8.3, 50 mM KC1) containing MgCL (1.5 
m M ) and the four dNTPs (200 pM each). Primer concentrations were usually 1 pM 
except where noted for specific amplifications. For each amplification 10 pi o f  either the 
random primed or oligo-(dT)17 adapter primed cDNA pool was used. Taq polymerase 
(2.5 units) was added to each reaction only after the mixture was denatured for 5 min at 
94° C and cooled to 72° C in the thermocycler.
For most amplifications the technique of touchdown PCR (Don et al., 1991) was 
used. In this technique the annealing temperature during the thermal cycling protocol 
was initially set higher than the expected annealing temperature of the primers. At each
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cycle, the annealing temperature was lowered incrementally through the expected 
annealing temperature. Several cycles of amplification were then performed using the 
lowest annealing temperature. This protocol should give a selective advantage to 
products resulting from primer template pairs with the fewest mismatches (highest Tm). 
Touchdown PCR has proven useful in reducing the number of nonspecific products in 
situations where degenerate primers have been used (Don et al., 1991; Roux et al., 1994) 
as is the case in the present study. The relative sizes of the PCR products were 
determined by agarose gel electrophoresis. Details of the specific amplification 
conditions for each fragment (SI, S2, S3 and S4) are given at the end of this section..
Cloning and sequencing of PCR products—  PCR products were cloned using 
the Prime PCR Cloner Kit (5prime- 3prime Inc, Boulder, Colorado). This kit 
incorporates a column clean-up step of the amplification reaction prior to modification 
and ligation of the PCR products. For all amplified fragments greater than 1 kb in size a 
gel purification step was substituted for the for the column clean-up step in the kit 
protocol. The gel purification step was necessary because of the presence of multiple 
nonspecific bands in many of the amplification reactions. This step also increased the 
yield of recombinant colonies per cloning reaction because it concentrated the DNA. The 
entire amplification reaction (100 pi) was separated by electrophoresis on a 1% agarose 
gel. Following electrophoresis and staining, the band of interest was cut from the gel.
The DNA was separated from the gel matrix using the GeneClean kit (Bio 101, Vista, 
California). The DNA was eluted from the resulting glass-milk suspension in 15 pi of 
H20 . The entire volume was then used in the PCR Cloner protocol according to the
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manufacturers instructions. Transformants were selected on Luria Bertani (LB) agar 
plates containing ampicillin (100 pg/ml), and recombinant colonies were selected by 
blue/white screening on LB agar plates containing isopropyl P-D-thiogalactopyranoside 
(IPTG) and 5-bromo-4-chloro-3-indolyl-P-D-galactopyranoside (X-gal) (Sambrook et al., 
1989). Colonies were screened for insert size by agarose gel electrophoresis. Single 
colonies with the expected insert were grown overnight in LB broth containing ampicillin 
(100 (ig/ml). Plasmids were isolated and prepared for sequencing using the standard 
alkali lysis protocol (Sambrook et al., 1989).
The nucleotide sequence of the cloned inserts was determined by routine dideoxy 
chain termination protocol using the Sequenase kit (United States Biochemical,
Cleveland, Ohio) following the manufacturers recommendations for sequencing double­
stranded templates, a Thio [35S]dATP was used as an internal label. Labeled products 
were resolved on a 6% acrylamide / 6M urea gel buffered with TBE (Sambrook et al., 
1989).
Specific Amplification conditions for spgp cDNA fragments—
I. Amplification o f the segment (SI) containing the 3' ATP binding region o f  
mummichog spgp— Degenerate oligonucleotide primers were used to amplify the distal 
(3') ATP binding region of the mummichog spgp transcript. These primers were designed 
to match the codons of vertebrate Pgp homologs in the vicinity o f the downstream 
Walker A and B nucleotide binding motifs. The nucleotide inosine was used in the 
primer sequences in the third position of codons with four base degeneracy to limit the 
number of different primer molecules (Knoth et al., 1988). The sense strand primer
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(Primer A, Table 3) codes for the amino acid sequence Val-Gly-Ser-Ser-Gly-Cys-Gly- 
Lys (VGSSGCGK) which corresponds to positions 1066-1073 of the hamster Pgpl 
amino acid sequence (Endicott et al., 1991). The antisense strand primer (Primer B,
Table 3) corresponds to the peptide Ala-Thr-Ser-Ala-Leu-Asp (ATSALD), positions 
1199-1204 of the hamster Pgpl sequence (Endicott et al., 1991). These amino acid 
positions are identical in all published vertebrate P-glycoprotein deduced amino acid 
sequences.
The predicted 417 bp fragment, SI, was amplifed from random primed cDNA 
using primers A and B (4 pM each) and a touchdown cycling protocol. Following 
denaturation at 94° C, the primers were annealed for 2 min initially at 62° C. The 
products were then extended at 72° C for 1.5 min followed by denaturation at 94° C for 30 
sec. Fifty cycles were carried out with an incremental decrease of 0.4° C in the annealing 
temperature at each cycle. An additional ten cycles were carried out with the annealing 
temperature fixed at 42° C. Products were then given a final extension at 72° C for 10 
min. The product was cloned and sequenced as described above. The sequence was used 
to generate a gene specific primer (gspl) which was used to amplify the 3' end of the 
mummichog spgp cDNA. (See 3 below). Additional gene specific primers were 
designed which were used in conjuction with another degenerate primer (primer C) to 
amplify the segment between the two ATP binding regions as described in 2 below.
2. Amplification o f the segments (S3 and S4) spanning the second transmembrane 
domain and the linker domain o f  mummichog spgp cDNA— Primer C (Table 3) was 
designed to match the consensus sequence of the upstream ATP binding region of
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vertebrate Pgps. This primer codes for the peptide Gly-Gln-Lys-Gln-Arg-Ile-Ala 
(GQKQRIA) corresponding to positions 533-539 of the hamster Pgpl deduced amino 
acid sequence (Endicott et al., 1991). These positions are identical in all published 
vertebrate Pgp deduced amino acid sequences. Primer C was used initially with a gene 
specific primer (gsp2, Table 3) designed from the downstream ATP binding region of the 
mummichog S 1 sequence. This primer pair was expected to amplify a segment spanning 
the two predicted ATP binding regions. These were used in a touch down cycling 
program with random primed mummichog liver cDNA pool. The cycling program was 
identical to that used for amplification of the S1 fragment except that the extension time 
was increased to 3 minutes. Under these conditions a 1.3 kb fragment, S3, was amplified. 
The sequence of this fragment matched the downstream portion of the expected product. 
However the gsp2 primer sequence was present on both ends of the amplified fragment.
A pair of overlapping gene specific primers (gsp3 and gsp4) were then designed from the 
sequence of S3 to be used in conjunction with primer C. Gsp3 and gsp4 were used in 
successive rounds of amplification. In the first round primer C and gsp3 were used in a 
touchdown cycling protocol. The annealing temperature was decreased from 60° C to 
50° C in 50 cycles. Annealing was for 1 min and extension for 2.5 min. The annealing 
temperature was maintained at 50° C for an additional ten cycles. All other cycling 
parameters were the same as described above. A fragment of expected size (1.2 kb) was 
amplified in low yield. This product was gel purified, and the DNA was extracted using 
the GeneClean kit. A 1 pi aliquot of the eluted DNA was subjected to a second round of 
amplification using primer C and gsp4. Thirty cycles were performed with the annealing
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temperature fixed at 50° C. A 1.2 kb fragment (S4, Table 1) was obtained in good yield.
3. Amplification o f  the 3' end (S2) o f the mummichog spgp cDNA—  The 3' end of 
the mummichog liver spgp cDNA was amplified using the method of rapid amplification 
of cDNA ends (31 RACE) (Frohman, 1988). This method uses an oligo (dT)17 primer 
with an adapter sequence (Table 1) at its 5' end to prime first strand cDNA synthesis.
This primer initiates cDNA synthesis at the complementary poly A tail of the mRNA. It 
also introduces an artificial sequence, the adapter, at the 5' end of the cDNA. The adapter 
sequence is used with an upstream gene specific primer to amplify the 3' end of the 
sequence in PCR. A gene specific primer (gspl, Table 3) and the adapter primer were 
used to amplify the mummichog liver cDNA pool that had been primed with the 
oligo(dT)17-adapter primer. A touchdown cycling program was used. The annealing 
temperature was decreased from 62° C to 48° C over 50 cycles. Annealing was for 2 min 
and extension was for 3 min. An additional 10 cycles were carried out with the annealing 
temperature maintained at 45° C. The resulting I kb product (S2) was cloned and 
sequenced as described.
4. Amplification o f  a mummichog fr-actin fragment— Universal actin 
oligonucleotide primers (Melanie Wilson, Mississippi State Medical Center, unpublished) 
were used as amplification controls in all cDNA amplifications. These primers gave the 
expected 660 bp fragment in amplification reactions of liver cDNA pool. This fragment 
was also cloned and sequenced as described for the mummichog spgp fragments. Its 
sequence verified that it was a P-actin cDNA fragment. This fragment was used as a 
control probe in northern blots of mummichog RNA.
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Sequence analysis—  Sequences were compiled and edited with the aid of of the 
computer program ESEE (The Eyeball Sequence Editor, version 3, Cabot and 
Beckenbach, 1989). The PROSITE computer program and data base on the ExPASy 
World Wide Web Molecular Biology Server (Geneva, Switzerland) was used for 
identification of putative protein kinase phosphorylation sites in the deduced amino acid 
sequence (Bairoch et al., 1995). The PCGene computer program package (Inteligenetics, 
Mountain View, California) was used to locate putative membrane spanning regions 
using Kyte and Doolitle hydropathy plots (Kyte and Doolittle, 1982) and the method of 
Eisenberg (Eisenberg et al., 1984). Other features o f the sequence were identified by 
inspection of the multiple sequence alignment and comparison with cDNA and deduced 
amino acid sequences of human (Chen et al., 1986; van der Bliek et al., 1988) hamster 
(Endicott et al., 1991) and Xenopus (Castillo et al., 1995) mdr isoforms and the rat spgp 
iso form (unpublished data kindly provided by Sarah Childs). Sequences of Pgp 
homologs were obtained from the GENBANK sequence database using the World Wide 
Web server at the National Center for Biotechnology Information (National Institutes of 
Health, Bethesda, Maryland).
Multiple alignment of the amino acid sequences of Pgp sequences was 
accomplished with the aid of the computer program CLUSTAL W (Thompson and 
Higgins, 1994) using the default parameters of the program. Similarity and identity 
scores on aligned sequences were calculated using the computer program Genedoc 
(Nicholas and Nicholas, 1996). For amino acid sequences similarity scores were 
calculated using the BLOSUM62 matrix provided with the program.
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Relationships among selected vertebrate and invertebrate P-glycoprotein 
sequences were assessed by phenetic (overall distance) and cladistic (parsimony) 
approaches. Both methods relied on the alignment o f the deduced amino acid sequences 
to assign homologous positions. The sequence of the yeast STE6 mating factor 
transporter (McGrath and Varshavsky, 1989), a member of the ABC superfamily, was 
also included in the analysis to serve as an out group sequence. The phenetic analysis 
was done with the aid o f the PHYLIP (Version 3.5c) computer program package 
(Felsenstein, 1993). A pairwise distance matrix of the aligned amino acid sequences was 
calculated using the PHYLIP Protdist computer program. The PAM/Dayhoff matrix 
option was used. The resulting distance matrix was used in the PHYLIP implemetation 
of the neighbor joining method to construct a phylogenetic tree (Saitou and Nei, 1987). 
For parsimony analysis, the aligned nucleotides of the coding regions o f Pgp homologs 
were input into the computer program PAUP (Swofford, 1993 ). The nucleotide 
alignment was created by using amino acid alignment from CLUSTAL W to align the 
codons of the selected Pgp homologs within the region of overlap with the mummichog 
sequence. Data were available for the winter flounder sequences and the pig spgp 
sequence only at the extreme 3' end of this region. The missing portions of these 
sequences were filled with gaps over the consensus length of the alignment. These were 
treated as missing data in the analysis. Untranslated regions were not considered in the 
analysis since no significant alignment could be found among any of the untranslated 
regions except the mammalian mdr sequences (data not shown). This gave an alignment
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with a consensus length of 2394 positions. All nucleotide positions were weighted 
equally, and uninformative characters were ignored. Most parsimonious trees were 
searched using the heuristic search option of the PAUP computer program.
Immunoblot detection of P-glycoprotein gene family member expression—  
Immunoblotting using the monoclonal antibody C219 (Signet Laboratories, Dedham, 
MA) was used in to detect expression of Pgp gene family members in mummichog liver, 
kidney, brain, intestine and gill. Immunoblotting and immunohistochemical staining 
were performed essentially as described in Chapters II and III of this dissertation. In the 
present study the method was modified to include preparation of a plasma membrane 
enriched microsomal fraction in order to increase the sensitivity of detection (Fredericks 
et al., 1991).
Mummichog liver, kidney, brain and gill samples were collected as described 
above (Fish collection and tissue processing). For these, the entire organs were 
homogenized to make membrane fractions. For intestines, only the epithelial lining was 
used. This was collected as follows. The entire intestinal tract was removed from the 
fish. The mesenteries and adhering organs were cut away. Then the intestines were 
flushed out with ice cold Tris-buffered saline (50 mM Tris-HCl, pH 7.4, 150 mM NaCl) 
by forcing the solution through from the anterior end using a syringe fitted with a 20 Ga 
needle. The intestine was cut along its entire length and laid open on a clean microscope 
slide. A second slide was then used to scrape off the lining of the intestine while the 
anterior end was held with forceps. The lining was then homogenized immediately.
All mummichog organs were homogenized in 20 volumes of ice cold Tris-
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buffered saline (50 mM Tris-HCl, 150 mM NaCI, pH 7.4) containing 5 mM EDTA and 
freshly added protease inhibitors, N-toluene sulfonamido-L-arginine methyl ester (0.38 
mg/ml), aprotinin (2% v/v), phenylmethyl sulfonyl fluoride (100 pg/ml) and leupeptin 
(10 jig/ml). All inhibitors were from Sigma. Homogenization was accomplished using a 
Polytron homogenizer (Brinkman Instruments, Westbury, NY).
The plasma membrane enriched microsomal fraction was prepared by differential 
centrifugation in a Sorvall RS28 centrifuge (DuPont, Wilmington, Delaware) using the 
F28/13 rotor. Homogenates were centrifuged at 4000 x g  for ten minutes at 4°C to 
collect a crude nuclear/mitochondrial pellet. The supernatant was collected and 
centrifuged at 100,000 x g  for 1 hr at 4° C. The supernatant was removed, and the 
microsomal pellet was dissolved in a minimum volume of Tris buffered saline containing 
1% v/v Triton X -100,1% w/v sodium deoxycholate, 0.1% w/v SDS and the protease 
inhibitors listed above. Protein concentrations were determined by the Lowry assay using 
bovine serum albumin as a standard.
The solubilized membrane fractions were then analyzed by immunoblotting. 
Membrane fractions (30 pg total protein) from each organ were separated by 
electrophoresis on a 5.6% acrylamide SDS-PAGE gel. A detergent extract of the 
colchicine-resistant cell line CHRC5 (Kartner et al., 1993) was also loaded as a positive 
control. Electrophoresis, electrophoretic transfer to a nitrocellulose membrane, and 
immunochemical detection conditions were identical to those described in Chapters II 
and III. The relative molecular weights o f immunoreactive bands were determined by 
comparing their positions with those of prestained protein molecular weight standards
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(BioRad, Richmond, California) on the immunoblot.
Northern Blot detection of mummichog spgp expression— Expression of 
mummichog spgp sequences was examined in total RNA of several mummichog organs 
using northern blots. Total RNA was prepared from mummichog intestine, gills, liver, 
and brain as described above. Total RNA (12 (ig) from each organ was electrophoresed 
on a 1% agarose-formaldehyde gel. Following electrophoresis, RNA was capillary- 
transferred to positively charged nylon membrane (Boehringer Mannheim) according to 
standard protocols (Farrell, 1993). After transfer, RNA was crosslinked to the membrane 
using ultraviolet light (Stratalinker, Stratagene, La Jolla, C A ). An antibody-based 
chemiluminescent labeling and detection system (Genius™ System, Boehringer- 
Mannheim, Indianapolis, Indiana) was used to prepare digoxigenin labeled cDNA probe 
and to detect hybridrizing RNA species. The membrane was probed with the digoxigenin 
(DIG) labeled S4 cDNA fragment or with a DIG labeled mummichog actin fragment.
The S4 fragment spans the poorly conserved linker region of the mummichog spgp and 
therefore was expected to serve as a gene specific probe. Labeled pobe was prepared by 
random priming of the gel-purified (GeneClean) S4 fragment or mummichog actin 
fragment with digoxigenin-11-dUTP using the Genius System Labeling Kit (Boehringer- 
Mannheim). The prehybridization and hybridization protocol followed that of Engler- 
Blum and colleagues (1993). The membrane was prehybridized for 1 hr at 68° C in 
0.25M sodium phosphate, pH 7.2, ImM EDTA, 20% SDS, 0.5% Boehringer-Mannheim 
blocking reagent. After lhr, the prehybridization solution was replaced with fresh 
prehybridization solution that contained an estimated 25 ng/ml of digoxigenin-labeled
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probe. The membrane was hybridized overnight at 68° C. On the following day, the 
membrane was washed three times for 20 min each of 20mM sodium phosphate, pH 7.2, 
ImM EDTA, 1% SDS at 65° C. After these washes, DIG-labelled hybrids were detected 
on the membrane according to the Genius™ System protocol using anti-digoxiginen 
alkaline phosphatase conjugate. Lumiphos 530 served as a chemiluminescent substrate. 
Chemiluminescent blots were exposed to X-ray film (Fuji RX) for from 1 to 5 hr.
RESULTS 
Amplification of expressed Pgp-related sequences from mummichog liver—
A combination of RT-PCR strategies was used to amplify four overlapping segments (Sl- 
S4) of a Pgp gene family member expressed in mummichog liver (Figure 10).
Degenerate oligonucleotide primers ( primers A and B, Table 3) to the conserved Walker 
A and B motifs of the ATP binding region of Pgp homologs were used to amplify the 
corresponding fragment of cDNA from mummichog liver. An amplified product of 
expected size (SI, 417 bp) was cloned and sequenced. The sequence of this fragment 
corresponded best to the downstream ATP binding region o f vertebrate Pgps. A gene 
specific primer (gspl, Table 3) was chosen from this new sequence and used in a 3'
RACE protocol with the adapter primer (Table 3) to amplify the region downstream of 
the S1 fragment and 3' end of the putative Pgp cDNA (Frohman et al., 1989). The 
sequence of the resulting product (S2, 1007 bp) was most similar to the 3' end of 
vertebrate Pgp homologs and included a portion of the 3' untranslated region (3' UTR).
To amplify sequences upstream of the SI segment, we used a degenerate oligonucleotide
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matching the Walker B motif for the upstream primer (primer C, Table 3) and a gene 
specific oligonucleotide (gsp2, Table 3) as the downstream primer. A product was 
amplified (S3,1327 bp) which overlapped with the SI region. The upstream sequence of 
S3 was similar to the transmembrane domain of the 3' half of vertebrate Pgps as expected 
but did not include the expected Walker B sequence (primer C). Instead it contained the 
gsp2 primer at the 5' end as well. A nested pair of downstream primers (gsp3 and gsp4, 
Table 3) was chosen from within the sequence of S3. Using nested amplifications with 
these gene specific primers and primer C, a fragment was amplified (S4, 1209 bp) which 
contained the transmembrane domain region and the expected upstream Walker B 
sequence.
Sequence of mummichog Pgp homolog— The overlapping clones o f the 
amplified fragments yielded the 3004 bp cDNA sequence shown in Figure 11. The 
fragment continued the reading frame of the C primer. This reading frame terminated in 
TAA 2295 bp downstream from the primer. There were 700 bp of untranslated sequence 
beyond the termination codon. The 3' untranslated region did not contain a consensus 
polyadenylation signal or a poly A tail. This apparently truncated product may have 
resulted from mispriming of the mRNA during first strand synthesis at an adenosine rich 
region upstream of the poly A tail. The translation of these overlapping cDNA fragments 
spanned 765 amino acids. A comparison of the deduced amino acid sequence of this 
mummichog pgp fragment with that of the full-length hamster pgpl cDNA indicated that 
the mumichog sequence spanned 58% of the coding region of the mRNA.
The basic features of P-glycoprotein sequences are present in the mummichog
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homolog (Figure 11). The fragment includes the Walker B motif o f the upstream ATP 
binding region, the linker region connecting the two halves of the protein, the membrane 
spanning domain of the second half o f the protein and the downstream ATP binding 
region including the Walker A and B motifs. Analysis of the mummichog sequence for 
membrane spanning helices using the Eisenberg (1984) algorhythm indicated the 
presence of only five membrane spanning segments in the mummichog sequence. The 
segments correponding to the ninth and tenth transmembrane helices in mammalian Pgp 
were identified as a single transmembrane segment. Hydropathy plots o f the mummichog 
deduced amino acid sequence and the hamster pgp3 sequence were very similar over this 
region (Figure 12) suggesting that the spgp P-glycoprotein also has six membrane 
spanning segments in this region as has been proposed for mammalian mdr P- 
glycoproteins (Endicott et al., 1991). Therefore transmembrane segments nine and ten 
(Figure 12) were assigned based on the multiple alignment o f vertebrate Pgp sequences 
(Figure 13B).
The mummichog sequence contained the epitope for the mAb C219 (Val-Gln- 
Glu-Ala-Leu-Asp, VQEALD, Georges et al., 1990) in both halves of the protein. The 
calcium and phospholipid dependent protein kinase (protein kinase C) recognition 
sequence (Kemp and Pearson, 1990) (Thr/Ser)X(Arg/Lys) occured eleven times in the 
mummichog deduced amino acid sequence (Figure 11). A cluster of three sites was 
present in the linker region of the protein in the sequence Ser-Tvr-Arg-Ala-Ser-Leu-Arg- 
Ala-Ser-Ile-Arg (potential phosphorylation sites underlined) in a similar location to the 
protein kinase C sites found in the linker region of mammalian mdr isoforms (Endicott et
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al., 1991). The sequence lacked the consensus cAMP dependent protein kinase (protein 
kinase A) recognition sequence found in the linker regions of mammalian mdr 1-type 
sequences (Endicott et al., 1991).
Sequence analysis—  The only published Pgp sequence data from teleosts are the 
winter flounder pgpA and pgpB sequences which comprise 348 and 354 nucleotides of 
the 3' end of the coding sequence respectively (Chan et al., 1993). For this reason the 
mummichog sequence was compared to other Pgp homologs over this region initially. A 
few small gaps were needed for alignment o f this portion of the mummichog deduced 
amino acid sequence and ten other vertebrate P-glycoprotein sequences (Figure 13 A). 
Over this region, 60 of 118 positions (51%) were occupied by identical amino acids and 
13 more positions by conservative substitutions in all eleven sequences (62% overall 
similarity). A pairwise comparison of the mummichog sequence to each of these 
sequences showed that the mummichog sequence was most similar to the three spgp class 
sequences (Table 4A). These are the pig spgp sequence (94% similar, 87% identical), the 
rat spgp sequence (93%  similar, 86% identical) and the winter flounder pgpA sequence 
(88% similar, 80% identical). All spgp-type sequences including the mummichog 
sequence share a distinctive conserved carboxyl teminal peptide, Thr-Gly-Ala-Pro-Ile- 
Ser. The similarity of the mummichog sequence to the other Pgp sequences was lower 
although still high (76-80% similar, 62-68% identical, Table 4A). This indicates that the 
region of Figure 13 A is well conserved in all of these P-glycoproteins.
The mummichog deduced amino acid sequence was aligned with six other 
vertebrate Pgp sequences over the entire region of overlap (Figure 13B). Significant gaps
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were placed in the poorly conserved linker region to optimize the multiple alignment. A 
pairwise comparison o f these sequences showed the mummichog sequence to be most 
similar to the rat spgp sequence (83% similar, 68% identical, Table 4B). The similarity 
to the other five vertebrate sequences was significantly lower than this (71-72% similar, 
48-50% identical). Both the rat spgp and the mummichog sequence had a longer linker 
region (78 and 90 amino acids) than the mdr sequences (59-62 amino acids). The 
alignment also showed that the rat spgp and the mummichog sequence shared the cluster 
of protein kinase C recognition sites within the linker region in the conserved sequence 
Ser-Tyr-Arg- X-Ser-Leu-Arg-Ala-Ser-Ile-Arg (where X is Ala in the mummichog 
sequence and Asp in the rat sequence). Like the mummichog sequence the rat spgp 
sequence lacked protein kinase A recognition sequences, Arg/Lys-Arg/Lys-X-Ser (Kemp 
and Pearson, 1990) present in the linker regions of the mdrl sequences and the Xenopus 
mdr sequence.
Relationships among Pgp sequences—  Both phenetic analysis of the deduced 
amino acid sequences and cladistic analysis of the aligned nucleotides of the cDNAs of a 
selection of vertebrate and invertebrate Pgp gave nearly identical relationships among the 
Pgp gene family members (Figure 14). In both cases the rat and mummichog spgp 
homologs were most closely related to each other and formed a sister group to all other 
vertebrate P-glycoproteins. Within the vetebrate mdr forms, the mammalian sequences 
were most closely related to each other while the Xenopus sequence was distant from 
these. The mammalian mdr homologs separated into two groups. This division parallels 
functional differences between the identified mdrl and mdr2 P-glycoproteins. The three
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Drosophila homologs formed a single clade which was the sister group to all o f the 
vertebrate P-glycoproteins. The Caenorhabditis elegans homologs, on the other hand, 
did not group together. Futhermore, the C. elegans mdrC/pgp3 form was quite divergent 
from all other P-glycoprotein homologs.
The winter flounder pgpA, pgpB and the pig spgp sequences were not included in 
the above analyses because of the small amount of coding sequence data available for 
these. When all vetebrate sequences including these were subjected to parsimony 
analysis, a single most parsimonious tree was obtained (Figure 15A). In this case, the pig 
spgp sequence was closest to the rat spgp sequence in the spgp clade as expected. Both 
of the flounder sequences also grouped in the spgp clade. However the placement of the 
winter flounder pgpB sequence in the spgp clade was unstable when the data were 
subjected to “bootstrap” resampling and replacement in the PAUP program. Included in 
the tree in Figure 15 are the levels of bootstrap support for each group in the tree. The 
pgpB sequence grouped with the spgp sequences in only 48% of the bootstrap replicates 
(60 of 124, Figure 15 A) while in 27% of the replicates (35 of 124, Figure 15 A) this 
sequence was grouped with the vertebrate mdr clade. In contrast the winter flounder 
pgp A sequence was within the spgp clade in 90% of the replicates (111 of 124, Figure 
15 A). All other groups within the vertebrate Pgp family members were supported in at 
least 92% of the replicates. When the winter flounder pgpB sequence was eliminated 
from the analysis, a single most parsimonious tree was found ( Figure 15B) supporting 
the division of the vertebrate Pgp gene family members into spgp and mdr classes. It also 
showed the winter flounder pgpA sequence as the closest homolog to the mummichog
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
1 2 2
spgp sequence.
Detection of expression of Pgp gene family members in mummichog— Both 
immunoblotting with the monoclonal antibody C219 and northern blotting using DIG- 
labelled mummichog S4 fragment were used to detect expression o f Pgp in mummichog 
organs. The mAb C219 was expected to recognize all P-glycoproteins while the S2 
fragment was expected to function as a gene specific probe for expression of mummichog 
spgp. The mAb C219 labeled a band at the molecular weight o f P-glycoprotein (170 
KDa) in immunoblots o f mummichog and intestine membrane fractions (Figure 16). 
Under the same conditions no band in the size range of P-glycoproteins was detected in 
the mummichog kidney, gill or brain membrane fractions. Several bands of lower 
molecular weight were present in the CHRC5, mummichog liver and brain lanes. These 
may have been cross-reactive proteins or proteolysis products. The mummichog spgp 
fragment S4 gave a hybridization signal in northern blots o f total RNA from mummichog 
liver (Figure 17). Under the same conditions no signal was seen in RNA from intestine, 
brain or anterior kidney. Comparison of the intensity of this signal from liver with that of 
an actin control suggested that the Pgp message is moderately expressed in liver. The 
molecular size of the band in liver RNA was estimated to be approximately 5.5 Kb.
DISCUSSION
We report the partial sequence of a cDNA for Pgp gene family member expressed 
in the liver of the mummichog. As far as we know, this is the most complete sequence of 
a P-glycoprotein cDNA from a teleost reported to date. The sequence of this cDNA was
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highly similar to the 3' terminal exons of the winter flounder pgpA gene, and the rat and 
pig spgp cDNA sequences. The mummichog sequence is therefore a transcript of the 
mummichog spgp gene of the newly described sister o f P-glycoprotein division o f the P- 
glycoprotein gene family which has recently been identified in three other vertebrate 
species (Childs et al., 1995).
The basic structure o f the P-glycoprotein gene family members is conserved in the 
mummichog spgp sequence. The fragment reported here contains the upstream Walker B 
nucleotide binding motif, the linker region connecting the two halves o f the gene product, 
the six putative transmembrane helices, followed by the downstream loop containing the 
ATP binding motifs. The mummichog sequence is most similar to the other vertebrate 
Pgp sequences in the ATP binding regions and is most divergent from the other 
sequences within the linker region.
The nucleotide sequence shows that the mummichog spgp transcript has a 
relatively long 3' untranslated region. Childs and colleagues (1995) have suggested that a 
long 3' UTR may be characteristic of spgp genes. Our data on the mummichog spgp 
transcript also support this idea. The 3' RACE product for the mummichog spgp cDNA 
obtained here has a truncated 3' UTR that is 700 bp long. The message size (5.5 Kb) of 
the spgp transcript estimated from northern blots of mummichog liver RNA indicates a 3' 
UTR longer than 1000 bp. This transcript is similar in size to the mRNA of the rat spgp 
gene (Childs et al., 1995). The winter flounder spgp gene ipgpA) transcript is predicted 
to have a 3' UTR in excess o f 1020 bp (Chan et al, 1992). The function of the 
untranslated region of mRNA is uncertain but is thought to influence message stability.
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The long 3' untranslated regions of the spgp transcripts may confer similar stabilities to 
these transcripts in different species.
Inspection of the alignment o f vertebrate P-glycoprotein homologs reveals some 
features which may be characteristic o f spgp proteins. All four representatives have a 
distinct carboxyl-terminal peptide, Thr-Gly-Ala-Pro-Ile-Ser (TGAPIS). However, the 
remainder of the sequence in the region o f overlap with the flounder and pig sequences is 
highly conserved with 78-80% of positions conserved between spgp and mdr P- 
glycoproteins. The alignment of the more complete sequences show some features that 
are shared only by the rat and by the mummichog spgp sequences. Both of these spgp 
sequences have a longer linker region compared to other vertebrate Pgp members forcing 
significant gaps into the multiple alignment. The linker region has been identified as a 
potential regulatory domain in Pgp family members and contains consensus recognition 
sequences for both the calcium phospholipid dependent protein kinase (protein kinase C) 
and the cyclic AMP dependent protein kinase (protein kinase A) in mammalian and 
Xenopus mdr sequences ( Endicott et al., 1991; Chambers et al., 1993; Castillo et al., 
1995). Both the rat and the mummichog spgp sequences share a cluster of three potential 
protein kinase C (PKC) phosphorylation sites at corresponding positions the within the 
linker region. A slightly different cluster o f conserved PKC recoginition sequences 
occurs in the linker region of mammalian and Xenopus mdr P-glycoproteins (Endicott et 
al., 1991; Castillo et al., 1995). These sites on the human MDR1 protein are 
phosphorylated in intact drug-resistant cell lines and in vitro in membrane vesicle 
prepartions by PKC (Chambers et al., 1992; Chambers et al., 1993). The mammalian
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mdrl-type P-glycoproteins and the Xenopus homolog also contain protein kinase A 
recognition sequences in the linker region. However neither the mummichog nor the rat 
Spgp sequences contain such sites. Phosphorylation seems to be involved in upregulating 
the pumping activity drug resistance homologs in drug-resistant cell lines (Chambers et 
al., 1990; Ma et al., 1991). The presence of analogous PKC phosphorylation sites in the 
spgp homologs suggests that they may also be phosphorylated and regulated by PKC.
The distinct but highly conserved nature of the cluster of protein kinase C recognition 
sequences in the linker region of the two spgp-type P-glycoproteins may indicate some 
divergence in regulation between the mdr and spgp isoforms.
Previous cladistic analysis of the deduced amino acid sequences of several ABC 
superfamily members and several P-glycoproteins indicated the existence of the spgp 
class of P-glycoproteins (Childs et al., 1996). This analysis was performed only over the 
limited data available for the deduced amino acid sequence of the 3' end of the pig spgp 
cDNA, a region that contains highly conserved amino acid positions among all P- 
glycoproteins. The previous analysis did not include any invertebrate Pgp sequences. In 
order to examine the validity and extent of the spgp category we have peformed cladistic 
and phenetic analyses o f the relationships among P-glycoprotein sequences using a 
different data set which includes the more complete mummichog spgp cDNA sequence 
and the rat spgp sequence (kindly provided by S.Childs). We have also included 
invertebrate P-glycoprotein sequences. Both phenetic analysis o f the deduced amino acid 
sequences and cladistic analysis of the coding sequence of P-glycoproteins support the 
spgp gene class as a distinct and well conserved lineage within the vertebrate P-
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glycoprotein gene family. In our analysis the spgp sequences from two teleosts and two 
mammals form a sister group to the vertebrate mdr sequences which includes the 
amphibian sequence (Xenopus mdr). This suggests that the apparent gene duplication 
event separating the spgp lineage from the mdr forms occured in some common ancestor 
of the vertebrates. However, it is notable that none of the invertebrate sequences nor the 
amphibian homolog can be assigned to either of the vertebrate P-glycoprotein categories 
(mdrl or mdr2) by this method. Furthermore the individual homo logs in Drosophila and 
the nematode (C.elegans) are less closely related within taxa than are the mammalian 
mdr and spgp forms. Although this is consistent with independent origins o f multiple P- 
glycoproteins in vertebrate and invertebrate lines, another explanation is the operation of 
a homogenization mechanism (concerted evolution) within the gene family in various 
lineages (Amheim, 1983). The very high relatedness of the mammalian mdr P- 
glycoproteins has been noted before, and there is evidence of concerted evolution within 
the mdr genes o f the hamster (Endicott et al., 1991), the mouse (Hsu et al., 1991) and man 
(Van der Bliek et al., 1988).
In order to determine the sites of expression of the mummichog spgp gene we 
have used immunoblotting to detect expression of all P-glycoprotein forms in 
mummichog organs. We also have used a poorly conserved region o f the mummichog 
spgp cDNA as a gene specific probe for mummichog spgp expression in northern blots of 
RNA from mummichog organs. The work in Chapter II and III o f this dissertation as 
well as another study in the guppy (Hemmer et al., 1995) have found P-glycoprotein 
expression in teleosts in the bile canalicular membrane of hepatocytes. Pgp expression
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
1 2 7
was also detected in the apical membrane of the epithelial cells of the kidney tubules and 
the intestine in the guppy (Hemmer et al., 1995). These are also sites of expression in 
mammals (Thiebault et al., 1987; Thiebault et al., 1989; Cordon-Cardo et al., 1990; 
Bradley et al., 1990). Our results here using immunoblots with mAb C219 show 
evidence of high level expression of P-glycoprotein family members in liver and lower 
level expression in intestine of the mummichog. However we did not detect P- 
glycoprotein expression in mummichog kidney. The reason for our inability to detect 
expression in this organ is unknown. It is possible that the large amount of hematopoetic 
tissue in the anterior kidney of the mummichog may have diluted the P-glycoprotein 
signal from the tubules. The hematopoeitic tissue did not react with C219 in 
immunohistochemical staining of guppy kidney (Hemmer, 1995). Therefore membrane 
fractions from the whole organ may not contain enough Pgp to detect in immunoblots 
under our conditions which have been developed for liver. Thus Pgp family members are 
likely expressed in mummichog liver, intestine and kidney. Since the mummichog spgp 
P-glycoprotein has the C219 epitope in two places in its sequence, immunochemical 
results using mAb C219 should detect both spgp and mdr P-glycoproteins. For this 
reason we have used the S4 fragment of the mummichog spgp cDNA to examine specific 
expression o f spgp gene in these organs. S4 spans the less well conserved linker region 
and should be less likely to cross-hybridize with mdr gene transcripts. Northern blots of 
RNA from brain, kidney, intestine and liver probed with S4 demonstrated expression of 
the spgp gene only in liver. This result is in accord with the liver specific expression 
reported for the rat spgp gene (Childs et al., 1995). Thus results here indicate that
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expression of the spgp homolog is responsible for a portion o f the signal seen in 
immunohistochemical staining of histologic sections and immunoblots of teleost liver 
with C219 in previous studies. The signal seen in other organs o f teleosts including 
kidney and intestine probably results from expression of one or more other homologs.
Restriction o f spgp expression to the liver in both the rat and the mummichog 
along with the highly conserved structure and sequence of the gene across such large 
evolutionary distances suggests that the spgp homolog has an essential role in normal 
liver physiology of all vertebrates. Immunohistochemical staining of mammalian and 
teleost liver with C219 has shown Pgp expression mainly on the bile canalicular 
membrane (Thiebault et al., 1987; Thiebault et al., 1989; Cordon-Cardo et al., 1990; 
Bradley et al., 1990; Hemmer et al., 1995). The mAb C219 also recognizes the spgp P- 
glycoprotein; therefore the spgp protein is probably expressed in the canaliculus as well. 
The sister of P-glycoprotein probably functions in ATP dependent transport of substances 
into the bile.
In mammalian liver the mdr homologs may have roles in in biliary excretion.
Both mdrl and mdr2 type P-glycoproteins are expressed in mammalian liver (Buschman 
et al., 1992; Smit et al., 1994; Teeter et al., 1990). Evidence suggests a physiological 
requirement for expression of mdr2 P-glycoprotein in transport o f phosphatidylcholine 
into bile (Smit et al.,1993; Ruetz and Gros, 1994). The role of the smaller amount of 
mdrl is less certain but seems to be that of a xenobiotic transporter (Schinkel et al.,
1994). Since the biliary excretion pathway is similar in teleosts and mammals (Honkanen 
et al., 1985; Sanz et al., 1993 ), fish are expected to have a requirement for a
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phosphatidylcholine translocator (mdr2 function) as well as a xenobiotic transporter 
(mdrl function) in addition to the spgp function. Southern blots o f genomic DNA of 
several fish species indicate the presence of two mdr genes (Ling et al., 1992). It seems 
likely that these will turn out to have homologous roles and expression patterns to the 
mammalian mdrl and mdr2 genes. One such gene may be the the winter flounder pgpB 
gene. However the relationship of the winter flounder pgpB gene to the other vertebrate 
genes is not resolved here because of the limited amount of coding sequence data which 
spans a highly conserved region. Perhaps additional sequence will show the winter 
flouder pgpB gene to be a member of the vertebrate mdr class.
Measurement o f Pgp expression in liver of teleosts with generic Pgp probes such 
as mAb C219 may be detecting as many as three different proteins (mdrl, mdr2 and 
spgp). These proteins will have different functions and the expression of each may be 
regulated differently. Our previous studies have shown elevation of expression of one or 
more Pgp isoforms in the livers of mummichog and liver tumors of mummichog from the 
highly contaminated Atlantic Wood site. Understanding the significance of our data on 
Pgp expression to the survival of mummichog at Atlantic Wood requires knowledge of 
the specific forms (xenobiotic transporters, phospatidylcholine translocators or spgp) 
being measured in mummichog liver and liver tumors. Chapter V of this dissertation 
reports the identification and sequence of a mummichog mdrl homolog expressed in 
intestine and liver.
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Figure 10. The strategy used to amplify segments of the mummichog spgp cDNA. The 
top of the Figure (dark line) shows a full-length mRNA for a pgp gene. The 5' end of the 
molecule is at the left. The Walker A and B nucleotide binding motifs of the upstream (A 
and B) and downstream (A’ and B’) ATP binding regions are shown. The 3' untranslated 
region (3' UTR) and the poly A tail (A(n)) are also shown. The mRNA was reverse 
transcribed (RT) to make first strand cDNA. cDNA was then amplified using the 
polymerase chain reaction (PCR) using primers (boxes with arrows) to specific regions of 
the cDNA. Primers A,B and C are degenerate primers to conserved regions. Primers 
gspl-gsp4 are gene specific primers to the mummichog spgp. Primers and the segments 
amplified are shown in Table 1.
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Table 3. Primer pairs used to amplify mummichog spgp cDNA. Peptide sequences are 
given for degenerate primers (A,B andC). The regions amplified are referenced to 
conserved features o f Pgp sequences; Walker A and Walker B = sequences of the 
nucleotide binding fold, TMD= transmembrane domain, UTR=untranslated region. The 
nucleotide binding folds and TMDs occur twice within the sequence and are identified as 
belonging to either the 5' or 3' half of the molecule. Plus (+) strand primers are 
complementary to the first strand cDNA. Minus (-) strand primers are complementary to 
the second strand cDNA. The size of the amplified fragment was determined by 
sequencing and includes the primer. Key to mixed and unusual base symbols: R=A+G, 
M=A+C, Y=C+T, H=A+C+T, I=inosine.
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Primer Sequence Strand Consensus Region Size of amplified
Name Peptide Amplified fragment
A GTIGGIAGYAGYGGITGTGG1AAR + VGSSGCGK. 3' Walker A - 3' Walker B 417 bp
B RTCIAGIGCIGAIGTIGC - ATSALD
gspl
adapter
ATTGCCAGGGCGATCATACG
TCTGAATTCTCGAGTCGACATCTT
+ 3' Walker B - 3* UTR 1007 bp
gsp2 CATGCTGATTTCCCGCAAGTTGTC -/+ 3' TMD - 3' Walker A 1327 bp
C GGICARAARCARMGIATHGC + GQKQRIA 5' Walker B - 3' TMD 1209 bp
gsp3 TCCTTCCCTAAGCCTGCGATGG -
gsp4 AGCCTGCGATGGTGCGGATGTTG -
1 3 4
Figure 11. Nucleotide and deduced amino acid sequence of the mummichog spgp cDNA 
determined from overlapping RT-PCR amplified fragments. The nucleotide sequence is 
numbered in 5' to 3' orientation. The sequence does not include the 3' degenerate primer 
(primer C). Amino acids are aligned with the second nucleotide o f each codon. 
Termination codon (TAA) is indicated by a * in the amino acid sequence. Sequences 
corresponding to the Walker A and Walker B nucleotide binding motifs are indicated 
with a line over the sequence. The C219 epitope is also indicated with an overline. The 
six transmembrane domains are indicated with a double overline and are numbered 
(TM7-TM12). Potential protein kinase C recognition sequences are marked with a ★.
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__________________________________________W a l k e r  B________________________________________________________________  C 2 1 9 _________
I A R A L V R N P R I L L L D M A T S A L D N E S E A T V Q E A L 3 3  
ATCGCTCGCGCTTTGGTCAGGAACCCACGCATCCTGCTGCTGGACATGGCGACTTCTGCTCTGGACAACGAGAGTGAAGCCACCGTTCAGGAAGCTCTG 9 9  
  ★
D K V R M G R T T I S I A L R L S T I K N A D I I V G F E H G R A 6 6  
GATAAAGTACGCATGGGACGCACCACCATCTCCATCGCTCTCCGGCTCTCCACCATAAAGAACGCAGACATAATTGTTGGCTTCGAGCACGGCCGGGCG 1 9 8
V E R G K H N E L L E R K G V Y F T L V T L Q S Q G D K A L N E K 9 9  
GTGGAGAGGGGCAAACACAACGAGCTGTTGGAGAGGAAGGGGGTGTACTTCACTCTTGTCACCCTGCAAAGCCAGGGAGACAAGGCTTTGAATGAGAAA 2 9 7
★ ★ ★
A R E M A E G E E Q E P Q R L N L S R A G S Y R A S L R A S I R Q  1 3 2  
GCCAGGGAAATGGCTGAGGGGGAAGAGCAGGAGCCACAGAGGTTAAATCTATCCAGAGCGGGCAGCTATCGCGCCAGTTTGAGAGCCTCGATCCGCCAG 3 9 6
R S R S Q L S N L I P E S S V P I A G D L G P R A Y S M S H E D K  1 6 5  
CGCTCCCGATCGCAGCTCTCCAACCTGATCCCAGAATCCTCAGTTCCCATTGCAGGAGATTTGGGCCCCAGAGCCTATTCTATGTCTCATGAAGATAAA 4 9 5
Y K K A A P A E E E E E E L V E P A P V A R I L K Y N L P E W P Y  1 9 8  
TATAAGAAAGCGGCACCAGCGGAGGAGGAGGAGGAGGAACTCGTGGAACCTGCTCCAGTTGCCAGGATTCTGAAATACAACTTACCGGAGTGGCCCTAC 5 9 4
TM7
M L F G S L G A A V N G G V N P V Y S L L F S Q I L A T F A V T D  2 3 1  
ATGCTGTTTGGATCTCTTGGGGCTGCAGTCAACGGAGGAGTTAACCCAGTTTACTCGCTGCTGTTCAGCCAGATCTTGGCGACGTTTGCTGTGACGGAT 6 9 3
TM8
P E A Q R R E I N G I C V F F V I V G V I S F F T Q M L Q G Y A F  2 6 4  
CCCGAGGCTCAGAGGAGGGAGATTAATGGAATCTGTGTGTTCTTTGTTATTGTTGGAGTCATCTCTTTCTTCACCCAAATGCTGCAGGGTTATGCCTTC 7 9 2
*
A K S G E L L T R R L R R I G F K A M L G Q E I G W F D D H R N S  2 9 7  
GCCAAATCTGGAGAGCTGCTGACCCGCAGGTTGCGGCGAATTGGTTTCAAAGCCATGCTCGGGCAAGAAATTGGCTGGTTTGATGATCACAGGAACAGC 8 9 1
*  TM9
P G A L T T R L A T D A S Q V Q G A T G S Q I G M I V N S L T N I  3 3 0  
CCTGGGGCCCTGACCACACGCCTGGCAACGGATGCCTCACAAGTGCAAGGGGCTACAGGCTCCCAGATTGGCATGATCGTCAACTCTCTGACCAACATC 9 9 0
^ = ^ = = = =  TM 10
G V A L I M S F Y F S S N V T L L I L C F L P F I A L S G G F Q A  3 6 3  
GGCGTGGCCCTCATCATGTCCTTCTACTTCAGCTCCAACGTCACGCTGCTCATCCTCTGCTTCCTGCCATTCATCGCACTCTCGGGCGGCTTCCAGGCC 1 0 8 9
K M L T G F A K Q D K Q A M E S A G Q V S G E A L N N  I  R T I A G  3 9 6  
AAGATGCTCACGGGTTTCGCCAAGCAGGACAAGCAGGCCATGGAGTCCGCTGGGCAGGTTTCAGGCGAGGCCTTGAACAACATCCGCACCATCGCAGGC 1 1 8 8
L G K E G S F V E K Y E A H L D S P Y Q A A L K K A N V Y G A C Y  4 2 9  
TTAGGGAAGGAGGGGAGCTTTGTGGAAAAGTACGAGGCTCACCTGGACTCTCCGTATCAAGCGGCCTTGAAGAAGGCGAACGTGTACGGGGCTTGTTAC 1 2 8 7
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L A Q C V I F L T N G A S F R F G G Y L V E Q E G L H F S L V F R  4 6 2  
CTCGCCCAGTGTGTGATCTTCTTGACGAACGGTGCGTCCTTCAGGTTCGGAGGCTACCTGGTGGAACAGGAAGGGCTCCATTTCAGCCTGGTGTTCAGG 1 3 8 6  
TM 12
V I S A I V T S G T A L G R A S S Y T P D Y A K A K T S A A R F F  4 9 5  
GTGATCTCGGCGATCGTCACCAGCGGCACAGCTTTAGGCAGAGCCTCCTCTTACACTCCGGATTACGCCAAGGCCAAGACATCAGCAGCGCGCTTCTTC 1 4 8 5
★
F Q L L D R V P P  I  S V Y S N R G E K W D N  F Q G N L E  F V H C K  5 2 8  
TTCCAGCTGCTGGACCGTGTGCCTCCAATCAGCGTCTACAGCAACAGGGGAGAAAAATGGGATAACTTCCAAGGGAACCTTGAGTTCGTACACTGCAAG 1 5 8 4
_____________±__________________________ W a lk e r  A___________________________
F T Y P T R P D I Q V L N G L N V S V R P G Q T L A F V G S S G C  5 6 1  
TTCACTTACCCCACCAGGCCCGACATCCAGGTCCTGAATGGCTTAAATGTGTCGGTGAGGCCCGGACAGACGTTGGCCTTCGTGGGCAGCAGCGGCTGC 1 6 8 3
G K S T S A Q L L E R F Y D P D H G K V L I D G H E S T R V S V P  5 9 4  
GGGAAGAGCACCAGCGCGCAGCTGCTGGAACGGTTCTACGATCCTGATCACGGCAAAGTGCTGATTGATGGCCACGAGTCGACTCGCGTCAGCGTGCCC 1 7 8 2
F L R S K I G I V S Q E P V L F D C S I A E N I K Y G D N L R E I  6 2 7  
TTCCTTCGTTCCAAGATTGGCATCGTTTCCCAGGAGCCCGTGCTGTTCGACTGCAGCATCGCGGAGAACATCAAGTACGGAGACAACTTGCGGGAAATC 1 8 8 1
S M N E V I S A A K K A Q L H D F V M S L P E K Y D A N V G S Q G  6 6 0  
AGCATGAACGAAGTCATCTCCGCTGCCAAGAAGGCCCAGCTCCATGACTTTGTTATGTCACTACCAGAGAAATACGACGCCAACGTGGGCTCTCAGGGC 1 9 8 0
________________________________ Walker B_________________________
S Q L S R G Q K Q R I A I A R A I  I  R D P K I  L L L D E A T S A L  6 9 3  
TCCCAGCTGTCCCGTGGCCAGAAGCAGCGCATCGCCATTGCCAGGGCGATCATACGAGACCCGAAGATCCTGCTCCTGGACGAGGCCACCTCGGCCCTG 2 0 7 9  
  ★  C 2 1 9 _________
D T E S E K T V Q E A L D K R R E G R T C I V I A H R L S T I Q N  7 2 6  
GACACGGAGAGCGAGAAGACTGTGCAAGAAGCCCTGGACAAACGGAGGGAGGGACGCACGTGCATCGTCATCGCTCATCGCCTGTCCACCATTCAGAAC 2 1 7 8
S D I I A V M S R G F V I E K G S H D Q L M A L K G A Y Y K L V T  7 5 9  
TCTGACATCATCGCCGTCATGTCCAGGGGCTTTGTGATCGAGAAAGGCTCGCACGACCAGCTGATGGCCCTGAAGGGGGCCTACTACAAGCTGGTGACG 2 2 7 7
T G A P I S  * 7 6 5
ACGGGAGCCCCGATCAGCTAACTGCCCACAGACGCTGCCAGAAGTGCCCTCTCTCGGCTGATCGGGACTGAAAGTATGCCTAACATGACATCAAGCACA 2 3 7 6  
CAAAAAGATGTATAAACCGATTTACTGTTGCGCTATTTATTATATGGAATATTGAGAAGCTGGAGACTTCATAAACGGGGGGAAATCAAGAGATTGCGG 2 4 7 5  
TGCTTAGAAATAGCTGCACAGGTTTTTTGTTTCTGACGGCTCTAAACATCTAGCAAGTACAACATCTACTGTACTAAATCAATTGCTAGCAGCAGCGGA 2 5 7 4  
GCAAATTAAGCTTTTACACTAGAACTTAAATTTAATTAGAACTTTTATTTACTTCCCACTTTGCTCTAAACATCTAGCAAGTACAACATCTACTGTACT 2 6 7  3 
AAATCAATTGCTAGCAGCAGCGGAGCAAATTAAGCTTTTACACTAGAACTTAAATTTAATTAGAACTTTTATTTACTTCCCACTTTGTGAAGTGAATGA 2 7 7 2  
TTAATTTGCTACGGAAGGATATATTGCTTTATTTACACATTAGTATGAGCCAGCGTGTCCTTTCAAGCCTGTTTTACTATAGAATTTAATAATGTGTTA 2 8 7 1  
TTTTTGTTTCATAAACTGCAGGTTTTTGATCTTCTACATAATGTGACAAATTCACGGTGATGGATAATAACGAAAAGTGTGCTGTTAGTGTAAGAAAGC 2 9 7 0  
TCTGCCAGTTTAATTTCCTCATATAGGAGGTACC 3 0 0 4
Figure 12. Hydropathy plots (Kyte and Doolittle, 1982) of the mummichog spgp (A) 
deduced amino acid sequence and the corresponding carboxyl terminal half of the 
hamster pgp3 (B) deduced amino acid sequence (Endicott et al., 1991). The plots were 
created using the SOAP program of the PCGene computer program package 
(Intelligenetics, Mountain View, California) using a window of nine amino acids.
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Figure 13. Multiple alignment of deduced amino acid sequences o f selected P- 
glycoproteins. Multiple alignments were created with the aid of the computer program 
CLUSTAL W (Thompson and Higgins, 1994). Positions with identical amino acids to 
mummichog spgp are shown as a dot ( .) . Gaps inserted into the sequences to optimize 
the alignment are shown as a dash (-). The positions of the Walker motifs, the linker 
region, the putative transmembrane segments (TM) and the C219 epitope are indicated.
A: Multiple alignment o f the carboxyl end of P-glycoproteins in the region of the 3' 
terminal exons of winter flounder sequences. B: Multiple alignment o f the carboxyl 
region of more complete P-glycoprotein sequences beginning at the N-terminal Walker B 
motif. References', human MDR1 (Chen et al., 1986); human MDR2 (van der Bliek et al.,
1988); hamster pgpl, pgp2 and pgp3 (Endicott et al., 1991); mouse m drla (Hsu et al., 
1990); mouse mdr2 (Gros et al., 1988); rat mdrlb (Silverman et al., 1991); rat mdr2 
(Brown et al., 1993); winter flounder pgpA and pgpB (Chan et al., 1993); pig spgp 
(Childs et al., 1995); rat spgp (unpublished data kindly provided by S.Childs); Xenopus 
mdr (Castillo et al., 1995).
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Figure 13A
________ Walker B___________ C219
Mummichog Spgp KYDANVGSQGSQLSRGQKQRIAIARAIIRDPKILLLDEATSALDTESEK-TVQEALDKRREGRTCIVIAHRL
Flounder PgpA . FNTL. . EG . G . M . G ...........LV.N.R M ......N...AII....... A .............
Pig Spgp ..ET............ E ......... V ...................... -...V....A..............
Rat Spgp . . ET ... I........ D......... V ...................... -...T....A..............
Flounder PgpB . F.TL. . DR.T .M.G V  LV.N.............. A. . .TIV......QASK IV....
Xenopus Mdr . . NTR. . DK. T . . . G ........... L..K.....................-V...... A.M............
Human MDR1 . . STK. . DK . T . . . G ........... LV . Q . H ...................-V...... A ..............
Hamster Pgpl . .NTR. . DK.T. . .G........... LV.Q.H...................-V...... A ..............
Hamster Pgp2 . .NTR. .DK.T. . .G........... LV.Q.H.................. -V...... A ..............
Human MDR2 . . ETR . . DK . T . . . G ........... L . . Q . Q ...................-V...... A ..............
Hamster Pgp3 . . KTR. . DK. T . . . G  L . . R . . L . . Q . RV................ -V....... A .............
Mummichog
Flounder
Pig
Rat
Flounder
Xenopu
Human
Hamster
Hamster
Human
Hamster
Spgp 
PgpA 
Spgp 
Spgp 
PgpB 
s Mdr 
MDR1 
Pgpl 
Pgp2 
MDR2 
Pgp3
STIQNSDIIAVMSRGFVIEKGSHDQLMALKGAYYKLVTT--GAPIS
• -Q.....
L.KR.V.HM 
LQ...V.FS
..................................Y .....T.N. . . V. . .
R ......... Q.M.T...T. EE . . . K . .
........ V.Q. V .....T.EK
..A .R ...LQG.V.V.Q.T.Q.
..A.K...IQN.K.V.Q.T.Q.
..A.L.V .FQN.R.K.H.T.Q.
..A.L.V.IQN.K.K.H.T.Q..L.Q.
..A .L .V .IQN.K.K.H.T.Q..L.Q. 
..A.L.V.FQN.R.K.H.T.Q..L.Q. 
..A.L.V.IQN.K .K.H.T.Q..L.Q.
L .Q .
. ..QM.HGRH 
. .IQL.HS —  
I.FSM.SVQA.TKRQ 
I.FSM.SVQA..KR- 
I.FSM.--QA..KRL 
I.FSM.SVQA.TQNL 
I .FSM.NIQA..QN.
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F i g u r e  13B
Mummichog Spgp 
Rat Spgp 
Xenopus Mdr 
Human MDR1 
Hamster Pgpl 
Hamster Pgp2 
Human Mdr2 
Hamster Pgp3
Walker B C 2 1 9
IARALVRNPRILLLDMATSALDNESEATVQEALDKVRMGRTTISIALRLSTIKNADIIVGFEHGRAVERGKH 
I . .K. . . .R . .N.IQH.H I ..V.H... . VRA .V. I .___ V. . . . .T.
. .K. . . . E . . .. . . T . .. .V. .S. . . . A .E. . ..VV.H .. . . . R . NA.A. .DN.VI. • Q. S .
. .K. . . . E . . . . . T . . .V. . V. • • • A .K. . ..V..H... .VR. . V.A. .DD.VI.. K . N .
. .K. . ..E... ...T..
. .K. . . . E . . . . T . . . V. .A. . . .A. E. . ..V..H... . VR. . V . A ..DG.VI. • Q.N.
. .K. . . . E . . . . T . . . E . .A. . . .A. E. . ..V..H... . VR. .V.A. ..D.VI.. Q . S .
. .K. . ..E... ...T... .E. . A .. . .A. F,. . • Q • S .
Linker
Mummichog Spgp 
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D . . M K E . . I . . K . . . M . T A . N E V E L . N . A D E S K -S . ID A LE M S S N D S R . S L IR K . S T R . SVRG  . ------------------
E . . M R E. . I . . K . . M T . T A . N E IE L G N E V G E S K -N . ID N LD M S S K D S A . S L IR R . S T R . S IR G  P------------------
E . . M K E . . I . C R . . MM. T R . N E V E LG S E A D G S Q -S D T IA S E . T S E E F K . P S V R -K S T C . S IC G . ------------------
5 . . MKK E ------- K . . NM. T S . S Q IQ S . E FE LN D  . K A A T . MAPNGWK. R L F R -H S T Q K N L K N . --------------------
5 . . MQK E ---------K . . NM . T S . S Q I . S Q E F E V E L S -. . KAADGMTPNGWK. H IF R -N S T K K S L K S . ------------------
Domain TM7
Mummichog Spgp 
Rat Spgp 
Xenopus Mdr 
Human MDR1 
Hamster Pgpl 
Hamster Pgp2 
Human Mdr2 
Hamster Pgp3
SSVPIAGDLGPRAYSMSHEDKYKKAAPAEEEEEELVEPAPVARILKYNLPEWPYMLFGSLGAAVNGGVNPVY 
PPLAV.---------- D.KSS. . DSKDND-VLV . E ..... R ......I...H.I.V...S..I..A.T.I.
-VP.TED.EVDEE.KKK..GPP.VSFFKVM.L .K .. 
--QAQDR.LSTKEAL--D.SIP.VSFW..M .L ..T. 
--.DQDR.LSTKEAL--D.D .P .ISFW....L.SS. 
■-QDQERRVSVKEAQ--D.D .PLVSFWG...L.IT. 
-QMCQ.SLDVETDGL--.AN.P .VSFLKV..L .KT. 
-RAHHHRLDVDAD.L— DAN.P .VSFLKV..L .KT.
.FVV.VIC.MI 
.FVV.VFC.II 
.FVV.IFC.I. 
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===== TM8
Mummichog Spgp SLLFSQILATFAVTDP-EAQRREINGICVFFVIVGVISFFTQMLQGYAFAKSGELLTRRLRRIGFKAMLGQE
Rat Spgp ..... L .G . .SLL.K-.Q . .S . .HSM.L . . . .L .CV.I . . .F . . T .K. .. KF.... . . . D
Xenopusi Mdr All..R.IGV..GPVS--QM.S .SSMYSLL.LAL.GV..I.FF... FT . G . A . . I..M. ..LGS..S ..R. .
Human MDR1 All. .K .IGV.TRI.DP.TK.QNS.LFSLL.LAL.I. . .I.FF. .. FT. G . A . . I ..K. ..YMV.RS.. R . D
Hamster Pgpl .11. .KVVGV.TRNTDD.TK.HDS.LFSLL.L .L .... I.FF. . . FT . G . A . . I ..K. ..YMV..S .. R. D
Hamster Pgp2 .IV..G .IGV.TRD.DPKTKQQNC.LFSL..LVM.M .C .V .YFF.. FT . G . A . . I..K. ..YMV..S .. R. D
Human Mdr2 .VI. .E .I.I.GPG.D-AVKQQKC.IFSLI.LFL.I.... FF. . . FT . G . A . . I.• . . ..SMA.... . R . D
Hamster Pgp3 .IIL.EMI.I .GPG.D-AVKQQKC.LFSLV.LGL..L___ FF.. . FT. G . A . . I ..T. .•SMA.... . R . D
TM9 TM10
Mummichog Spgp 
Rat Spgp 
Xenopus Mdr 
Human MDR1 
Hamster Pgpl 
Hamster Pgp2 
Human Mdr2 
Hamster Pgp3
IGWFDDHRNSPGALTTRLATDASQVQGATGSQIGMIVNSLTNIGVALIMS--FYFSSNVTLLILCFLPFIAL 
..... L..N..V.................... V..M...F. .TIA. .LIA--.F. . WKLS . I . TI. F. .L. .
VS
VS
.S
MS
.SK..T .................... TRLALLAQNVA. L . T . I
.PK.TT....... N. .A. .K. .1. . RLAV . TQNIA. L . TGI
NPK.TT........N..G..K... . ARLAV . TQNIA. L . TGI
  T ....... S . . AN . K . . MS . RLAG . TQNVA. L . TGI
. . .K. .T. . .S...... A ....... TRLAL . AQNIA. L . TGI
— LIYGWQL. 
--LVYGWQL. 
— .IYGWQL.
MS YK. .T. . .S..... RA....... TRLAL . AQNTA. L . TGI. I I Y G W Q L .
--.IYGWQL.....Al V . V . .A
--.IYGWQL...L.AIV.I..1
, L . AI V. I . . I 
,LVVIA.L .I. 
.L.AVV.I..V 
, L . SVV V
Mummichog Spgp 
Rat Spgp 
Xenopus Mdr 
Human MDR1 
Hamster Pgpl 
Hamster Pgp2 
Human Mdr2 
Hamster Pgp3
SGGFQAKMLTGFAKQDKQAMESAGQVSGEALNNIRTIAGLGKEGSFVEKYEAHLDSPYQAALKKANVYGACY
. . AV. T .......S . .
A.LVEM..FA.H ..K . 
A.VVEM...S.Q.LK. 
A.VVEM...S.Q.LK. 
..MMEM.V.S.Q.LK. 
..IVEM.L.A.N..R. 
..IVEM...A .N ..R .
•.L .K .•.ITS.•.S..
KEL.K..KI.TD.VL.. 
KEL.G..KIAT..IE.F 
KEL.GS.KIAT..IE, 
KEL.VS.KIAT..IE, 
KEL.A..KIAT..IE, 
K.L.A..KIAT..IE,
.V ..I .SG.R .IKAF.VE.QTS.KT.VR...I ..L .F 
.VVS.TR.RK.EAM..KS.EG..RNSI...HLH.LT.
.VVS.TQ.QK.EHM.AQS.QV..RNS.R ..HIF.ITF
F ..VVS.TR.QK.ENM.AQS.QI..RN.....H .F .ITF
F..VVS.TR.QK.ENM.AQS.QI..RN.....H .F.ITF
...VVS.TQ.RK.ESM.VEK.YG..RNSVQ..HI..ITF 
...VVS.TQ.RK.ESM.VEK.HE..RNSVQM.HI..ITF
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Figure 13B (cont.)
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TM12
-LAQCVIFLTNGASFR-FGGYLVEQEGLHFSLVFRVISAIVTSGTALGRASSYTPDYAKAKTSAARFFFQLL
AFS.GIA. .A .S .AY.-Y IAY...G..H V.SVAL.
G .S .AHHV.CLCWV.SVL.A. . .VEGLMKLDE. .L .S  LG
SFT.AMMYFSYA.C ..-..A ...AR.LMT.EN.LL.F .
SIS.AFMYFSYAGC. .A..IVNGHMR.RD.IL.F ____FGAV,
.V .TF. .S.S. a a a I a
• • QT. aFA a a a T .MI aa a H-I a S a a
.V QV. aFA___ a a I aa a H-IIMII
.V •QV. aFA___ a a V. .SH-IIMII
• A .N. a a FA___ a .V. .SH-IIRIM
H. a aFA___ a .La ..H-L.M.F
H. a aFA___ a .La ..H-L.S.F
WalkerA
Mummichog Spgp 
Rat Spgp 
Xenopus Mdr 
Human MDR1 
Hamster Pgpl 
Hamster Pgp2 
Human Mdr2 
Hamster Pgp3
DRVPPISVYSNRGEKWDNFQGNLEFVHCKFTYPTRPDIQVLNGLNVSVRPGQTLAFVGSSGCGKSTSAQLLE
I.K...N...EA.........KID.ID......S .......... S...N...........   I....
E . . . Q 
EKT.L
EK..S.DS..TG 
EKI.S.DS..T.
E .Q .L .DS..EE 
E .Q .L .DS..GE
DS..DQ...PK.CS..VV.KGVN.N , 
DS..TE.LMPNTLE..VT.GEVV.N , 
L.PNTLE. . VK . N E W  . N , 
L .PNWLE..VK.NEVV.N, 
L.P.K.E..IT.NEVV.N, 
LWP.K.E.SVT.NEVV.N
.T. 
.P. 
. P, 
. P .  
ANVP, 
ANMP,
• Q.
• Q.
• Q.
• Q.
• Q.
• Q.
.D I..KQ.E ...L...
.SLE.KK L. . .
a a LE a a a a a a II a a a
a SLE.KK.....La a a
a SLE.KK.....La a a
a SLE.KK.....La a a
• TVS. 
a VV. a 
a VV. a 
a VV. a 
a VV. a 
a VV. a
Mummichog Spgp RFYDPDHGKVLIDGHESTRVSVPFLRSKIGIVSQEPVLFDCSIAENIKYGDNLREISMNEVISAAKKAQLHD
Rat Spgp .... Q.T.M.a a . D.KK.NIQ___ N ..... a a .MD.... a .TK. a a VERA. A a a• Q ....
Xenopus Mdr a a a a FE a E a a V a.LSVRNLNIQWV.AQM a a I a a aa a .GD. a A. a. . N a KVTQE a IET a a•E.NI.S
Human MDR1 a a a a LA a a a a L a.K.IK.LN.QW..AHL___ a a I a a a...... A. a a aS.VV.QE.IVR. aa E a NI a A
Hamster Pgpl a a a a MA a T a FL aa K a VNQLN a QW a .AHL. a a a a a I a a a...... A. a a a S a VV.QD. IER. aa E a NI a Q
Hamster Pgp2 a a a a MA a T a FL a.K.IKQLN.QW..AHL___ a a I a a a...... A. a a .S a VV.QD. IER. aa E a NI a Q
Human Mdr2 a a a a LA a T a .La .Q.AKKLN.QW..AQL___ a .1. a a...... A. a a .S. VV.QD. IV. a aa A a NI a P
Hamster Pgp3 ___ MA a T a a L a .Q.AKKLNIQW..AQL___ ............... ...... A. a a a S a VV a QD a IVR a .a A a NI a P
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_________ WalkerB________  C219
Mummichog Spgp FVMSLPEKYDANVGSQGSQLSRGQKQRIAIARAIIRDPKILLLDEATSALDTESEKTVQEALDKRREGRTCI
Rat Spgp .........ET ... I ........ D.......... V ......................... T....A.......
Xenopus Mdr . IE . . TD. . NTR ..DK.T...G........... L..K.....................V ...... A.M.....
Human MDR1 . IE . . . N . . STK . . DK. T . . . G .......... LV.Q.H...................V ...... A .......
Hamster Pgpl . IE. . .D. .NTR. .DK.T. . .G.......... LV.Q.H...................V ...... A .......
Hamster Pgp2 . IE . . . D . . NTR. . DK. T . . . G .......... LV.Q.H...................V ...... A .......
Human Mdr2 . IET. . H . . ETR..DK.T...G...........L..Q.Q.................. V .......A .......
Hamster Pgp3 . IET . . Q . . KTR. . DK.T . . . G  L . . R . . L . . Q. RV................ V .......A .......
Mummichog Spgp VIAHRLSTIQNSDIIAVMSRGFVIEKGSHDQLMALKGAYYKLVTT--GAPIS
Rat Spgp 
Xenopus Mdr 
Human MDR1 
Hamster Pgpl 
Hamster Pgp2 
Human Mdr2 
Hamster Pgp3
. V. Q. V, .T.EK. . .Q........ I.—
..A .K ...IQN.K.V.Q.T.Q..LQ.. 
..A.L.V.FQN.R.K.H.T.Q..L.Q. 
..A.L.V.IQN.K.K.H.T.Q..L.Q. 
..A.L.V.IQN.K.K.H.T.Q..L.Q. 
..A.L.V.FQN.R.K.H.T.Q..L.Q.
V.FS...IQL.HS—  
I.FSM.SVQA.TKRQ 
I.FSM.SVQA..KR- 
I.FSM.--QA..KR- 
I .FSM.SVQA.TQNL
....A.L.V.IQN.K.K.H.T.Q..L.Q..1.FSM.NIQA..QN.
1 4 6
Table 4. Pairwise comparison matrices o f the deduced amino acid sequences for a 
selection of Pgp homologs. The three numbers for each entry below the diagonal give the 
number of positions in the alignment that are identical between the two sequences (top 
number), identical positions plus conservative substitutions (center number) and the 
number o f positions that line up with a gap (bottom number). The region of the matrix 
above the diagonal gives these values as percentages. The number along the diagonal 
gives the number of amino acids in the sequence. Conservative substitution groups from 
the BLOSUM 62 scoring matrix are (D, N); (E, Q); (S, T); (K, R); (Y, W, F) and (L, I, V, 
M). A: Pairwise matrix of the comparison over the region of the winter flounder 
sequences. B: Pairwise matrix for sequences with complete data over the length o f the 
mummichog spgp sequence. References: human MDRl(Chen et al., 1986); human 
MDR2 (van der Bliek et al., 1988); hamster pgpl, pgp2 and pgp3 (Endicott et al., 1991); 
mouse mdr la  (Hsu et al., 1990); mouse mdr2 (Gros et al., 1988); rat mdr lb (Silverman et 
al., 1991); rat mdr2 (Brown et al., 1993); winter flounder pgpA and pgpB (Chan et al., 
1993); pig spgp (Childs et al., 1995); rat spgp (unpublished data kindly provided by 
S.Childs); Xenopus mdr (Castillo et al., 1995).
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Table 4 A
Mummichog
Spgp
Flounder
PgpA
Pig
Spgp
Ral
Spgp
Flounder
PgpB
Xenopus
Mdr
Human
MDRI
Human
MDR2
Hamster
Pgpl
Hamster
Pgp2
1 lamste 
Pgp3
80% 87% 86% 62% 70% 67% 68% 68°/'. 68% 61%
Mummichog Spgp IIS 88% 94% 93% 79% 80% 76% 78% 79% 78% 78%
0% 0% 0% 2% 3% 1% 1% 2% 3% 1%
93 77% 77% 68% 69“/'. 66% 66% 68% 68% 66%
Flounder PgpA 103 116 8S% 84“/. 82% 79“/'. 76% 76% 77% 77% 77%
1 0% 0°/. 1% 4% 2“,'. 2% 3% 4% 2%
101 90 91% 62% 68% 67% 67% 68°/'. 68% 65%
Pifi Spgp 109 99 IIS 96% 82“/. 79% 79% 81% 81% 80% 82%
0 1 0% 2% 3% 1% 1% 2% 3% 1%
100 90 105 62% 68% 69% 69% 70% 70% 67%
Ral Spgp 107 98 III 115 81% 78% 77% 79% 79% 79% 81%
0 1 0 2% 3% 1% 1% 2% 3% 1%
7-1 81 74 74 74% 70% 68% 70% 70% 66V.
Flounder PgpB 94 97 97 96 118 85% 83% 83% 83% 83% 81%
3 2 3 3 2% 0% 0% 1% 2% 0%
83 82 80 80 88 80% 82% 84% 83% 82%
Xenopus MDR 94 94 93 92 101 115 88% 88% 90% 88% 88%
4 5 4 4 3 1% 1% 0% 3“,'. 1%
79 79 79 81 83 94 94% 94% 93% 87%
Human MDR1 90 90 93 91 99 104 117 97% 97% 95% 94%
2 3 2 2 1 2 0“,'. 0% 1% 0%
80 78 79 81 81 96 no 92“,'. 91% 90%
Human MDR2 92 90 95 93 99 104 114 117 95% 94% 96%
2 3 2 2 1 2 0 0% 1% 0%
80 81 80 82 83 98 111 108 97% 90%
Hamster Pgpl 93 92 95 93 99 105 114 112 116 97% 95%
3 4 3 3 2 1 1 1 2% 0%
80 81 80 82 83 98 109 107 114 90%
Hamster Pgp2 92 91 94 93 98 103 112 111 114 115 94%
4 5 4 4 3 4 2 2 3 1%
79 78 77 79 79 96 102 106 106 106
Hamster Pgp3 92 91 96 95 96 103 110 113 112 no 117
2 3 2 2 1 2 0 0 1 2
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Table 4B
Mummichog Spgp
Rat Spgp
Xenopus Mdr
Human MDR1
Human MDR2
Hamster Pgpl
Hamster Pgp2
Hamster Pgp3
Mummichog Rat
68%
765 83%
1 %
526
639 753
14
386 370
549 528
36 26
376 371
550 536
33 23
386 368
552 531
34 24
380 367
548 534
34 24
372 363
551 539
37 27
378 366
548 531
32 22
Xenopus Human Human Hamster Hamster Hamster
50% 48% 50%
71% 71% 71%
4% 4% 4%
48% 48% 48%
69% 70% 70%
3% 3% 3%
66% 66%
737 82% 82%
1 % 1 %
496 76%
616 740 88%
11 0%
493 568
612 654 737
12 5
498 653 546
609 704 640
10 I 6
473 607 535
593 685 634
13 4 7
490 548 668
603 642 707
10 3 2
49% 48% 49%
71% 71% 71%
4% 4% 4%
48% 47% 48%
70% 71% 70%
3% 3% 2%
67% 63% 65%
81% 79% 81%
1 % 1 % 1 %
88% 82% 73%
95% 92% 86%
0% 0% 0%
73% 72% 90%
86% 85% 95%
0% 0% 0%
84% 73%
739 93% 85%
0% 0%
623 71%
692 736 84%
3 0%
541 530
634 627 739
4 5
1 4 9
Figure 14. Relationships among vertebrate and invertebrate P-glycoproteins. A: Results 
o f phenetic (distance) analysis using the PHYLIP computer program package 
(Felsenstein, 1993) of aligned amino acid sequences. Neighbor-Joining (Saitou and Nei, 
1987) was used to assess relationships. Branch lengths are scaled to reflect distances. B: 
The single most parsimonious tree resulting from cladistic analysis on aligned nucleotide 
sequences using the PAUP computer program (Swofford, 1993). Branch lengths are 
scaled to the number of steps along each branch. References: human MDRl(Chen et al., 
1986); human MDR2 (van der Bliek et al., 1988); hamster pgpl, pgp2 and pgp3 (Endicott 
et al., 1991); mouse mdrla (Hsu et al., 1990); mouse mdr2 (Gros et al., 1988); rat mdrlb 
(Silverman et al., 1991); rat mdr2 (Brown et al., 1993); rat spgp (unpublished data kindly 
provided by S.Childs); Xenopus mdr (Castillo et al., 1995); Caenorhabditis elegans 
mdrA/pgpl and mdr C/pgp3 (Lincke et al., 1992); Drosophila mdr49 and mdr65 (Wu et 
al.,1991) and mdr49 (Gerrard et al., 1993); yeast STE6 (McGrath and Varsharvsky,
1989).
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Figure 15. Cladistic analysis of the relationships among the vertebrate P-glycoprotein 3' 
nucleotide sequences including the sequences with limited data (flounder pgpA and pgpB 
and pig spgp). Analysis was accomplished with the PAUP computer program (Swofford, 
1993). Branch lengths are not shown because of incomplete data. A: Single most 
parsimonious tree obtained with all sequences. Levels of bootstrap support for each node 
are given. Values are the number of times out of 124 replicates of resampling and 
replacement that the groups subtended by that node were supported. B: Single most 
parsimonius tree obtained without the winter flounder pgpB sequence. References: 
winter flounder pgpA and pgpB (Chan et al., 1993), pig spgp (Childs et al., 1995). The 
references for the other sequences are given in Figure 14.
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Figure 16. Immunoblot of membrane fractions (30 pg per lane) from mummichog 
organs probed with mAb C219. Lane 1: Extract of cholchicine resistant CHRC5 cell line. 
Lane 2: Gill. Lane 3: Brain. Lane 4: Intestine. Lane 5: Anterior kidney. Positions of 
molecular weight standards are shown at the left.
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Figure 17. Northern blot of total RNA from mummichog organs probed with DIG- 
labeled mummichog spgp fragment S4 (upper panel) or mummichog P-actin fragment 
(lower panel). Hybridizing bands were identified using anti-digoxigenin antibody 
conjugated with alkaline phosphatase and Lumiphos 530 as a chemiluminescent 
substrate. Lane 1: Anterior kidney. Lane 2: Liver. Lane 3: Brain. Lane 4: Intestine.
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Chapter V: Partial sequence of a multidrug resistance transporter (mdr) cDNA 
from the mummichog (Fundulus heteroclitus)
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INTRODUCTION
Chapter IV of this dissertation reports on the analysis of cDNA fragments from 
the liver of the mummichog which were derived from transcripts o f the mummichog 
sister of P-glycoprotein gene. Using one of these amplified fragments as a probe in 
northern blots, we have shown that, as in mammals (Childs et al., 1995), expression of 
the spgp gene may be restricted to liver in the mummichog. This is the first information 
on tissue specific expression of Pgp genes in a teleost. These results indicate that some of 
the signal seen in the immunoblots and immunohistochemical staining of mummichog 
liver and liver tumors reported in Chapters II and III of this dissertation results from 
expression of the mummichog spgp gene. The toxicological significance of expression of 
spgp P-glycoprotein homologs is unknown the physiological role o f these proteins has 
not been determined in any animal. Our primary interest in P-glycoprotein expression in 
mummichog is understanding the role that expression of potential xenobiotic transporter 
(mdrl-type) P-glycoproteins may play in the resistance or tolerance of mummichog to the 
toxic components of creosote. Results reported in Chapter III o f this dissertation show 
elevation of one or more Pgp homologs in the livers and liver tumors of mummichog 
from a creosote contaminated site. The elevation of Pgp in the livers o f a chemically 
resistant fish is interesting because of the paralell to the role o f the mdrl P-glycoproteins 
in xenobiotic transport in drug-resistant cell lines and tumors. Several other biochemical 
alterations reported in the livers of these fish are similar to alterations seen in drug- 
resistant cell lines and tumors (Van Veld and Westbrook, 1995). However understanding 
the sigificance of elevated hepatic Pgp will require identification and characterization of
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
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the specific Pgp homologs that are elevated in the liver and liver tumors of the Atlantic 
Wood mummichog because of the diversity of function of the vertebrate P-glycoprotein 
gene products. An approach to this problem is molecular cloning and sequence analysis 
of the P-glycoprotien transcripts expressed in mummichog liver.
In the present study we have used the same RT-PCR strategies reported in 
Chapter IV to amplify overlapping fragments corresponding to a second member of the 
Pgp gene family from mummichog intestine and liver RNA. We report that we have 
amplified and cloned cDNA fragments that are most closely related to the vertebrate mdr 
branch of the P-glycoprotein multigene family. These fragments are probably those of 
the mummichog mdr 1-type P-glycoprotein homolog, a xenobiotic transporter. This is 
represents the first cDNA sequence of an mdr homolog from a teleost. Gene specific 
probes derived from these fragments should be useful in investigating expression of mdr 
genes in teleosts. Increased expression of this homolog in the liver s of Atlntic Wood fish 
could potentially contribute to the survival of these fish in the creosote-contaminated 
environment.
MATERIALS AND METHODS
Procedures for collection and processing of mummichog liver and intestinal RNA, 
synthesis of first strand cDNA, general conditions for amplifications of cDNAs by the 
polymerase chain rection and cloning and sequencing of PCR products were identical to 
those detailed in Chapter IV of this dissertation. Procedures specific to the present 
Chapter are given below.
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Southern blot identification of mdr specific amplification products—  Because 
many of the amplification reactions gave multiple products, it was necessary to identify 
amplified mdr fragments by Southern blotting. A fragment of the human MDR1 cDNA- 
pHDRV13 (Choi et al., 1988)- was used as a probe in Southern blots o f PCR reactions to 
identify mdr specific fragments. An aliquot (10 pi) of the amplification reaction was 
separated on a 2% agarose gel. The separated products were capillary transferred to 
postively charged nylon membranes (Boehringer-Mannheim, Indianapolis, Indiana) 
according to standard protocols (Sambrook et al., 1989). An antibody-based colorimetric 
labeling and detection system (Genius™ System, Boehringer-Mannheim, Indianapolis, 
Indiana) was used to prepare digoxigenin (DIG) labeled cDNA probe and to detect 
hybridizing species in Southern blots. Labeled pobe was prepared by random priming of 
the gel-purified (GeneClean) HDR13 fragment with digoxigenin-11-dUTP using the 
Genius System Labeling Kit (Boehringer-Mannheim). Following transfer and UV cross- 
linking of the DNA to the membrane, the membrane was prehybridized for 1 hr at 65° C 
in 5X SSC containing 0.1% sodium N-Iauroylsarcosine, 0.1% SDS and 1% Boehringer- 
Mannheim blocking reagent. After lhr, the prehybridization solution was replaced with 
fresh prehybridization solution that contained an estimated 25 ng/ml o f DIG-labeled 
probe. The membrane was hybridized overnight at 50° C. On the following day, the 
membrane was washed briefly in 2X SSC, 0.1% SDS and then in two changes of 0.5X 
SSC, 0.1% SDS at 50° C for 15 min each. After these washes, DIG-labeled hybrids were 
detected on the membrane according to the Genius System protocol using anti- 
digoxiginen alkaline phosphatase conjugate with p-nitro blue tetrazolium (NBT) and 5-
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bromo-4-chloro-indolyl phosphate (BCIP) as colorimetric substrates for the alkaline 
phosphatase conjugate.
Amplification of the 5' ATP binding region of mummichog mdr cDNA—
Degenerate oligonucleotide primers were used to amplify the cDNA sequences 
corresponding to the 5' ATP binding region of the mummichog mdr transcript from poly 
A+ selected intestinal RNA. These primers were used in Chapter IV to amplify the 
downstream ATP binding region of the mummichog spgp cDNA from liver RNA . The 
sense strand (upstream) primer (primer A, Table 3, Chapter IV this dissertation) matches 
codons near the conserved Walker A motif which occurs twice in all known Pgp deduced 
amino acid sequences. The antisense strand (downstream) primer (primer B, Table 3, 
Chapter IV this dissertation) matches codons near the conserved Walker B motif which 
also occurs twice in all known P-glycoproteins. A touchdown PCR protocol similar to 
that given in Chapter IV was used to ampilify this region of the cDNA. Primers A and B 
(4 (J.M each) were used with random primed first strand cDNA pool from mummichog 
intestine. Following denaturation at 94° C, the primers were annealed for 1 min at 60° C. 
The products were then extended at 72° C for 1.5 min followed by denaturation at 94° C 
for 30 sec. Fifty cycles were carried out with an incremental decrease of 0.25° C in the 
annealing temperature at each cycle. The annealing temperature maintained at 45° C for 
ten more cycles. A final extension was performed at 72° C for 10 min. The resulting 
product (Ml) was cloned and sequenced.
Amplification of segments downstream of the ATP binding fold of the 
mummichog mdr cDNA— Primer A (4 pM) was used in a 3' RACE protocol (Frohman
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et al., 1988) with an adapter primer (Table 3, Chapter IV this dissertation) to amplify first 
strand cDNA pool from mummichog intestine. The first strand synthesis of this cDNA 
pool had been primed with an oligo(dT)17-adapter primer (Frohman et al., 1988). The 
touchdown cycling protocol used here was identical to that used above for amplification 
of the nucleotide binding fold sequences. To increase the yield of specific product a 
second round of amplification was performed using another sense strand degenerate 
primer (primer C, Table 3, Chapter IV this dissertation) which is downstream o f the 
primer A sequence. In the second round of amplification 1 pi of the 3'-RACE reaction 
was used with primer C (8 pM) and the adapter primer (0.5 pM). Annealing was at 54° C 
for 30 sec followed by extension at 12° C for 30 sec and denaturation at 94° C for 30 sec. 
No touchdown was used in this amplification. After 40 cycles, products were extended 
for an additional 10 min at 72° C. A 460 bp product (M2) was obtained which was 
cloned and sequenced.
Primer C was also used with two gene specific primers in a pair of nested 
reactions to amplify mdr cDNA fragments from mummichog liver RNA. In the first 
reaction, primer C was used with a downstream spgp-gene specific primer (primer 111, 
CT-GAT-GTC-TTG-GCC-TTG-GCG). Primer 111 matches the sequence of the 
mummichog spgp cDNA (reported in Chapter IV) just downstream of the nucleotides 
coding for transmembrane segment 12. We observed that RT-PCR amplification of 
mummichog liver RNA with the mummichog spgp specific primer 111 and the 
degenerate Walker B primer (primer C) resulted in two products which hybridized to a 
fragment o f the MDR1 cDNA in Southern blots (not shown). Because the mummichog
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spgp cDNA is longer than the mdr cDNAs in the region amplified by these two primers, 
we assumed that the shorter product detected in Southern blots was an mdr product. We 
therefore used the mdr specific primer BLFA (CTG-GTT-ACC-ATG-CAG-ACC-TTC) 
that was designed from the sequence of the 460 bp mdr cDNA fragment (M2) from 
intestine with primer 111 to reamplify an aliquot of PCR products derived from liver 
cDNA, primer C and primer 111. For primer 111 and primer C annealing was at 45° C 
for 1 min followed by extension at 72° C for 2 min and denaturation at 94° C for 30 sec. 
After 40 cycles, products were given a final extension for 10 min at 72° C. An aliquot of 
this reaction (1 pi) was then subjected to a second round of amplification with primer 111 
and BLFA . This mixture underwent 40 cycles of annealing at 58° C for 1 min, followed 
by extension at 72° C for 1.5 min, and denaturation 94° C for 30 sec. Products were 
extended for an additional 10 min at 72° C. A 1.2 kb product was obtained which was 
cloned and sequenced.
Sequence analysis—  Sequences were compiled, edited and analyzed essentially 
as described in Chapter IV. Many features of the sequence were identified by inspection 
of the multiple sequence alignment and comparison with cDNA and deduced amino acid 
sequences of human (Chen et al., 1986; van der Bliek et al., 1988) hamster (Endicott et 
al., 1991) and Xenopus (Castillo et al., 1995) mdr isoforms. Sequences of Pgp homo logs 
were obtained from the GENBANK sequence database using the World Wide Web server 
at the National Center for Biotechnology Information (National Institutes of Health, 
Bethesda, Maryland).
Multiple alignment of the amino acid sequences of Pgp sequences was
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accomplished with the aid o f the computer program CLUSTAL W (Thompson and 
Higgins, 1994) using the default parameters of the program. Similarity and identity 
scores on aligned sequences were calculated using the computer program Genedoc 
(Nicholas and Nicholas, 1996). For amino acid sequences, similarity scores were 
calculated using the BLOSUM62 matrix provided with the program.
Relationships among vertebrate P-glycoprotein sequences were assessed by 
distance analysis of the deduced amino acid sequences of vertebrate Pgp homologs. The 
sequence of the MdrA/Pgpl P-glycoprotein from the nematode, Caenorhabditis elegans 
(Lincke et al., 1992) was included in the analysis to serve as an out-group sequence. As 
discussed in Chapter IV, this nematode sequence cannot be assigned to either the 
vertebrate mdr of spgp P-glycoprotein categories. The deduced amino acid sequences 
were aligned with the aid of CUSTAL W over the length o f the mummichog mdr 
sequence. This gave an alignment with a consensus length o f490 positions including 
gaps. The distance analysis was done with the aid of the PHYLIP (Version 3.5c) 
computer program package (Felsenstein, 1993). A pairwise distance matrix of the 
aligned amino acid sequences was calculated with the PHYLIP Protdist program using 
the PAM/Dayhoff option. The resulting distance matrix was used in the PHYLIP 
implemetation of the Neighbor-Joining (Saitou and Nei, 1987) method to construct a gene 
tree.
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Amplification and analysis of the 5' ATP binding region of mummichog mdr 
cDNA—  Degenerate oligonucleotide primers were used in RT-PCR to amplify a cDNA 
fragment (M l) coding for the ATP binding domain of a P-glycoprotein from mummichog 
intestinal RNA (Figure 18). The mummichog nucleotide sequence and the deduced 
amino acid sequence were most similar to the Xenopus and hamster P-glycoprotein 
cDNA sequences corresponding to the 5' or amino (N) terminal ATP binding region. 
Optimal alignment with the carboxyl-terminal ATP binding domain amino acid 
sequences required inserting a two position gap in the mummichog sequence (Figure 19). 
This gap was also required to align the N- and C- terminal ATP binding domains of the 
other vertebrate mdr-type P-glycoproteins. At the nucleotide level the identity of the 
mummichog sequence to the 5' vertebrate sequences ranged from 71% to 75% identity 
while the identity to the 3' sequences was lower, 59-62%. At the amino acid level, the 
mummichog sequence was most similar to the N-terminal ATP binding domain of the 
Xenopus and hamster mdr sequences (91-94% similar, 78-81% identical) and less similar 
to the C-terminal ATP binding domain of these proteins (80-83% similar, 58-65% 
identical, Table 5). These relationships paralleled the relationships between the two ATP 
binding domains of the Xenopus and hamster sequences (Table 5). Furthermore 
comparison of the two domains within the individual Xenopus and hamster mdr 
sequences gave analogous relationships (78-80% similar, 56-64% identical, Table 5).
Amplification and analysis of cDNA sequences downstream of the 5' ATP 
binding domain of mummichog mdr— We used degenerate primers (primers A and C)
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in a nested 3' RACE protocol in an attempt to amplify the 3' end of the mummichog mdr 
cDNA from mummichog intestinal RNA. Repeated attempts resulted in no specific 
product o f predicted size. However, a 460 bp product was detected in Southern blots of 
the 3' RACE reactions probed with a fragment of the human MDR1 cDNA (data not 
shown). The sequence of the 5’ end of this product (M2, Figure 18) was identical with 48 
bp of the 3' end of the amplified mummichog mdr ATP binding domain sequence (Ml) 
and contains the upstream primer (primer C) and the 3' RACE adapter primer in the 
expected orientation. However the sequence continued the reading frame of the upstream 
primer without an in-frame termination codon and therefore did not contain the 3' end of 
the cDNA. The deduced amino acid sequence of the 5' end of this cDNA fragment was 
similar to that of the ATP binding domains of vertebrate P-glycoproteins. The amino 
acid sequence had the highly conserved amino acid positions surrounding the Walker B 
nucleotide binding motif of ABC transporters and the peptide epitope (Val-Glu-Ala-Ala- 
Leu-Asp) for the mAb C219 present in all P-glycoproteins (Figure 18). The deduced 
amino acid sequence of the 3' end of the M2 segment was weakly similar to the linker 
domain of vertebrate P-glycoproteins. The deduced amino acid sequence of the M2 
fragment was 50-53% identical to the corresponding positions in the carboxyl terminal 
ATP-binding domains and linker domains of the hamster, human and Xenopus mdr-type 
P-glycoproteins. The overlapping sequence of Ml and M2 occurs in a highly conserved 
region. The nucleotide sequences of the highly related hamster pgp I and pgp2 nucleotide 
sequences (Endicott et al., 1991) are 100 % identical in this region. For this reason there 
is a possibility that Ml and M2 were amplified fragments of different P-glycoprotein
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genes.
The sequence of M2 was used to design a gene specific primers for 3' RACE of 
the mummichog mdr cDNA. Repeated 3' RACE attempts yielded no specific product 
from mummichog intestinal RNA. The major product amplified was an nonspecific 800 
bp fragment which contained the adapter primer at both ends. However we did amplify 
an mdr specific product when we used one of the mummichog mdr primers (PBLFA) in a 
nested amplification of mummichog liver RNA. The 5' end of the sequence of the 
resulting 1200 bp product (M3, Figure 18) overlapped with 146 bp of the sequence of 
M2. The deduced amino acid sequence of the 3' end of M3 aligned with and was similar 
to the transmembrane domain of vertebrate P-glycoproteins. The deduced amino acid 
sequence of the mummichog M3 fragment was 53-55% identical and 72-74% similar to 
the corresponding positions of the linker domain and transmembrane domain of the 
hamster, human and Xenopus mdr-type P-glycoproteins. The similarity to the 
mummichog spgp sequence was lower (36% identical, 58% similar).
Five membrane spanning helices were identified in the deduced amino acid 
sequence of the M3 fragment using the method of Eisenberg (1984). The transmembrane 
helices corresponding to TM9 and TM10 of the human and hamster P-glycoproteins were 
identified as a single transmembrane helix in our analysis. However because the Kyte 
and Doolittle hydropathy plots (Kyte and Doolittle, 1982) of the mummichog M3 amino 
acid sequence and the hamster pgpl P-glycoprotein (Figure 20) were nearly identical over 
these positions, the locations of TM9 and TM10 have been assigned by comparison with 
the hamster pgpl sequence (Endicott et al., 1991).
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The sequences of clones of M2 and M3 were nearly identical (98%) in the 145 bp 
overlapping portion that corresponds to the poorly conserved linker domain o f P- 
glycoproteins. The nucleotide sequence of the hamster pgpl and pgp2 cDNAs are only 
67% identical in this region while the pgp3 sequence is 43% and 36% identical to pgpl 
and pgp2 in this region. Therefore it is likely that M2 and M3 were derived from 
transcripts o f the same gene.
The deduced amino acid sequences o f M2 and M3 contained serine and threonine 
residues in consensus protein kinase recognition sequences (Kemp and Pearson, 1990) for 
both the calcium and phospholipid dependent protein kinase (protein kinase C) and the 
cyclic AMP-dependent protein kinase (protein kinase A). The sequence (Thr/Ser)-X- 
(Arg/Lys) compatible with protein kinase C phosphorylation occured six times in the 
combined sequences of M2 and M3 (Figure 18). Only one of these locations is within the 
linker domain and coincides with the pair of potential protein kinase A phosphorylation 
sites in the sequence Arg-Arg-Lys-Ser-Thr-Arg. This corresponds to the conserved 
protein kinase A recognition sequence present in the linker domain of human MDR1 and 
rodent mdr la  P-glycoproteins (Hsu et al., 1989; Endicott et al., 1991).
The deduced amino acid sequences of M2 and M3 are shown combined in the 
multiple sequence alignment of vertebrate P-glycoproteins in Figure 21. The alignment 
spans the carboxyl end of the N-terminal ATP binding domain, the complete linker 
domain and the complete transmembrane domain with the six putative membrane 
spanning segments (TM7-TM12) of the second half of P-glycoproteins. The mummichog 
sequence was most similar to the vertebrate mdr-type P-glycoproteins in the alignment
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(56-58% identical, 74-77% similar) and less similar to the mummichog spgp sequence 
(42% identical, 61% similar). The Walker B region of the ATP binding domain and the 
intracellular loop between TM8 and TM9 were the best conserved regions among all of 
the sequences. The putative extracellular loop between TM7 and TM8 and the linker 
domain were regions o f reduced similarity among all sequences. Significant gaps were 
required to align the sequences in the linker region particularly to accommodate the 
longer and quite divergent linker domain of the mummichog spgp sequence.
Relationships among P-glycoprotein sequences—  The pairwise distances 
between the amino acid sequences corresponding to the combined mummichog M2 and 
M3 segments of vertebrate P-glycoproteins were analyzed using the Neighbor-Joining 
method. The resulting phenogram (Figure 22) demonstrated that the mummichog 
sequence derived from M2 and M3 was more closely related to the vertebrate mdr-type 
sequences than to the mummichog and rat spgp forms. The mummichog sequence was 
basal to the remaining vertebrate mdr-type sequences and like the Xenopus sequence was 
not assigned to either the mammalian mdrl (human MDR1, hamster pgpl and pgp2) or 
the mdr2 (human and hamster mdr2) classes by this method.
DISCUSSION
In this study we cloned and sequenced RT-PCR amplified fragments of a P- 
glycoprotein cDNA from the mummichog liver and intestinal RNA. The sequence of 
these combined fragments indicates that they are amplified fragments of a vertebrate mdr- 
type P-glycoprotein. This is the first report of an mdr cDNA sequence from a teleost.
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As a part o f our on-going studies of P-glycoprotein expression in mummichog 
liver and liver tumors, we have used several RT-PCR strategies to amplify an mdr-type P- 
glycoprotein sequence from the mummichog. Although our primary interest is 
expression in liver we initially amplified the mdr cDNA sequences from mummichog 
intestine. In Chapter IV of this dissertation we report using degenerate oligonucleotide 
primers to amplify cDNA sequences corresponding to the ATP binding domain of the 
carboxyl terminal half o f mummichog spgp in RT-PCR o f mummichog liver RNA . 
Contrary to our expectations, we never obtained sequences for the amino-terminal ATP 
binding domain of spgp or the sequences of any other P-glycoprotein cDNAs from 
mummichog liver RNA with this technique. For this reason in the present study we 
applied this technique to mummichog intestinal RNA in to amplify mummichog mdr 
sequences. This organ was not expected to express spgp and in mammals expresses only 
mdrl-type P-glycoproteins (Croop et al., 1989; Teeter et al., 1990; Childs et al., 1995). 
Using the degenerate ATP-binding domain primers, we amplified cDNA sequences 
corresponding to the carboxyl-terminal ATP binding domain of a P-glycoprotein.
Repeated attempts to amplify the 3' end of this cDNA from intestinal RNA failed 
possibly because of competing amplification of an undesired product. We amplified an 
abortive product which matched the N-terminal ATP-binding domain and linker domain 
of vertebrate mdr-type P-glycoproteins. This product may have resulted from mispriming 
of the first strand cDNA by the oligo(dT)17 adapter primer in the A-rich codons of the 
linker region.
Using additional RT-PCR strategies we were able to amplify a cDNA fragment
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from mummichog liver cDNA pool that overlapped with the downstream end of the 
abortive 3' RACE product from intestinal cDNA and aligned with the linker domain and 
transmembrane domain of the carboxyl terminal half o f vertebrate mdr-type P- 
glycoproteins. Because the sequences of the liver and intestinal cDNA fragments 
matched in a poorly conserved region of P-glycoproteins, we conclude that these 
fragments are products of the same mummichog gene which is expressed both in 
mummichog intestine and mummichog liver.
The deduced amino acid sequence of the mummichog cDNA is very similar to the 
corresponding positions of vertebrate mdr-type P-glycoproteins and indicates a 
homologous structure for these proteins. This includes the highly conserved sequence 
near the ATP binding site, a hydrophillic linker domain and a hydropathy profile 
indicating the presence of six membrane spanning segments in the transmembrane 
domain of the protein.
Mammalian mdr-type P-glycoproteins may be divided into mdrl and mdr2 
categories based on sequence similarities. These two classes also have distinct patterns of 
expression and distinct functions in mammalian physiology. The mammalian mdr2-type 
P-glycoproteins, which are not involved in multidrug resistance, have been shown to have 
a role in transport of phosphatidylcholine into the bile (Smit et al., 1993; Ruetz and Gros, 
1994). This is consistent with predominant expression of the mdr2 forms in the bile 
canaliculus of the liver (Buschman et al., 1992; Smit et al., 1994). The mdrl forms, 
which can confer multidrug resistance, may be involved in protection from toxic 
xenobiotics either by exclusion of toxicants from sensitive organs such as the brain and
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testes or by excretion of xenobiotics through the apical membrane o f excretory epithelia 
(Theibaut et al., 1987; Thiebaut et al., 1989; Teeter et al., 1990; Schinkel et al., 1994).
The mdrl forms may also be involved in steroid excretion or uptake in tissues involved in 
steroid metabolism (Ueda et al., 1992; van Kalken et al., 1993). The mdr gene products 
o f fish have not been previously characterized. Southern blots o f teleost genomic DNA 
indicate that fish, similar to humans, have two mdr-type P-glycoprotein genes (Ling et al., 
1992; Chan et al., 1993). The products of these two teleost genes are probably the 
functional equivalents of the human MDR1 and MDR2 proteins.
In a effort to assign the mummichog mdr sequence to either the mdrl or mdr2 
categories we have analyzed the relationships among the vertebrate P-glycoprotein genes 
using a distance approach. While this analysis confirms that the mummichog mdr 
sequence is most closely related to the vertebrate mdr homologs rather than the spgp 
homologs, it also indicates that the mammalian mdrl and mdr2 homologs are more 
similar to each other than either class is to the mummichog homolog. The high similarity 
o f the mammalian mdr sequences has been noted before (van der Bliek et al., 1988; 
Endicott et al., 1991; Hsu et al., 1991; Chan et al., 1992). There is evidence that a 
homogenization mechanism, concerted evolution (Amheim, 1983), has erased many of 
the intraspecies differences between the mdr genes in the hamster (Endicott et al., 1991), 
the mouse (Hsu et al., 1991) and man (van der Bliek et al., 1988). This has masked the 
more ancient origin of the mammalian mdrl and mdr2 gene lineages. The concerted 
evolution among the mammalian genes within taxa makes the inference of the functional 
class of the mummichog mdr sequence based on sequence homologies difficult. This is
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especially true because the sequential determinants conferring differing functions on the 
mdrl and mdr2 P-glycoproteins are unknown.
In spite of this, comparison of the linker domains of the P-glycoprotein deduced 
amino acid sequences indicates that the mummichog mdr sequence may be an mdr I-type 
P-glycoprotein. The linker domain is a poorly conserved region that contains sequences 
that are not conserved between the mammalian mdrl and mdr2 classes (Hsu et al., 1989). 
Evidence from analysis of silent and replacement substitutions along the length of the 
human mdr3 sequence suggested that gene conversion has not affected this domain (Van 
der Bliek et al., 1988). The linker region has been identified as a regulatory domain in P- 
glycoproteins and may be the primary site of phosphorylation. The human MDR1 P- 
glycoprotein is phosphorylated by both protein kinase A (Mellado and Horwitz, 1987) 
and protein kinase C in vitro (Chambers et al., 1992). The linker domain contains 
conserved recognition sequences for protein kinase C in both mdrl-type and mdr-2 P- 
glycoproteins (Hsu et al., 1989; Endicott et al., 1991; Chambers et al., 1993). The linker 
region o f mammalian mdrl P-glycoproteins also has protein kinase A recognition 
sequences which are lacking in mdr2 P-glycoproteins. An unusual overlapping protein 
kinase A recognition sequence with two potential phosphorylation sites (Arg/Lys)- 
(Arg/Lys)-(Arg/Lys)-Ser-(Ser/Thr) is present in the linker regions of the human MDR1 
and rodent mdr la  homologs (Hsu et al., 1989; Endicott et al., 1991; Chambers et al., 
1993). This sequence is also present in the mummichog mdr linker domain. This is 
evidence that the mummichog mdr protein is regulated in a similar manner to mammalian 
mdrl proteins and that the mummichog mdr protein may have a function similar to the
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mammalian mdrl proteins.
In mammals expression of both mdrl and mdr2 class genes has been detected in 
liver (Theibaut et al., 1987; Teeter et al., 1990; Buschman et al., 1992; Smit et al., 1994). 
However only mdrl expression has been found in mammalian intestine (Croop et al.
1989; Teeter et al., 1990). P-glycoprotein in teleosts has been detected by 
immunohistochemical staining on the lumenal surfaces of the epithelia of the intestine 
and kidney and on the canalicular surface of hepatocytes (Hemmer et al., 1995; Chapters 
II and III, this dissertation) just as in mammals. Although the specific homo logs that 
were expressed in these sites in fish tissues were not identified in these 
immunohistochemical studies, the results indicate that the tissue specific expression 
patterns observed in mammals for mdrl and mdr2 P-glycoproteins are probably 
conserved in teleosts. Therefore amplification of the mummichog mdr from both liver 
and intestinal RNA in the present study is further evidence that the cDNA fragments 
reported here those of an mdrl-type P-glycoprotein with similar tissue specific expression 
patterns to the mammalian mdrl genes.
We have amplified fragments of a mummichog mdr cDNA from mummichog 
liver. This may be a portion of the cDNA for the mummichog xenobiotic transporter 
(mdrl). In Chapter IV we identified another member of the P-glycoprotein gene family 
(spgp) expressed in mummichog liver. We have now identified two of the potential gene 
products contributing to the signal seen in our immunochemical studies of P-glycoprotein 
expression during environmental hepatocarcinogenesis in the Atlantic Wood 
mummichog. Gene specific cDNA probes are now in hand for both the mdrl and spgp
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genes. Future studies using cDNA probes should investigate tissue specific expression 
patterns of the mummichog mdrl gene and should study regulation of expression o f both 
genes by xenobiotics. It is necessary to test whether increased expression of either of 
these genes is associated with the elevated levels o f P-glycoprotein antigens that we have 
observed in liver and liver tumors o f these fish. With a partial sequence of the 
mummichog xenobiotic transporter now in hand, it should be possible to specifically 
address the role o f this protein in tolerance or resistance of Atlantic Wood mummichog to 
creosote.
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Figure 18. Nucleotide (upper) and deduced amino acid (lower) sequences of the 
mummichog mdr cDNA fragment determined from the sequence o f RT-PCR amplified 
cDNA products (M1-M3) from mummichog intestine (Ml and M2) and liver (M3). The 
nucleotide sequence is numbered in 5' to 3' orientation. The upstream degenerate primer 
sequence is not included. Amino acids are aligned with the second nucleotide of each 
codon. The conserved Walker B sequence of the nucleotide binding fold of ABC 
transporters and the C219 epitope are underlined. The six putative transmembrane 
segments are indicated with a double underline and are numbered TM7-TM12. Potential 
protein kinase A phosphorylation sites are indicated with a ^  and potential protein kinase 
C phosphorylation site are indicated with a ★.
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M l AGCACGACTATCCAGCTGCTGGAGAGGTTCTACGACCCTCAGGAAGGATCTGTTTCCATCGATGGGCACGACATC 7 5 
S T T I Q L L E R F Y D P Q E G S V S I D G H D I 2 5
CGCTCTCTTAATGTGCGCTACCTGAGGGGAATGATCGGCGTGGTGAGCCAGGAGCCCATCCTCTTCGCCACCACC 150 
R S L N V R Y L R G M I G V V S Q E P I L F A T T 5 0
ATCGCTGAGAACATCCGCTACGGCCGACCCGACGTGACGGAGGAGGAGATCGAAAAAGCTGCCAAGGAAGCCAAT 225 
I A E N I R Y G R P D V T E E E I E K A A K E A N 7 5
GCTTACGACTTCATCATGAACCTTCCTGATAAGTTTGAGACACTAGTCGGCGACCGAGGAACCCAGATGAGCGGA 300 
A Y D F I M N L P D K F E T L V G D R G T Q M  S G_ 100
GGACAGAAGCAGAGGATTGCGATCGCTCGAGCTTTGGTCCGAAAACCCAAAATCCTGCTGTTGGACGAA 369
M2 ATCGCTCGAGCTTTGGTCCGAAAACCCAAAATCCTGCTGTTGGACGAAGCCACG 54 
G O K O R I A I A R A L V R K P K I L L L D E A T  125
Walker B
TCTGCCCTGGATGCTGAGAGTGAGACTATCGTTCAAGCTGCACTCGATAAGGTGCGACAGGGTCGGACCACTCTA 12 9 
S A T. D A E S E T I V O A A L D K V R Q G R T T L  150
C219
ATCGTGGCTCACTGCCTCTCAACCATCAGAAATGCAGATGTGATTGCGGGCTTGGAGAAAGGTAAAGTTGTAGAG 204 
I V A H C L S T I R N A D V I A G L E K G K V V E  175
★
CTGGGGACTCACAGCGAGCTGATGGAGAAGAAAGGAGTCTACCACACGCTGGTTACCATGCAGACCTTCCAGAAA 27 9
M3 CAGAAA 6
L G T H S E L M E K K G V Y H T L V T M Q T F Q K  200
GCGGATGAAGGGGAGGATGAAGACAATCTCTCGGCGGGTGAGAAAAGTCCCATTCACAACAACGTCATTGAGTCG 354 
GCGGATGAAGGGGAGGATGAAGACAATCTCTCGGCGGGTGAGAAAAGTCCCATTCACAACAACGTCATTGAGTCG 81 
A D E G E D E D N L S A G E K S P I H N N V I E S  225
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CCGCTGCTGAGGAGGAAATCTACCAGAGGCTCGTCATTTGCAGCTTCAATTGGAGAGAAGGGAGAC 420
CCGCTGCTGAGGAGGAAATCTACCAGAGGCTCGTCATTTGCAGCTTCAATTGGAGAGAAGGGAGACAAAAAACAG 156 
P L L R R K S T R G S S F A A S I G E K G D K K Q  250
★  ★
GAAAAGGAGGACGAGGACAAAACAGAAGAGGATGAGGACTTCCCCATGGTGTCGATCTTTAAGGTGCTGCGTCTC 231 
E K E D E D K T E E D E D F P M V S I F K V L R L  275
AACGCTTCGGAGTGGCCTTATATTCTGGTGGGGCTGATCTGCGCCACCATAAACGGAGCCATACAGCCTCTGTTT 306 
N A S E W P Y I L V G L I C A T I N G A T O P L  F 300
TM7
GCCGTCCTCTTCTCCAAGATTATCACTGTGTTTGCAGAGCCAGATCAGACGATTATCAGGCAAAGAGCCAACTTC 381 
A V L F S K I  I T V F A E P D Q T I  I R Q R A N F  325
TTTTCCCTCATGTTTGTGGTGATCGGAGTTGTTTGCTTTTTCACCATGTTTCTACAGGGATTCTGTTTTGGAAAA 4 56 
F S L M F V V I G V V C F F T M F L O G F C F  G K 350
TM8
TCTGGAGAGGTTCTCACCTTGAAGCTGAGGCTTGGGGCCTTCAAGTCCATGTTGAGACAGGATCTCGGTTGGTTT 531 
S G E V L T L K L R L G A F K S M L R Q D L G W F  375 
★
GACAGCCCCAAAAACAGTGTCGGTGCGCTTACTACCAGGCTGGCTACAGACGCAGCCCAAGTTCAGGGGGCCTCA 606 
D S P K N S V G A L T T R L A T D A A Q V Q G A  £_ 400 
★ ★
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GGGGTACGCCTGGCAACATTCGCCCAGAACATTGCCAACCTCGGCACCGGTGTGATCCTGGCCTTCGTGTACGGC 681 
G V R T .  A T F A O N T A N L G T G V I L  A F V Y G 425
TM9
TGGGAGCTGACTCTGCTGATTCTGGCCGTGGTGCCCGTCATTGCTTTGGCCGGAGCCGTGCAGATGAAAATGCTC 756 
W E L T T .  L I T .  A V V P V I A L A G A V  Q M K M L 450
TM10
ACGGGGCATGCAGCCGAAGATAAGAAGGAGCTGGAGAAGGCTGGGAAGATTGCAACAGAGGCCATAGAGAACATT 831 
T G H A A E D K K E L E K A G K I A T E A I E N I  475
CGTACTGTCGCCTCTCTCACCAGAGAACCAAAATTTGAGTCTTTGTATGAGGAAAATCTCGTAGTTCCATATAAG 906 
R T V A S L T R E P K F E S L Y E E N L V V P Y K  500
AACTCTCAGAAAAAGGCCCACGTGTACGGCTTCACCTTCTCCTTCTCCCAGGCTATGATCTACTTTGCCTACGCG 981 
N S Q K K A H V Y G F T F S  F S O A M I Y F A Y A  525
★ TM11
GCCTGTTTCCGTTTCGGAGCCTGGCTCATTGTGGAGGGCCGGATAGATGTGGAAGCAGTATTCCTCGTGATCTCT 1056 
A C F R F G A W L I V E G R  T D V F .  A V F L V I S  550
TM12
GTCGTCCTGTTCGGCGCCATGGCCGTCGGAGAGGCCAACTCCTTCGCTCCAAAC 1110
V V L F G A M A V G  E A N S F A P N  568
1 8 2
Figure 19. Alignment of the deduced amino acid sequence of the mummichog mdr ATP 
binding domain with the amino (N) terminal and carboxyl (C) terminal ATP binding 
domains of Xenopus and hamster mdr-type P-glycoproteins. Positions that are identical 
to the mummichog sequence are indicated with a dot ( .) . Gaps are indicated with a 
dash (-). References: Xenopus mdr (Castillo et al., 1995); Hamster sequences (Endicott 
et al., 1991).
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
Reproduced 
with 
perm
ission 
of the 
copyright ow
ner. 
Further reproduction 
prohibited 
without perm
ission.
Mummichog Mdr STTIQLLERFYDPQEGSVSIDGHDIRSLNVRYLRGMIGVVSQEPILFA
Xenopus Mdr ...V..IQ. • . .ED.VITL. .Q..... I. . . .El..... .... . D
N Hamster Pgpl ...V...Q.L . . T . . V .... Q...TI......El..... . . V. . .
N Hamster Pgp2 ...V...Q.L . . T . . V .... Q...TI......El..... . .V. . s
N Hamster Pgp3 T. .L. .• Q.L
C Xenopus Mdr ...VS. .... ..F ..E .LV..LSV.N ..IQWV.AQM.I .. . D
C Hamster Pgpl ..VV..• • • . ..MA.T .FL..KEVNQ...QW..AHL.I , D
C Hamster Pgp2 ..VV.. • • • • ..MA.T .FL..KE.KQ...QW..AHL.I . D
C Hamster Pgp3 ..VV.. .... ..MA.T .LL..QEAKK..IQW..AQL.I.. . .V. . D
Mummichog Mdr 
Xenopus Mdr 
N Hamster Pgpl 
N Hamster Pgp2 
N Hamster Pgp3 
C Xenopus Mdr 
C Hamster Pgpl 
C Hamster Pgp2 
C Hamster Pgp3
TTIAENIRYGRPD— VTEEEIEKAAKEANAYDFIMNLPDKFETLVGDR
____ D. . . E . - - . . K . . . .R T. . . . . K ____ L ____ .F, ,
. . EN— . . MD. V .  . . . . K . . H . . D . . . F
. . EN— . . MD. V. . . . . K . . H . . D . . . F
. . GN— . . M . . . K . V . . . . . . E . . . K . . Q . . D . . . F,
C S . G D . .A. . DNNRK. . Q . . .T . I H S  . . E S . T . . Y N . R . . . K
C S ____ .A. . D N S R V .S Q D . , , R • IH Q . . E S ____ Y N . R . . . K
C S ____ .A. . D N S R V .S Q D . . . R • IH Q . . E S ____ Y N . R . . . K
C S ____ .A. .D N S R V .S Q D . .V R . .A. . I H P . . E T . . Q . Y K . R . . . K
Mummichog Mdr 
Xenopus
N Hamster Pgpl 
N Hamster Pgp2 
N Hamster Pgp3 
C Xenopus Mdr 
C Hamster Pgpl 
C Hamster Pgp2 
C Hamster Pgp3
GTQMSGGQKQRIAIARALVRKPKILLLDE 
. . .L................ N ........
, A . L ____ ____N.
, A ,. L ____ . . . .N.
. A , L ____ , . . .N.
, L . . . . , . I  . . .
, . . .Q.
. L . . . . ------Q. , H.............
. L . . . . ____L . . R . . . . I . Q . . RV...........
1 8 4
Table 5. Pairwise comparison matrix of the deduced amino acid sequences of the 
mummichog mdr ATP binding domain and the N and C terminal ATP binding domains 
of the Xenopus and hamster mdr-type P-glycoproteins. The three numbers for each pair 
below the diagonal give the number of positions that are occupied by identical amino 
acids in the two sequences (top number), identical plus conservative substitutions 
(BLOSUM62) (middle number) and the number of positions that align with a gap in the 
other sequence (bottom number). The region of the matrix above the diagonal gives these 
values as percentages. The numbers along the diagonal give the number o f residues in the 
region of comparison. References'. Xenopus mdr (Castillo et al., 1995); Hamster 
(Endicott et al., 1991).
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Mummichog
Mdr
N Xenopus 
Mdr
N Hamster 
Pgpl
N Hamst< 
Pgp2
80% 81% 81%
Mummichog Mdr 123 94% 91% 91%
0% 0% 0%
99 82% 82%
N Xenopus Mdr 2 123 95% 95%
0 0% 0%
100 101 100%
N Hamster Pgp 1 3 117 123 100%
0 0 0%
100 101 123
N Hamster Pgp2 4 117 123 123
0 0 0
96 97 111 111
N Hamster Pgp3 5 115 119 119
0 0 0 0
82 80 75 75
C Xenopus Mdr 6 100 97 97
2 2 2 2
82 80 77 77
C Hamster Pgp 1 7 99 98 98
2 2 2 2
83 81 78 78
C Hamster Pgp2 8 100 99 99
2 2 2 2
73 74 72 72
C Hamster Pgp3 9 97 96 96
2 2 2 2
N Hamster C Xenopus C Hamster C Hamster C Hamster 
Pgp3_______ Mdr_______ Pgpl_______ Pgp2_______Pgp3
78%
92%
0%
78%
93%
0%
90%
96%
0%
90%
96%
0%
123
73
98
2
73 
100 
2
74 
101 
2
70
97
65%
82%
1 %
64%
80%
1 %
60%
77%
1%
60%
77%
1 %
58%
78%
1 %
125
98
11 0
0
97
1 1 1
0
92
106
0
65%
82%
1 %
64%
80%
1 %
61%
79%
1 %
61%
79%
1 %
58%
80%
1%
78%
88%
0%
125
123
124 
0
106
116
0
66%
83%
1 %
64%
80%
1 %
62%
80%
1 %
62%
80%
1 %
59%
81%
1 %
77%
88%
0%
98%
99%
0%
125
107
117
0
58%
80%
1 %
59%
78%
1 %
57%
77%
1 %
57%
77%
1 %
56%
78%
1 %
73%
84%
0%
84%
92%
0%
85%
93%
0%
125
1 8 6
Figure 20. Hydropathy plots (Kyte and Doolittle, 1982) of the mummichog mdr deduced 
amino acid sequence for cDNA fragment M3 (A) and the corresponding region of the 
hamster pgpl (B) sequence (Endicott et al., 1991). The plots were created using the 
SOAP program of the PCGene computer program package (Intelligenetics, Mountain 
View, California) using a window of nine amino acids.
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Figure 21. Multiple alignment of deduced amino acid sequences o f selected P- 
glycoproteins over the region o f overlap with the mummichog mdr sequence. Multiple 
alignments were created with the aid of the computer program CLUSTAL W (Thompson 
and Higgins, 1994). Positions with identical amino acids to mummichog spgp are shown 
as a dot ( .) . Gaps inserted into the sequences to optimize the alignment are shown as a 
dash (-). The positions o f the conserved Walker B motif of ABC transporters, the linker 
region, the putative transmembrane segments (TM7-TM12) and the C219 epitope are 
indicated. References: Xenopus mdr (Castillo et al., 1995); human MDR1 (Chen et al., 
1986); human MDR2 (van der Bliek et al., 1988); hamster pgpl, pgp2 and pgp3 (Endicott 
et al., 1991); mummichog spgp (Chapter IV, this dissertation).
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______ Walker B____________  C219
Mummichog Mdr IARALVRKPKILLLDEATSALDAESETIVQAALDKVRQGRTTLIVAHCLSTIRNADVIAG
Xenopus Mdr . . . A . E ....IV...R .
Human MDR1 ...... N ....... ...... T. .AV. , V ...A.K. ...IVI..R . .V.
Hamster Pgpl ...... N ....... ...... T. .AV. . . . A . E ....IVI.. R , . V. . . I . . .
Hamster Pgp2 ...... N ....... ...... T. .AV. • • • . . . A . E ....IVI. .R . V.
Human MDR2 ...... N ....... ...... T. .AE. .  • • ...A.E. ...IVI..R. . V.
Hamster Pgp3 ...... N ....... ...... T. .AE. .  . ...A.E. ...IVI..R . • V.
Mummichog Spgp ...... N.R.....M ......N...AT..E......M . . . . ISI. LR ....K...I.V.
Mummichog Mdr 
Xenopus Mdr 
Human MDR1 
Hamster Pgpl 
Hamster Pgp2 
Human MDR2 
Hamster Pgp3 
Mummichog Spgp
LEKGKVVELGTHSELMEKKGVYHTLVTMQTFQKAD— EGEDEDNL SAGEKSPIHNNV
FDN.VI..Q.S.K. 
FDD.VI..K .N .D. 
FDG.VI..Q.N.E. 
FDG.VI..Q.N.E. 
F.D.VI. .Q.S. . . 
F.D.VI..Q.S. . .
. RG. 
KE. . 
RE. , 
, KE . 
K.E,
. . FN. . . L .
I . FK....
I.FK..MT. 
I.CR..M.
. . FK. .N . ,
Q.E...FK..N.
.VET SKDTE..LE—
.AGNEVEL.NAADESK-- 
.AGNEIELGN.VGESK-- 
.RGNEVELGS.ADGSQ--
.SGSQIQS.EFELND--
.SGSQILSQEFEVELS--
-THIYEKK.PVTH
- . EIDALEMSS.D 
-NEIDNLDMSSKD
— . DTIA.ELTSEE 
• —  EKAATRMAP.G 
— EEKAADGMTP.G
F.H.RA..R.K.N..L.R....F....L.SQGDKALN.KAR.MAEGEEQEPQRLNLSRAG
Linker Domain
Mummichog Mdr 
Xenopus Mdr 
Human MDR1 
Hamster Pgpl 
Hamster Pgp2 
Human MDR2 
Hamster Pgp3
Mummichog Spgp SYRAS..ASIRQRSRSQLSNLIPESSVPIAGDLGPRAYSM.HED.YK.AAPA.E .E----
IESPLLRRKSTRG-
TH.N.V S.—
SR.S.I.KR..
SA.S.I..R... —■
FK..SV.-...C—  
WK.R.F.-H..Q-- 
WK.HIF.-N..K--
-SSFAASIGEKGDKKQEKEDEDKTEE
-NTIKSKVP.TE..EVDE.EKK K
-R.VRG.-QAQDR.LST..AL-----
-R.IRGP-HDQDR.LST..AL-----
-R.ICG.-QDQERRVSV..AQ-----
-KNLKN.QMCQKSLDV.TDGL-----
-K.LKS.RAHHHRLDVDADEL-----
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Mummichog Mdr 
Xenopus Mdr 
Human MDR1 
Hamster Pgpl 
Hamster Pgp2 
Human MDR2 
Hamster Pgp3 
Mummichog Spgp
________  TM7
DEDFPMVSIFKVLRLNASEWPYILVGLICATINGAIQPLFAVLFSKIITVFAEPDQ-TII
E.GP.P..F...MK..KP.
..SI.P..FWRIMK..LT. 
...V.PI.FWRI.K..S.. 
...V.L..FWGI.K..IT. 
EANV.P ..FL...K ..KT. 
.ANV.P ..FL...K ..KT. 
E.LVEPAPVARI.KY.LP.
. FV..V . . 
. FV. .VF. 
. FV . . IF. 
.LV..VL. 
.FV..TV. 
.FV..TV.
• M. . 
. I . . 
. IV. 
.V. . 
.IA. 
. IV.
.M.F.SLG.AV.
.T..A..II..R..G...G .VS— QM
GL. .A. .II G. . TRI . DPETK
.L..A.SII...VVG..TRNTDDETK 
CM..V.SIV..G..G..TRD.DPKTK 
GL..A .S .I ..E ..Al.GPG.D-AVK 
.L..AISIIL.EM.AI.GPG.D-AVK 
GVN.VYSL...Q .LAT..VT.P-EAQ
TM8
Mummichog Mdr RQRANFFSLMFVVIGVVCFFTMFLQGFCFGKSGEVLTLKLRLGAFKSMLRQDLGWFDSPK
Xenopus Mdr .SESSMY..L.LAL.G.S.I.F..
Human MDR1 ..NS.L...L.LAL.IIS.I.F.. ..T...A. . T ..KR. . YMV.R......VS... D . .
Hamster Pgpl .HDS.L...L.LIL..IS.I.F.. ..T ...A. . I ..KR. .YMV.... ....VS...N. .
Hamster Pgp2 Q.NC.L...F.L.M.MI..V.Y.F ..T...A. . I ..KR. .YMV.... . . . . IS . . . DHR
Human MDR2 Q.KC.I...I.LFL.IIS...F.. ..T...A. . T ..RR. .SM...A. ___ MS. . . DH.
Hamster Pgp3 Q . KC . L • • . V . LGL. . LS • • • F • • ..T...A. . 1 . • TR. •SM...A. ___ MS. . .DY.
Mummichog Spgp .REI.GICVF..IV..IS...QM. .YA . A . . . .L. • RR. .RIG..A. .G.EI... .DHR
TM9 TM1Q
NSVGALTTRLATDAAQVQGASGVRLATFAQNIANLGTGVILAFVYGWELTLLILAVVPVIMummichog Mdr 
Xenopus Mdr 
Human MDR1 
Hamster Pgpl 
Hamster Pgp2 
Human MDR2 
Hamster Pgp3 
Mummichog Spgp ..P........... S
. .T...........S .....T.T.
.TT........N  K
.TT........N. .G. .K
. .T........S. . .N.K. .MSS.
. .T. . .S............. T.T.
. .T. . .S......R ...... T.T.
LL...V.
I.S...VIT___
T.A...VIT___
GIT..V.
LI....
LI...T.
.AI.IS.I 
..I.IS.I
ISLI 
ISL. 
IS.I 
IS. I
• Q.
• Q.
• Q.
• Q.
• Q.
• Q.
. T .SQIGMIVNSLT.I .VAL.MS.YFSSNV.
L. .1. .1. 
L . . I . . I .
LVVIA.L.
L.S...F. 
..CFL.F.
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Mummichog Mdr ALAGAVQMKMLTGHAAEDKKELEKAGKIATEAIENIRTVASLTREPKFESLYEENLVVPY
Xenopus Mdr 
Human MDR1 
Hamster Pgpl 
Hamster Pgp2 
Human MDR2 
Hamster Pgp3 
Mummichog Spgp
.A. .L .E . . .FA...KK. . 
.I..V.E....S.Q.LK.. 
.I..V.E S.Q.LK..
I.S.MME..V.S.Q.LK.. 
.VS.I.E..L.A.N.KR.. 
.VS.I.E A.N.KR. .
. G. ,
.GS 
.VS 
.A. , 
A. .A.
D
S.GF.A F.KQ..QAM.S..QVSG
V L
LN
.V.
.V.
.V.
.V.
.V.
.V.
..R...AM..KS.EG. 
Q.Q...HM.AQS.Q.. 
..Q...NM.AQS.QI. 
..Q...NM.AQS.QI,
Q.R M.V.K.YG.
Q.R M. V.K.HE.
.I.G.GK.GS.VEK..AH.DS
TM11 TM12
Mummichog Mdr KNSQKKAHVYGFTFSFSQAMIYFAYAACFR-FGAWLIVEGRIDVEAVFLVISVVLFGAMA 
Xenopus Mdr R ..I ....LH.L .YGL...HHVLCLCWV.SVL..Y .V ...LMKLDE....S .AIVL....
Human MDR1 R..LR.. TF .F.A.V..
Hamster Pgpl 
Hamster Pgp2
R.AL... . . F. T . . .T. . .M. s . . . Y .VARELMTF.N.L F AIV
R.AL... , F T . . .T. , M S . . .Y .VAHQIMTF.N.M. .F.A.V... I
Human MDR2 R..VQ... I. .I .. . I . .. FM. .S. .G. ......Y ...N .HMRFRD.I ..F.AIV...V
Hamster Pgp3 R ..VQM.. T . .T .. . I . .. FM. . S ,, G ......Y ...N.HMRFRD.I. .F.AIV... V
Mummichog Spgp QAAL...N...ACY-LA.CV.FLTNG.S ..-..GY.VEQEGLHFSL..R...AIVTSGT
Mummichog Mdr VGEANSFAPN
Xenopus Mdr L.QTS. . . . D
Human MDR1 . . QVS . . . .D
Hamster Pgpl ..QVS. . . . D
Hamster Pgp2 A.N.S. . . .D
Human MDR2 L.H.S. . . . D
Hamster Pgp3 L.H.S. . . .D
Mummichog Spgp L • R • S •YT.D
193
Figure 22. Phenogram of the relationships among P-glycoprotien deduced amino acid 
sequences. Relationships derived from Neighbor-Joining analysis of the pairwise 
distances between sequences. Branch lengths are scaled to reflect distances along each 
branch.The computer program package PHYLIP was used to calculate the distance matrix 
and construct the phenogram (Felsenstein, 1993).
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